id	sid	tid	token	lemma	pos
dpc-4137	1	1	dermatology	dermatology	NOUN
dpc-4137	1	2	:	:	PUNCT
dpc-4137	1	3	practical	practical	ADJ
dpc-4137	1	4	and	and	CCONJ
dpc-4137	1	5	conceptual	conceptual	ADJ
dpc-4137	1	6	original	original	ADJ
dpc-4137	1	7	article	article	NOUN
dpc-4137	1	8	|	|	ADV
dpc-4137	1	9	dermatol	dermatol	ADJ
dpc-4137	1	10	pract	pract	NOUN
dpc-4137	1	11	concept	concept	NOUN
dpc-4137	1	12	.	.	PUNCT
dpc-4137	2	1	2024;14(3):e2024177	2024;14(3):e2024177	NUM
dpc-4137	2	2	1	1	NUM
dpc-4137	2	3	gasdermin	gasdermin	NOUN
dpc-4137	2	4	a	a	DET
dpc-4137	2	5	(	(	PUNCT
dpc-4137	2	6	gsdma	gsdma	NOUN
dpc-4137	2	7	)	)	PUNCT
dpc-4137	2	8	tissue	tissue	NOUN
dpc-4137	2	9	expression	expression	NOUN
dpc-4137	2	10	,	,	PUNCT
dpc-4137	2	11	serum	serum	NOUN
dpc-4137	2	12	and	and	CCONJ
dpc-4137	2	13	urinary	urinary	ADJ
dpc-4137	2	14	concentrations	concentration	NOUN
dpc-4137	2	15	with	with	ADP
dpc-4137	2	16	clinicopathologic	clinicopathologic	ADJ
dpc-4137	2	17	outcome	outcome	NOUN
dpc-4137	2	18	in	in	ADP
dpc-4137	2	19	psoriasis	psoriasis	NOUN
dpc-4137	2	20	julia	julia	PROPN
dpc-4137	2	21	nowowiejska1	nowowiejska1	PROPN
dpc-4137	2	22	,	,	PUNCT
dpc-4137	2	23	anna	anna	PROPN
dpc-4137	2	24	baran1	baran1	PROPN
dpc-4137	2	25	,	,	PUNCT
dpc-4137	2	26	anna	anna	PROPN
dpc-4137	2	27	pryczynicz2	pryczynicz2	PROPN
dpc-4137	2	28	,	,	PUNCT
dpc-4137	2	29	justyna	justyna	PROPN
dpc-4137	2	30	magdalena	magdalena	PROPN
dpc-4137	2	31	hermanowicz3	hermanowicz3	PROPN
dpc-4137	2	32	,	,	PUNCT
dpc-4137	2	33	beata	beata	VERB
dpc-4137	2	34	sieklucka3	sieklucka3	NOUN
dpc-4137	2	35	,	,	PUNCT
dpc-4137	2	36	dariusz	dariusz	PROPN
dpc-4137	2	37	pawlak3	pawlak3	NOUN
dpc-4137	2	38	,	,	PUNCT
dpc-4137	2	39	iwona	iwona	PROPN
dpc-4137	2	40	flisiak1	flisiak1	PROPN
dpc-4137	2	41	1	1	NUM
dpc-4137	2	42	department	department	NOUN
dpc-4137	2	43	of	of	ADP
dpc-4137	2	44	dermatology	dermatology	NOUN
dpc-4137	2	45	and	and	CCONJ
dpc-4137	2	46	venereology	venereology	NOUN
dpc-4137	2	47	,	,	PUNCT
dpc-4137	2	48	medical	medical	ADJ
dpc-4137	2	49	university	university	NOUN
dpc-4137	2	50	of	of	ADP
dpc-4137	2	51	bialystok	bialystok	ADJ
dpc-4137	2	52	,	,	PUNCT
dpc-4137	2	53	bialystok	bialystok	ADJ
dpc-4137	2	54	,	,	PUNCT
dpc-4137	2	55	poland	poland	PROPN
dpc-4137	2	56	2	2	NUM
dpc-4137	2	57	department	department	NOUN
dpc-4137	2	58	of	of	ADP
dpc-4137	2	59	general	general	ADJ
dpc-4137	2	60	pathomorphology	pathomorphology	NOUN
dpc-4137	2	61	,	,	PUNCT
dpc-4137	2	62	medical	medical	ADJ
dpc-4137	2	63	university	university	NOUN
dpc-4137	2	64	of	of	ADP
dpc-4137	2	65	bialystok	bialystok	ADJ
dpc-4137	2	66	,	,	PUNCT
dpc-4137	2	67	bialystok	bialystok	ADJ
dpc-4137	2	68	,	,	PUNCT
dpc-4137	2	69	poland	poland	PROPN
dpc-4137	2	70	3	3	NUM
dpc-4137	2	71	department	department	NOUN
dpc-4137	2	72	of	of	ADP
dpc-4137	2	73	pharmacodynamics	pharmacodynamic	NOUN
dpc-4137	2	74	,	,	PUNCT
dpc-4137	2	75	medical	medical	ADJ
dpc-4137	2	76	university	university	NOUN
dpc-4137	2	77	of	of	ADP
dpc-4137	2	78	bialystok	bialystok	ADJ
dpc-4137	2	79	,	,	PUNCT
dpc-4137	2	80	bialystok	bialystok	ADJ
dpc-4137	2	81	,	,	PUNCT
dpc-4137	2	82	poland	poland	PROPN
dpc-4137	2	83	key	key	ADJ
dpc-4137	2	84	words	word	NOUN
dpc-4137	2	85	:	:	PUNCT
dpc-4137	2	86	gasdermin	gasdermin	NOUN
dpc-4137	2	87	a	a	DET
dpc-4137	2	88	,	,	PUNCT
dpc-4137	2	89	gsdma	gsdma	NOUN
dpc-4137	2	90	,	,	PUNCT
dpc-4137	2	91	pyroptosis	pyroptosis	NOUN
dpc-4137	2	92	,	,	PUNCT
dpc-4137	2	93	psoriasis	psoriasis	NOUN
dpc-4137	2	94	,	,	PUNCT
dpc-4137	2	95	hyperkeratosis	hyperkeratosis	NOUN
dpc-4137	2	96	citation	citation	NOUN
dpc-4137	2	97	:	:	PUNCT
dpc-4137	2	98	nowowiejska	nowowiejska	PROPN
dpc-4137	2	99	j	j	PROPN
dpc-4137	2	100	,	,	PUNCT
dpc-4137	2	101	baran	baran	NOUN
dpc-4137	2	102	a	a	PRON
dpc-4137	2	103	,	,	PUNCT
dpc-4137	2	104	pryczynicz	pryczynicz	NOUN
dpc-4137	2	105	a	a	NOUN
dpc-4137	2	106	,	,	PUNCT
dpc-4137	2	107	et	et	PROPN
dpc-4137	2	108	al	al	PROPN
dpc-4137	2	109	.	.	PROPN
dpc-4137	3	1	gasdermin	gasdermin	PROPN
dpc-4137	3	2	a	a	DET
dpc-4137	3	3	(	(	PUNCT
dpc-4137	3	4	gsdma	gsdma	NOUN
dpc-4137	3	5	)	)	PUNCT
dpc-4137	3	6	tissue	tissue	NOUN
dpc-4137	3	7	expression	expression	NOUN
dpc-4137	3	8	,	,	PUNCT
dpc-4137	3	9	serum	serum	NOUN
dpc-4137	3	10	and	and	CCONJ
dpc-4137	3	11	urinary	urinary	ADJ
dpc-4137	3	12	concentrations	concentration	NOUN
dpc-4137	3	13	with	with	ADP
dpc-4137	3	14	clinicopathologic	clinicopathologic	ADJ
dpc-4137	3	15	outcome	outcome	NOUN
dpc-4137	3	16	in	in	ADP
dpc-4137	3	17	psoriasis	psoriasis	NOUN
dpc-4137	3	18	.	.	PUNCT
dpc-4137	4	1	dermatol	dermatol	NOUN
dpc-4137	4	2	pract	pract	PROPN
dpc-4137	4	3	concept	concept	NOUN
dpc-4137	4	4	.	.	PUNCT
dpc-4137	5	1	2024;14(3):e2024177	2024;14(3):e2024177	NUM
dpc-4137	5	2	.	.	PUNCT
dpc-4137	5	3	doi	doi	PROPN
dpc-4137	5	4	:	:	PUNCT
dpc-4137	5	5	https://doi.org/10.5826/dpc.1403a177	https://doi.org/10.5826/dpc.1403a177	PROPN
dpc-4137	5	6	accepted	accept	VERB
dpc-4137	5	7	:	:	PUNCT
dpc-4137	5	8	april	april	PROPN
dpc-4137	5	9	3	3	NUM
dpc-4137	5	10	,	,	PUNCT
dpc-4137	5	11	2024	2024	NUM
dpc-4137	5	12	;	;	PUNCT
dpc-4137	5	13	published	publish	VERB
dpc-4137	5	14	:	:	PUNCT
dpc-4137	6	1	july	july	PROPN
dpc-4137	6	2	2024	2024	NUM
dpc-4137	6	3	copyright	copyright	NOUN
dpc-4137	6	4	:	:	PUNCT
dpc-4137	6	5	©	©	PROPN
dpc-4137	6	6	2024	2024	NUM
dpc-4137	6	7	nowowiejska	nowowiejska	PROPN
dpc-4137	6	8	et	et	PROPN
dpc-4137	6	9	al	al	PROPN
dpc-4137	6	10	.	.	PUNCT
dpc-4137	7	1	this	this	PRON
dpc-4137	7	2	is	be	AUX
dpc-4137	7	3	an	an	DET
dpc-4137	7	4	open	open	ADJ
dpc-4137	7	5	-	-	PUNCT
dpc-4137	7	6	access	access	NOUN
dpc-4137	7	7	article	article	NOUN
dpc-4137	7	8	distributed	distribute	VERB
dpc-4137	7	9	under	under	ADP
dpc-4137	7	10	the	the	DET
dpc-4137	7	11	terms	term	NOUN
dpc-4137	7	12	of	of	ADP
dpc-4137	7	13	the	the	DET
dpc-4137	7	14	creative	creative	ADJ
dpc-4137	7	15	commons	common	NOUN
dpc-4137	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4137	7	17	license	license	NOUN
dpc-4137	7	18	(	(	PUNCT
dpc-4137	7	19	by	by	ADP
dpc-4137	7	20	-	-	PUNCT
dpc-4137	7	21	nc-4.0	nc-4.0	NOUN
dpc-4137	7	22	)	)	PUNCT
dpc-4137	7	23	,	,	PUNCT
dpc-4137	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4137	7	25	,	,	PUNCT
dpc-4137	7	26	which	which	PRON
dpc-4137	7	27	permits	permit	VERB
dpc-4137	7	28	unrestricted	unrestricted	ADJ
dpc-4137	7	29	noncommercial	noncommercial	ADJ
dpc-4137	7	30	use	use	NOUN
dpc-4137	7	31	,	,	PUNCT
dpc-4137	7	32	distribution	distribution	NOUN
dpc-4137	7	33	,	,	PUNCT
dpc-4137	7	34	and	and	CCONJ
dpc-4137	7	35	reproduction	reproduction	NOUN
dpc-4137	7	36	in	in	ADP
dpc-4137	7	37	any	any	DET
dpc-4137	7	38	medium	medium	NOUN
dpc-4137	7	39	,	,	PUNCT
dpc-4137	7	40	provided	provide	VERB
dpc-4137	7	41	the	the	DET
dpc-4137	7	42	original	original	ADJ
dpc-4137	7	43	authors	author	NOUN
dpc-4137	7	44	and	and	CCONJ
dpc-4137	7	45	source	source	NOUN
dpc-4137	7	46	are	be	AUX
dpc-4137	7	47	credited	credit	VERB
dpc-4137	7	48	.	.	PUNCT
dpc-4137	8	1	funding	funding	NOUN
dpc-4137	8	2	:	:	PUNCT
dpc-4137	8	3	the	the	DET
dpc-4137	8	4	part	part	NOUN
dpc-4137	8	5	of	of	ADP
dpc-4137	8	6	the	the	DET
dpc-4137	8	7	study	study	NOUN
dpc-4137	8	8	involving	involve	VERB
dpc-4137	8	9	the	the	DET
dpc-4137	8	10	assessment	assessment	NOUN
dpc-4137	8	11	of	of	ADP
dpc-4137	8	12	serum	serum	NOUN
dpc-4137	8	13	and	and	CCONJ
dpc-4137	8	14	urinary	urinary	ADJ
dpc-4137	8	15	gsdma	gsdma	NOUN
dpc-4137	8	16	was	be	AUX
dpc-4137	8	17	funded	fund	VERB
dpc-4137	8	18	by	by	ADP
dpc-4137	8	19	the	the	DET
dpc-4137	8	20	national	national	PROPN
dpc-4137	8	21	science	science	PROPN
dpc-4137	8	22	center	center	PROPN
dpc-4137	8	23	,	,	PUNCT
dpc-4137	8	24	poland	poland	PROPN
dpc-4137	8	25	,	,	PUNCT
dpc-4137	8	26	no	no	DET
dpc-4137	8	27	ncn/1	ncn/1	PROPN
dpc-4137	8	28	/	/	SYM
dpc-4137	8	29	mi/22/001/1149	mi/22/001/1149	PROPN
dpc-4137	8	30	.	.	PUNCT
dpc-4137	9	1	the	the	DET
dpc-4137	9	2	part	part	NOUN
dpc-4137	9	3	of	of	ADP
dpc-4137	9	4	the	the	DET
dpc-4137	9	5	study	study	NOUN
dpc-4137	9	6	involving	involve	VERB
dpc-4137	9	7	the	the	DET
dpc-4137	9	8	assessment	assessment	NOUN
dpc-4137	9	9	of	of	ADP
dpc-4137	9	10	tissue	tissue	NOUN
dpc-4137	9	11	expression	expression	NOUN
dpc-4137	9	12	of	of	ADP
dpc-4137	9	13	gsdma	gsdma	NOUN
dpc-4137	9	14	was	be	AUX
dpc-4137	9	15	funded	fund	VERB
dpc-4137	9	16	by	by	ADP
dpc-4137	9	17	the	the	DET
dpc-4137	9	18	medical	medical	ADJ
dpc-4137	9	19	university	university	PROPN
dpc-4137	9	20	of	of	ADP
dpc-4137	9	21	bialystok	bialystok	PROPN
dpc-4137	9	22	,	,	PUNCT
dpc-4137	9	23	poland	poland	PROPN
dpc-4137	9	24	,	,	PUNCT
dpc-4137	9	25	no	no	DET
dpc-4137	9	26	b.sub.23.358	b.sub.23.358	NOUN
dpc-4137	9	27	.	.	PUNCT
dpc-4137	10	1	competing	compete	VERB
dpc-4137	10	2	interests	interest	NOUN
dpc-4137	10	3	:	:	PUNCT
dpc-4137	10	4	none	none	NOUN
dpc-4137	10	5	.	.	PUNCT
dpc-4137	11	1	authorship	authorship	NOUN
dpc-4137	11	2	:	:	PUNCT
dpc-4137	11	3	all	all	DET
dpc-4137	11	4	authors	author	NOUN
dpc-4137	11	5	have	have	AUX
dpc-4137	11	6	contributed	contribute	VERB
dpc-4137	11	7	significantly	significantly	ADV
dpc-4137	11	8	to	to	ADP
dpc-4137	11	9	this	this	DET
dpc-4137	11	10	publication	publication	NOUN
dpc-4137	11	11	.	.	PUNCT
dpc-4137	12	1	corresponding	correspond	VERB
dpc-4137	12	2	author	author	NOUN
dpc-4137	12	3	:	:	PUNCT
dpc-4137	12	4	julia	julia	PROPN
dpc-4137	12	5	nowowiejska	nowowiejska	PROPN
dpc-4137	12	6	md	md	PROPN
dpc-4137	12	7	,	,	PUNCT
dpc-4137	12	8	phd	phd	PROPN
dpc-4137	12	9	,	,	PUNCT
dpc-4137	12	10	department	department	NOUN
dpc-4137	12	11	of	of	ADP
dpc-4137	12	12	dermatology	dermatology	NOUN
dpc-4137	12	13	and	and	CCONJ
dpc-4137	12	14	venereology	venereology	NOUN
dpc-4137	12	15	,	,	PUNCT
dpc-4137	12	16	medical	medical	ADJ
dpc-4137	12	17	university	university	NOUN
dpc-4137	12	18	of	of	ADP
dpc-4137	12	19	bialystok	bialystok	ADJ
dpc-4137	12	20	,	,	PUNCT
dpc-4137	12	21	bialystok	bialystok	ADJ
dpc-4137	12	22	,	,	PUNCT
dpc-4137	12	23	poland	poland	PROPN
dpc-4137	12	24	.	.	PUNCT
dpc-4137	13	1	e	e	X
dpc-4137	13	2	-	-	NOUN
dpc-4137	13	3	mail	mail	NOUN
dpc-4137	13	4	:	:	PUNCT
dpc-4137	13	5	julia.nowowiejska@umb.edu.pl	julia.nowowiejska@umb.edu.pl	PRON
dpc-4137	13	6	introduction	introduction	NOUN
dpc-4137	13	7	:	:	PUNCT
dpc-4137	13	8	psoriasis	psoriasis	NOUN
dpc-4137	13	9	is	be	AUX
dpc-4137	13	10	a	a	DET
dpc-4137	13	11	frequent	frequent	ADJ
dpc-4137	13	12	and	and	CCONJ
dpc-4137	13	13	incurable	incurable	ADJ
dpc-4137	13	14	skin	skin	NOUN
dpc-4137	13	15	disease	disease	NOUN
dpc-4137	13	16	that	that	PRON
dpc-4137	13	17	is	be	AUX
dpc-4137	13	18	an	an	DET
dpc-4137	13	19	important	important	ADJ
dpc-4137	13	20	issue	issue	NOUN
dpc-4137	13	21	in	in	ADP
dpc-4137	13	22	contemporary	contemporary	ADJ
dpc-4137	13	23	dermatology	dermatology	NOUN
dpc-4137	13	24	,	,	PUNCT
dpc-4137	13	25	although	although	SCONJ
dpc-4137	13	26	its	its	PRON
dpc-4137	13	27	pathogenesis	pathogenesis	NOUN
dpc-4137	13	28	is	be	AUX
dpc-4137	13	29	still	still	ADV
dpc-4137	13	30	uncertain	uncertain	ADJ
dpc-4137	13	31	.	.	PUNCT
dpc-4137	14	1	gasdermin	gasdermin	VERB
dpc-4137	14	2	a	a	DET
dpc-4137	14	3	(	(	PUNCT
dpc-4137	14	4	gsdma	gsdma	NOUN
dpc-4137	14	5	)	)	PUNCT
dpc-4137	14	6	is	be	AUX
dpc-4137	14	7	a	a	DET
dpc-4137	14	8	member	member	NOUN
dpc-4137	14	9	of	of	ADP
dpc-4137	14	10	the	the	DET
dpc-4137	14	11	gasdermin	gasdermin	ADJ
dpc-4137	14	12	protein	protein	NOUN
dpc-4137	14	13	family	family	NOUN
dpc-4137	14	14	which	which	PRON
dpc-4137	14	15	are	be	AUX
dpc-4137	14	16	able	able	ADJ
dpc-4137	14	17	to	to	PART
dpc-4137	14	18	cause	cause	VERB
dpc-4137	14	19	pore	pore	ADJ
dpc-4137	14	20	formation	formation	NOUN
dpc-4137	14	21	in	in	ADP
dpc-4137	14	22	cellular	cellular	ADJ
dpc-4137	14	23	membranes	membrane	NOUN
dpc-4137	14	24	leading	lead	VERB
dpc-4137	14	25	to	to	ADP
dpc-4137	14	26	cell	cell	NOUN
dpc-4137	14	27	death	death	NOUN
dpc-4137	14	28	called	call	VERB
dpc-4137	14	29	pyroptosis	pyroptosis	NOUN
dpc-4137	14	30	.	.	PUNCT
dpc-4137	15	1	objective	objective	NOUN
dpc-4137	15	2	:	:	PUNCT
dpc-4137	15	3	our	our	PRON
dpc-4137	15	4	aim	aim	NOUN
dpc-4137	15	5	was	be	AUX
dpc-4137	15	6	to	to	PART
dpc-4137	15	7	investigate	investigate	VERB
dpc-4137	15	8	the	the	DET
dpc-4137	15	9	role	role	NOUN
dpc-4137	15	10	of	of	ADP
dpc-4137	15	11	gsdma	gsdma	NOUN
dpc-4137	15	12	in	in	ADP
dpc-4137	15	13	psoriatic	psoriatic	ADJ
dpc-4137	15	14	patients	patient	NOUN
dpc-4137	15	15	.	.	PUNCT
dpc-4137	16	1	method	method	NOUN
dpc-4137	16	2	:	:	PUNCT
dpc-4137	16	3	the	the	DET
dpc-4137	16	4	study	study	NOUN
dpc-4137	16	5	enrolled	enrol	VERB
dpc-4137	16	6	60	60	NUM
dpc-4137	16	7	patients	patient	NOUN
dpc-4137	16	8	with	with	ADP
dpc-4137	16	9	active	active	ADJ
dpc-4137	16	10	plaque	plaque	NOUN
dpc-4137	16	11	-	-	PUNCT
dpc-4137	16	12	type	type	NOUN
dpc-4137	16	13	psoriasis	psoriasis	NOUN
dpc-4137	16	14	and	and	CCONJ
dpc-4137	16	15	30	30	NUM
dpc-4137	16	16	sexand	sexand	NOUN
dpc-4137	16	17	age	age	NOUN
dpc-4137	16	18	-	-	PUNCT
dpc-4137	16	19	matched	match	VERB
dpc-4137	16	20	volunteers	volunteer	NOUN
dpc-4137	16	21	without	without	ADP
dpc-4137	16	22	dermatoses	dermatosis	NOUN
dpc-4137	16	23	.	.	PUNCT
dpc-4137	17	1	gsdma	gsdma	NOUN
dpc-4137	17	2	concentration	concentration	NOUN
dpc-4137	17	3	was	be	AUX
dpc-4137	17	4	assessed	assess	VERB
dpc-4137	17	5	in	in	ADP
dpc-4137	17	6	serum	serum	NOUN
dpc-4137	17	7	and	and	CCONJ
dpc-4137	17	8	urine	urine	NOUN
dpc-4137	17	9	samples	sample	NOUN
dpc-4137	17	10	of	of	ADP
dpc-4137	17	11	all	all	DET
dpc-4137	17	12	participants	participant	NOUN
dpc-4137	17	13	using	use	VERB
dpc-4137	17	14	elisa	elisa	NOUN
dpc-4137	17	15	.	.	PUNCT
dpc-4137	18	1	gsdma	gsdma	NOUN
dpc-4137	18	2	tissue	tissue	NOUN
dpc-4137	18	3	expression	expression	NOUN
dpc-4137	18	4	was	be	AUX
dpc-4137	18	5	assessed	assess	VERB
dpc-4137	18	6	by	by	ADP
dpc-4137	18	7	immunohistochemistry	immunohistochemistry	NOUN
dpc-4137	18	8	.	.	PUNCT
dpc-4137	19	1	results	result	NOUN
dpc-4137	19	2	:	:	PUNCT
dpc-4137	19	3	gsdma	gsdma	NOUN
dpc-4137	19	4	serum	serum	NOUN
dpc-4137	19	5	concentration	concentration	NOUN
dpc-4137	19	6	was	be	AUX
dpc-4137	19	7	significantly	significantly	ADV
dpc-4137	19	8	higher	high	ADJ
dpc-4137	19	9	in	in	ADP
dpc-4137	19	10	patients	patient	NOUN
dpc-4137	19	11	compared	compare	VERB
dpc-4137	19	12	to	to	ADP
dpc-4137	19	13	controls	control	NOUN
dpc-4137	19	14	,	,	PUNCT
dpc-4137	19	15	whereas	whereas	SCONJ
dpc-4137	19	16	urinary	urinary	ADJ
dpc-4137	19	17	gsdma	gsdma	PROPN
dpc-4137	19	18	/	/	SYM
dpc-4137	19	19	creatinine	creatinine	NOUN
dpc-4137	19	20	ratio	ratio	NOUN
dpc-4137	19	21	was	be	AUX
dpc-4137	19	22	insignificantly	insignificantly	ADV
dpc-4137	19	23	lower	low	ADJ
dpc-4137	19	24	.	.	PUNCT
dpc-4137	20	1	gsdma	gsdma	NOUN
dpc-4137	20	2	tissue	tissue	NOUN
dpc-4137	20	3	expression	expression	NOUN
dpc-4137	20	4	was	be	AUX
dpc-4137	20	5	more	more	ADV
dpc-4137	20	6	prominent	prominent	ADJ
dpc-4137	20	7	in	in	ADP
dpc-4137	20	8	psoriatic	psoriatic	ADJ
dpc-4137	20	9	plaque	plaque	NOUN
dpc-4137	20	10	compared	compare	VERB
dpc-4137	20	11	to	to	ADP
dpc-4137	20	12	non	non	ADJ
dpc-4137	20	13	-	-	ADJ
dpc-4137	20	14	lesional	lesional	ADJ
dpc-4137	20	15	patients	patient	NOUN
dpc-4137	20	16	’	'	PUNCT
dpc-4137	20	17	skin	skin	NOUN
dpc-4137	20	18	and	and	CCONJ
dpc-4137	20	19	healthy	healthy	ADJ
dpc-4137	20	20	skin	skin	NOUN
dpc-4137	20	21	of	of	ADP
dpc-4137	20	22	subjects	subject	NOUN
dpc-4137	20	23	without	without	ADP
dpc-4137	20	24	dermatoses	dermatosis	NOUN
dpc-4137	20	25	.	.	PUNCT
dpc-4137	21	1	there	there	PRON
dpc-4137	21	2	was	be	VERB
dpc-4137	21	3	a	a	DET
dpc-4137	21	4	strong	strong	ADJ
dpc-4137	21	5	negative	negative	ADJ
dpc-4137	21	6	correlation	correlation	NOUN
dpc-4137	21	7	between	between	ADP
dpc-4137	21	8	gsdma	gsdma	NOUN
dpc-4137	21	9	serum	serum	NOUN
dpc-4137	21	10	concentration	concentration	NOUN
dpc-4137	21	11	and	and	CCONJ
dpc-4137	21	12	alt	alt	VERB
dpc-4137	21	13	activity	activity	NOUN
dpc-4137	21	14	.	.	PUNCT
dpc-4137	22	1	gsdma	gsdma	NOUN
dpc-4137	22	2	did	do	AUX
dpc-4137	22	3	not	not	PART
dpc-4137	22	4	correlate	correlate	VERB
dpc-4137	22	5	with	with	ADP
dpc-4137	22	6	pasi	pasi	NOUN
dpc-4137	22	7	or	or	CCONJ
dpc-4137	22	8	psoriasis	psoriasis	NOUN
dpc-4137	22	9	duration	duration	NOUN
dpc-4137	22	10	.	.	PUNCT
dpc-4137	23	1	abstract	abstract	ADJ
dpc-4137	23	2	2	2	NUM
dpc-4137	23	3	original	original	ADJ
dpc-4137	23	4	article	article	NOUN
dpc-4137	23	5	|	|	ADV
dpc-4137	23	6	dermatol	dermatol	ADJ
dpc-4137	23	7	pract	pract	NOUN
dpc-4137	23	8	concept	concept	NOUN
dpc-4137	23	9	.	.	PUNCT
dpc-4137	24	1	2024;14(3):e2024177	2024;14(3):e2024177	NUM
dpc-4137	24	2	introduction	introduction	NOUN
dpc-4137	24	3	psoriasis	psoriasis	NOUN
dpc-4137	24	4	is	be	AUX
dpc-4137	24	5	a	a	DET
dpc-4137	24	6	common	common	ADJ
dpc-4137	24	7	chronic	chronic	ADJ
dpc-4137	24	8	dermatosis	dermatosis	NOUN
dpc-4137	24	9	that	that	PRON
dpc-4137	24	10	occurs	occur	VERB
dpc-4137	24	11	with	with	ADP
dpc-4137	24	12	an	an	DET
dpc-4137	24	13	average	average	ADJ
dpc-4137	24	14	frequency	frequency	NOUN
dpc-4137	24	15	of	of	ADP
dpc-4137	24	16	2	2	NUM
dpc-4137	24	17	%	%	NOUN
dpc-4137	24	18	worldwide	worldwide	ADV
dpc-4137	24	19	[	[	X
dpc-4137	24	20	1	1	NUM
dpc-4137	24	21	]	]	PUNCT
dpc-4137	24	22	.	.	PUNCT
dpc-4137	25	1	although	although	SCONJ
dpc-4137	25	2	this	this	DET
dpc-4137	25	3	disease	disease	NOUN
dpc-4137	25	4	is	be	AUX
dpc-4137	25	5	a	a	DET
dpc-4137	25	6	constant	constant	ADJ
dpc-4137	25	7	subject	subject	NOUN
dpc-4137	25	8	of	of	ADP
dpc-4137	25	9	scientists	scientist	NOUN
dpc-4137	25	10	’	'	PUNCT
dpc-4137	25	11	investigations	investigation	NOUN
dpc-4137	25	12	,	,	PUNCT
dpc-4137	25	13	its	its	PRON
dpc-4137	25	14	pathogenesis	pathogenesis	NOUN
dpc-4137	25	15	is	be	AUX
dpc-4137	25	16	still	still	ADV
dpc-4137	25	17	not	not	PART
dpc-4137	25	18	fully	fully	ADV
dpc-4137	25	19	understood	understand	VERB
dpc-4137	25	20	.	.	PUNCT
dpc-4137	26	1	it	it	PRON
dpc-4137	26	2	encompasses	encompass	VERB
dpc-4137	26	3	genetic	genetic	ADJ
dpc-4137	26	4	predisposition	predisposition	NOUN
dpc-4137	26	5	and	and	CCONJ
dpc-4137	26	6	complex	complex	ADJ
dpc-4137	26	7	immunological	immunological	ADJ
dpc-4137	26	8	disturbances	disturbance	NOUN
dpc-4137	26	9	,	,	PUNCT
dpc-4137	26	10	additionally	additionally	ADV
dpc-4137	26	11	exacerbated	exacerbate	VERB
dpc-4137	26	12	by	by	ADP
dpc-4137	26	13	external	external	ADJ
dpc-4137	26	14	stimuli	stimulus	NOUN
dpc-4137	26	15	[	[	X
dpc-4137	26	16	2,3	2,3	NUM
dpc-4137	26	17	]	]	PUNCT
dpc-4137	26	18	.	.	PUNCT
dpc-4137	27	1	the	the	DET
dpc-4137	27	2	microscopic	microscopic	ADJ
dpc-4137	27	3	picture	picture	NOUN
dpc-4137	27	4	of	of	ADP
dpc-4137	27	5	psoriasis	psoriasis	NOUN
dpc-4137	27	6	consists	consist	VERB
dpc-4137	27	7	of	of	ADP
dpc-4137	27	8	the	the	DET
dpc-4137	27	9	areas	area	NOUN
dpc-4137	27	10	of	of	ADP
dpc-4137	27	11	acanthosis	acanthosis	NOUN
dpc-4137	27	12	(	(	PUNCT
dpc-4137	27	13	epidermal	epidermal	ADJ
dpc-4137	27	14	hyperplasia	hyperplasia	NOUN
dpc-4137	27	15	)	)	PUNCT
dpc-4137	27	16	and	and	CCONJ
dpc-4137	27	17	parakeratosis	parakeratosis	NOUN
dpc-4137	27	18	in	in	ADP
dpc-4137	27	19	the	the	DET
dpc-4137	27	20	stratum	stratum	NOUN
dpc-4137	27	21	corneum	corneum	VERB
dpc-4137	27	22	with	with	ADP
dpc-4137	27	23	mounds	mound	NOUN
dpc-4137	27	24	of	of	ADP
dpc-4137	27	25	neutrophils	neutrophil	NOUN
dpc-4137	27	26	(	(	PUNCT
dpc-4137	27	27	munro	munro	PROPN
dpc-4137	27	28	’s	’s	PART
dpc-4137	27	29	microabscesses	microabscesse	NOUN
dpc-4137	27	30	)	)	PUNCT
dpc-4137	27	31	,	,	PUNCT
dpc-4137	27	32	inflammatory	inflammatory	ADJ
dpc-4137	27	33	infiltrates	infiltrate	NOUN
dpc-4137	27	34	in	in	ADP
dpc-4137	27	35	the	the	DET
dpc-4137	27	36	dermis	dermis	NOUN
dpc-4137	27	37	,	,	PUNCT
dpc-4137	27	38	and	and	CCONJ
dpc-4137	27	39	dilated	dilated	ADJ
dpc-4137	27	40	vessels	vessel	NOUN
dpc-4137	27	41	in	in	ADP
dpc-4137	27	42	dermal	dermal	ADJ
dpc-4137	27	43	papillae	papillae	NOUN
dpc-4137	27	44	[	[	X
dpc-4137	27	45	4	4	NUM
dpc-4137	27	46	]	]	PUNCT
dpc-4137	27	47	.	.	PUNCT
dpc-4137	28	1	clinically	clinically	ADV
dpc-4137	28	2	,	,	PUNCT
dpc-4137	28	3	such	such	ADJ
dpc-4137	28	4	abnormalities	abnormality	NOUN
dpc-4137	28	5	translate	translate	VERB
dpc-4137	28	6	into	into	ADP
dpc-4137	28	7	erythematous	erythematous	ADJ
dpc-4137	28	8	-	-	PUNCT
dpc-4137	28	9	scaly	scaly	NOUN
dpc-4137	28	10	lesions	lesion	NOUN
dpc-4137	28	11	called	call	VERB
dpc-4137	28	12	psoriatic	psoriatic	ADJ
dpc-4137	28	13	plaques	plaque	NOUN
dpc-4137	28	14	[	[	X
dpc-4137	28	15	4	4	NUM
dpc-4137	28	16	]	]	PUNCT
dpc-4137	28	17	.	.	PUNCT
dpc-4137	29	1	due	due	ADP
dpc-4137	29	2	to	to	ADP
dpc-4137	29	3	the	the	DET
dpc-4137	29	4	clinical	clinical	ADJ
dpc-4137	29	5	appearance	appearance	NOUN
dpc-4137	29	6	of	of	ADP
dpc-4137	29	7	the	the	DET
dpc-4137	29	8	lesions	lesion	NOUN
dpc-4137	29	9	and	and	CCONJ
dpc-4137	29	10	sometimes	sometimes	ADV
dpc-4137	29	11	their	their	PRON
dpc-4137	29	12	significant	significant	ADJ
dpc-4137	29	13	exacerbation	exacerbation	NOUN
dpc-4137	29	14	and	and	CCONJ
dpc-4137	29	15	unfavorable	unfavorable	ADJ
dpc-4137	29	16	localization	localization	NOUN
dpc-4137	29	17	,	,	PUNCT
dpc-4137	29	18	psoriasis	psoriasis	NOUN
dpc-4137	29	19	may	may	AUX
dpc-4137	29	20	impair	impair	VERB
dpc-4137	29	21	the	the	DET
dpc-4137	29	22	quality	quality	NOUN
dpc-4137	29	23	of	of	ADP
dpc-4137	29	24	patients	patient	NOUN
dpc-4137	29	25	’	'	PUNCT
dpc-4137	29	26	lives	life	NOUN
dpc-4137	29	27	and	and	CCONJ
dpc-4137	29	28	ability	ability	NOUN
dpc-4137	29	29	to	to	PART
dpc-4137	29	30	work	work	VERB
dpc-4137	29	31	[	[	X
dpc-4137	29	32	5,6	5,6	NUM
dpc-4137	29	33	]	]	X
dpc-4137	29	34	.	.	PUNCT
dpc-4137	30	1	nowadays	nowadays	ADV
dpc-4137	30	2	,	,	PUNCT
dpc-4137	30	3	there	there	PRON
dpc-4137	30	4	is	be	VERB
dpc-4137	30	5	a	a	DET
dpc-4137	30	6	wide	wide	ADJ
dpc-4137	30	7	range	range	NOUN
dpc-4137	30	8	of	of	ADP
dpc-4137	30	9	antipsoriatic	antipsoriatic	ADJ
dpc-4137	30	10	therapies	therapy	NOUN
dpc-4137	30	11	,	,	PUNCT
dpc-4137	30	12	both	both	CCONJ
dpc-4137	30	13	topical	topical	ADJ
dpc-4137	30	14	and	and	CCONJ
dpc-4137	30	15	systemic	systemic	ADJ
dpc-4137	30	16	agents	agent	NOUN
dpc-4137	30	17	,	,	PUNCT
dpc-4137	30	18	including	include	VERB
dpc-4137	30	19	biological	biological	ADJ
dpc-4137	30	20	agents	agent	NOUN
dpc-4137	30	21	,	,	PUNCT
dpc-4137	30	22	yet	yet	CCONJ
dpc-4137	30	23	the	the	DET
dpc-4137	30	24	disease	disease	NOUN
dpc-4137	30	25	is	be	AUX
dpc-4137	30	26	not	not	PART
dpc-4137	30	27	permanently	permanently	ADV
dpc-4137	30	28	curable	curable	ADJ
dpc-4137	30	29	[	[	X
dpc-4137	30	30	7,8	7,8	NUM
dpc-4137	30	31	]	]	PUNCT
dpc-4137	30	32	.	.	PUNCT
dpc-4137	31	1	that	that	PRON
dpc-4137	31	2	makes	make	VERB
dpc-4137	31	3	it	it	PRON
dpc-4137	31	4	an	an	DET
dpc-4137	31	5	important	important	ADJ
dpc-4137	31	6	problem	problem	NOUN
dpc-4137	31	7	of	of	ADP
dpc-4137	31	8	contemporary	contemporary	ADJ
dpc-4137	31	9	dermatology	dermatology	NOUN
dpc-4137	31	10	.	.	PUNCT
dpc-4137	32	1	gasdermins	gasdermin	NOUN
dpc-4137	32	2	are	be	AUX
dpc-4137	32	3	a	a	DET
dpc-4137	32	4	group	group	NOUN
dpc-4137	32	5	of	of	ADP
dpc-4137	32	6	proteins	protein	NOUN
dpc-4137	32	7	that	that	PRON
dpc-4137	32	8	are	be	AUX
dpc-4137	32	9	made	make	VERB
dpc-4137	32	10	up	up	ADP
dpc-4137	32	11	of	of	ADP
dpc-4137	32	12	similar	similar	ADJ
dpc-4137	32	13	two	two	NUM
dpc-4137	32	14	-	-	PUNCT
dpc-4137	32	15	domain	domain	NOUN
dpc-4137	32	16	molecular	molecular	ADJ
dpc-4137	32	17	structure	structure	NOUN
dpc-4137	32	18	,	,	PUNCT
dpc-4137	32	19	namely	namely	ADV
dpc-4137	32	20	globular	globular	ADJ
dpc-4137	32	21	nand	nand	NOUN
dpc-4137	32	22	c	c	NOUN
dpc-4137	32	23	-	-	PUNCT
dpc-4137	32	24	terminal	terminal	ADJ
dpc-4137	32	25	domains	domain	NOUN
dpc-4137	32	26	separated	separate	VERB
dpc-4137	32	27	by	by	ADP
dpc-4137	32	28	a	a	DET
dpc-4137	32	29	flexible	flexible	ADJ
dpc-4137	32	30	linker	linker	NOUN
dpc-4137	32	31	region	region	NOUN
dpc-4137	33	1	[	[	X
dpc-4137	33	2	9	9	NUM
dpc-4137	33	3	]	]	PUNCT
dpc-4137	33	4	.	.	PUNCT
dpc-4137	34	1	their	their	PRON
dpc-4137	34	2	properties	property	NOUN
dpc-4137	34	3	and	and	CCONJ
dpc-4137	34	4	functions	function	NOUN
dpc-4137	34	5	are	be	AUX
dpc-4137	34	6	still	still	ADV
dpc-4137	34	7	being	be	AUX
dpc-4137	34	8	discovered	discover	VERB
dpc-4137	34	9	,	,	PUNCT
dpc-4137	34	10	but	but	CCONJ
dpc-4137	34	11	available	available	ADJ
dpc-4137	34	12	data	datum	NOUN
dpc-4137	34	13	point	point	NOUN
dpc-4137	34	14	to	to	ADP
dpc-4137	34	15	their	their	PRON
dpc-4137	34	16	pleiotropic	pleiotropic	ADJ
dpc-4137	34	17	impact	impact	NOUN
dpc-4137	34	18	[	[	X
dpc-4137	34	19	10	10	NUM
dpc-4137	34	20	]	]	PUNCT
dpc-4137	34	21	.	.	PUNCT
dpc-4137	35	1	they	they	PRON
dpc-4137	35	2	have	have	AUX
dpc-4137	35	3	been	be	AUX
dpc-4137	35	4	associated	associate	VERB
dpc-4137	35	5	with	with	ADP
dpc-4137	35	6	cell	cell	NOUN
dpc-4137	35	7	proliferation	proliferation	NOUN
dpc-4137	35	8	and	and	CCONJ
dpc-4137	35	9	differentiation	differentiation	NOUN
dpc-4137	35	10	.	.	PUNCT
dpc-4137	36	1	they	they	PRON
dpc-4137	36	2	are	be	AUX
dpc-4137	36	3	engaged	engage	VERB
dpc-4137	36	4	in	in	ADP
dpc-4137	36	5	immune	immune	ADJ
dpc-4137	36	6	response	response	NOUN
dpc-4137	36	7	,	,	PUNCT
dpc-4137	36	8	inflammation	inflammation	NOUN
dpc-4137	36	9	,	,	PUNCT
dpc-4137	36	10	and	and	CCONJ
dpc-4137	36	11	tumorigenesis	tumorigenesis	NOUN
dpc-4137	36	12	[	[	X
dpc-4137	36	13	11	11	NUM
dpc-4137	36	14	]	]	PUNCT
dpc-4137	36	15	.	.	PUNCT
dpc-4137	37	1	most	most	ADV
dpc-4137	37	2	importantly	importantly	ADV
dpc-4137	37	3	,	,	PUNCT
dpc-4137	37	4	they	they	PRON
dpc-4137	37	5	play	play	VERB
dpc-4137	37	6	a	a	DET
dpc-4137	37	7	role	role	NOUN
dpc-4137	37	8	in	in	ADP
dpc-4137	37	9	cell	cell	NOUN
dpc-4137	37	10	death	death	NOUN
dpc-4137	37	11	via	via	ADP
dpc-4137	37	12	different	different	ADJ
dpc-4137	37	13	pathways	pathway	NOUN
dpc-4137	37	14	.	.	PUNCT
dpc-4137	38	1	their	their	PRON
dpc-4137	38	2	unique	unique	ADJ
dpc-4137	38	3	chemical	chemical	NOUN
dpc-4137	38	4	structure	structure	NOUN
dpc-4137	38	5	allows	allow	VERB
dpc-4137	38	6	them	they	PRON
dpc-4137	38	7	to	to	PART
dpc-4137	38	8	be	be	AUX
dpc-4137	38	9	executors	executor	NOUN
dpc-4137	38	10	of	of	ADP
dpc-4137	38	11	pyroptosis	pyroptosis	NOUN
dpc-4137	38	12	–	–	PUNCT
dpc-4137	38	13	the	the	DET
dpc-4137	38	14	inflammatory	inflammatory	ADJ
dpc-4137	38	15	cell	cell	NOUN
dpc-4137	38	16	death	death	NOUN
dpc-4137	38	17	type	type	NOUN
dpc-4137	38	18	resulting	result	VERB
dpc-4137	38	19	in	in	ADP
dpc-4137	38	20	the	the	DET
dpc-4137	38	21	formation	formation	NOUN
dpc-4137	38	22	of	of	ADP
dpc-4137	38	23	pores	pore	NOUN
dpc-4137	38	24	in	in	ADP
dpc-4137	38	25	cellular	cellular	ADJ
dpc-4137	38	26	membranes	membrane	NOUN
dpc-4137	38	27	and	and	CCONJ
dpc-4137	38	28	the	the	DET
dpc-4137	38	29	release	release	NOUN
dpc-4137	38	30	of	of	ADP
dpc-4137	38	31	inflammatory	inflammatory	ADJ
dpc-4137	38	32	cytokines	cytokine	NOUN
dpc-4137	38	33	[	[	X
dpc-4137	38	34	12	12	NUM
dpc-4137	38	35	]	]	PUNCT
dpc-4137	38	36	.	.	PUNCT
dpc-4137	39	1	it	it	PRON
dpc-4137	39	2	has	have	AUX
dpc-4137	39	3	been	be	AUX
dpc-4137	39	4	shown	show	VERB
dpc-4137	39	5	that	that	SCONJ
dpc-4137	39	6	cells	cell	NOUN
dpc-4137	39	7	that	that	PRON
dpc-4137	39	8	express	express	VERB
dpc-4137	39	9	gasdermins	gasdermin	NOUN
dpc-4137	39	10	are	be	AUX
dpc-4137	39	11	determined	determined	ADJ
dpc-4137	39	12	to	to	PART
dpc-4137	39	13	die	die	VERB
dpc-4137	39	14	in	in	ADP
dpc-4137	39	15	order	order	NOUN
dpc-4137	39	16	to	to	PART
dpc-4137	39	17	become	become	VERB
dpc-4137	39	18	a	a	DET
dpc-4137	39	19	part	part	NOUN
dpc-4137	39	20	of	of	ADP
dpc-4137	39	21	the	the	DET
dpc-4137	39	22	cornified	cornified	ADJ
dpc-4137	39	23	layer	layer	NOUN
dpc-4137	39	24	of	of	ADP
dpc-4137	39	25	the	the	DET
dpc-4137	39	26	skin	skin	NOUN
dpc-4137	39	27	or	or	CCONJ
dpc-4137	39	28	the	the	DET
dpc-4137	39	29	hardened	hardened	ADJ
dpc-4137	39	30	tube	tube	NOUN
dpc-4137	39	31	of	of	ADP
dpc-4137	39	32	the	the	DET
dpc-4137	39	33	inner	inner	ADJ
dpc-4137	39	34	root	root	NOUN
dpc-4137	39	35	sheath	sheath	NOUN
dpc-4137	39	36	or	or	CCONJ
dpc-4137	39	37	to	to	PART
dpc-4137	39	38	disintegrate	disintegrate	VERB
dpc-4137	39	39	and	and	CCONJ
dpc-4137	39	40	release	release	VERB
dpc-4137	39	41	lipid	lipid	NOUN
dpc-4137	39	42	compounds	compound	VERB
dpc-4137	40	1	[	[	X
dpc-4137	40	2	13	13	NUM
dpc-4137	40	3	]	]	PUNCT
dpc-4137	40	4	.	.	PUNCT
dpc-4137	41	1	the	the	DET
dpc-4137	41	2	name	name	NOUN
dpc-4137	41	3	of	of	ADP
dpc-4137	41	4	the	the	DET
dpc-4137	41	5	whole	whole	ADJ
dpc-4137	41	6	group	group	NOUN
dpc-4137	41	7	‘	'	PUNCT
dpc-4137	41	8	gasdermins	gasdermin	NOUN
dpc-4137	41	9	’	'	PUNCT
dpc-4137	41	10	originates	originate	NOUN
dpc-4137	41	11	from	from	ADP
dpc-4137	41	12	gasdermins	gasdermin	NOUN
dpc-4137	41	13	’	'	PUNCT
dpc-4137	41	14	expression	expression	NOUN
dpc-4137	41	15	in	in	ADP
dpc-4137	41	16	the	the	DET
dpc-4137	41	17	gastrointestinal	gastrointestinal	ADJ
dpc-4137	41	18	tract	tract	NOUN
dpc-4137	41	19	and	and	CCONJ
dpc-4137	41	20	skin	skin	NOUN
dpc-4137	41	21	.	.	PUNCT
dpc-4137	42	1	this	this	PRON
dpc-4137	42	2	is	be	AUX
dpc-4137	42	3	exactly	exactly	ADV
dpc-4137	42	4	where	where	SCONJ
dpc-4137	42	5	the	the	DET
dpc-4137	42	6	first	first	ADJ
dpc-4137	42	7	member	member	NOUN
dpc-4137	42	8	of	of	ADP
dpc-4137	42	9	this	this	DET
dpc-4137	42	10	family	family	NOUN
dpc-4137	42	11	is	be	AUX
dpc-4137	42	12	mainly	mainly	ADV
dpc-4137	42	13	observed	observe	VERB
dpc-4137	42	14	–	–	PUNCT
dpc-4137	42	15	gasdermin	gasdermin	NOUN
dpc-4137	42	16	a	a	DET
dpc-4137	42	17	(	(	PUNCT
dpc-4137	42	18	gsdma	gsdma	NOUN
dpc-4137	42	19	)	)	PUNCT
dpc-4137	43	1	[	[	X
dpc-4137	43	2	14	14	NUM
dpc-4137	43	3	]	]	PUNCT
dpc-4137	43	4	.	.	PUNCT
dpc-4137	44	1	its	its	PRON
dpc-4137	44	2	encoding	encoding	NOUN
dpc-4137	44	3	gene	gene	NOUN
dpc-4137	44	4	is	be	AUX
dpc-4137	44	5	located	locate	VERB
dpc-4137	44	6	on	on	ADP
dpc-4137	44	7	chromosome	chromosome	NOUN
dpc-4137	44	8	17q21.1	17q21.1	NUM
dpc-4137	45	1	[	[	X
dpc-4137	45	2	15	15	NUM
dpc-4137	45	3	]	]	PUNCT
dpc-4137	45	4	,	,	PUNCT
dpc-4137	45	5	and	and	CCONJ
dpc-4137	45	6	it	it	PRON
dpc-4137	45	7	has	have	VERB
dpc-4137	45	8	the	the	DET
dpc-4137	45	9	ability	ability	NOUN
dpc-4137	45	10	to	to	PART
dpc-4137	45	11	participate	participate	VERB
dpc-4137	45	12	not	not	PART
dpc-4137	45	13	only	only	ADV
dpc-4137	45	14	in	in	ADP
dpc-4137	45	15	pyroptosis	pyroptosis	NOUN
dpc-4137	45	16	but	but	CCONJ
dpc-4137	45	17	also	also	ADV
dpc-4137	45	18	in	in	ADP
dpc-4137	45	19	apoptosis	apoptosis	NOUN
dpc-4137	45	20	by	by	ADP
dpc-4137	45	21	activating	activate	VERB
dpc-4137	45	22	caspase	caspase	PROPN
dpc-4137	45	23	3	3	NUM
dpc-4137	45	24	and	and	CCONJ
dpc-4137	45	25	7	7	NUM
dpc-4137	45	26	or	or	CCONJ
dpc-4137	45	27	via	via	ADP
dpc-4137	45	28	transforming	transform	VERB
dpc-4137	45	29	growth	growth	NOUN
dpc-4137	45	30	factor	factor	NOUN
dpc-4137	45	31	β	β	X
dpc-4137	45	32	(	(	PUNCT
dpc-4137	45	33	tgf	tgf	PROPN
dpc-4137	45	34	-	-	PUNCT
dpc-4137	45	35	β	β	NOUN
dpc-4137	45	36	)	)	PUNCT
dpc-4137	46	1	[	[	X
dpc-4137	46	2	12	12	NUM
dpc-4137	46	3	]	]	PUNCT
dpc-4137	46	4	.	.	PUNCT
dpc-4137	47	1	so	so	ADV
dpc-4137	47	2	far	far	ADV
dpc-4137	47	3	,	,	PUNCT
dpc-4137	47	4	gsdma	gsdma	NOUN
dpc-4137	47	5	has	have	AUX
dpc-4137	47	6	been	be	AUX
dpc-4137	47	7	implicated	implicate	VERB
dpc-4137	47	8	in	in	ADP
dpc-4137	47	9	the	the	DET
dpc-4137	47	10	pathogenesis	pathogenesis	NOUN
dpc-4137	47	11	of	of	ADP
dpc-4137	47	12	asthma	asthma	NOUN
dpc-4137	47	13	,	,	PUNCT
dpc-4137	47	14	inflammatory	inflammatory	ADJ
dpc-4137	47	15	bowel	bowel	NOUN
dpc-4137	47	16	diseases	disease	NOUN
dpc-4137	47	17	,	,	PUNCT
dpc-4137	47	18	systemic	systemic	ADJ
dpc-4137	47	19	sclerosis	sclerosis	NOUN
dpc-4137	47	20	,	,	PUNCT
dpc-4137	47	21	streptococcal	streptococcal	ADJ
dpc-4137	47	22	infections	infection	NOUN
dpc-4137	47	23	in	in	ADP
dpc-4137	47	24	humans	human	NOUN
dpc-4137	47	25	,	,	PUNCT
dpc-4137	47	26	and	and	CCONJ
dpc-4137	47	27	alopecia	alopecia	NOUN
dpc-4137	47	28	in	in	ADP
dpc-4137	47	29	mice	mouse	NOUN
dpc-4137	47	30	[	[	X
dpc-4137	47	31	16	16	NUM
dpc-4137	47	32	-	-	SYM
dpc-4137	47	33	20	20	NUM
dpc-4137	47	34	]	]	PUNCT
dpc-4137	47	35	.	.	PUNCT
dpc-4137	48	1	surprisingly	surprisingly	ADV
dpc-4137	48	2	,	,	PUNCT
dpc-4137	48	3	it	it	PRON
dpc-4137	48	4	has	have	AUX
dpc-4137	48	5	been	be	AUX
dpc-4137	48	6	suggested	suggest	VERB
dpc-4137	48	7	that	that	SCONJ
dpc-4137	48	8	gsdma	gsdma	NOUN
dpc-4137	48	9	is	be	AUX
dpc-4137	48	10	probably	probably	ADV
dpc-4137	48	11	not	not	PART
dpc-4137	48	12	essential	essential	ADJ
dpc-4137	48	13	for	for	ADP
dpc-4137	48	14	the	the	DET
dpc-4137	48	15	maintenance	maintenance	NOUN
dpc-4137	48	16	of	of	ADP
dpc-4137	48	17	the	the	DET
dpc-4137	48	18	skin	skin	NOUN
dpc-4137	48	19	barrier	barrier	NOUN
dpc-4137	48	20	,	,	PUNCT
dpc-4137	48	21	but	but	CCONJ
dpc-4137	48	22	its	its	PRON
dpc-4137	48	23	role	role	NOUN
dpc-4137	48	24	emerges	emerge	VERB
dpc-4137	48	25	when	when	SCONJ
dpc-4137	48	26	pathogens	pathogen	NOUN
dpc-4137	48	27	or	or	CCONJ
dpc-4137	48	28	other	other	ADJ
dpc-4137	48	29	stimuli	stimulus	NOUN
dpc-4137	48	30	appear	appear	VERB
dpc-4137	48	31	,	,	PUNCT
dpc-4137	48	32	and	and	CCONJ
dpc-4137	48	33	that	that	PRON
dpc-4137	48	34	is	be	AUX
dpc-4137	48	35	related	relate	VERB
dpc-4137	48	36	to	to	ADP
dpc-4137	48	37	the	the	DET
dpc-4137	48	38	further	further	ADJ
dpc-4137	48	39	path	path	NOUN
dpc-4137	48	40	of	of	ADP
dpc-4137	48	41	gsdma	gsdma	NOUN
dpc-4137	48	42	activation	activation	NOUN
dpc-4137	48	43	[	[	X
dpc-4137	48	44	14	14	NUM
dpc-4137	48	45	]	]	PUNCT
dpc-4137	48	46	.	.	PUNCT
dpc-4137	49	1	our	our	PRON
dpc-4137	49	2	interest	interest	NOUN
dpc-4137	49	3	in	in	ADP
dpc-4137	49	4	gsdma	gsdma	NOUN
dpc-4137	49	5	originated	originate	VERB
dpc-4137	49	6	from	from	ADP
dpc-4137	49	7	the	the	DET
dpc-4137	49	8	reports	report	NOUN
dpc-4137	49	9	that	that	SCONJ
dpc-4137	49	10	a	a	DET
dpc-4137	49	11	mutation	mutation	NOUN
dpc-4137	49	12	in	in	ADP
dpc-4137	49	13	gsdma	gsdma	NOUN
dpc-4137	49	14	gene	gene	NOUN
dpc-4137	49	15	in	in	ADP
dpc-4137	49	16	mice	mouse	NOUN
dpc-4137	49	17	causes	cause	VERB
dpc-4137	49	18	hyperplasia	hyperplasia	NOUN
dpc-4137	49	19	of	of	ADP
dpc-4137	49	20	the	the	DET
dpc-4137	49	21	epidermis	epidermis	NOUN
dpc-4137	49	22	,	,	PUNCT
dpc-4137	49	23	which	which	PRON
dpc-4137	49	24	is	be	AUX
dpc-4137	49	25	exactly	exactly	ADV
dpc-4137	49	26	what	what	PRON
dpc-4137	49	27	we	we	PRON
dpc-4137	49	28	see	see	VERB
dpc-4137	49	29	in	in	ADP
dpc-4137	49	30	psoriatic	psoriatic	ADJ
dpc-4137	49	31	skin	skin	NOUN
dpc-4137	49	32	[	[	X
dpc-4137	49	33	4,20,21	4,20,21	NUM
dpc-4137	49	34	]	]	X
dpc-4137	49	35	.	.	PUNCT
dpc-4137	50	1	therefore	therefore	ADV
dpc-4137	50	2	,	,	PUNCT
dpc-4137	50	3	it	it	PRON
dpc-4137	50	4	would	would	AUX
dpc-4137	50	5	be	be	AUX
dpc-4137	50	6	valuable	valuable	ADJ
dpc-4137	50	7	to	to	PART
dpc-4137	50	8	investigate	investigate	VERB
dpc-4137	50	9	the	the	DET
dpc-4137	50	10	role	role	NOUN
dpc-4137	50	11	of	of	ADP
dpc-4137	50	12	gsdma	gsdma	NOUN
dpc-4137	50	13	in	in	ADP
dpc-4137	50	14	psoriasis	psoriasis	NOUN
dpc-4137	50	15	.	.	PUNCT
dpc-4137	51	1	objective	objective	ADJ
dpc-4137	51	2	considering	consider	VERB
dpc-4137	51	3	the	the	DET
dpc-4137	51	4	role	role	NOUN
dpc-4137	51	5	of	of	ADP
dpc-4137	51	6	gsdma	gsdma	NOUN
dpc-4137	51	7	in	in	ADP
dpc-4137	51	8	cell	cell	NOUN
dpc-4137	51	9	proliferation	proliferation	NOUN
dpc-4137	51	10	and	and	CCONJ
dpc-4137	51	11	differentiation	differentiation	NOUN
dpc-4137	51	12	and	and	CCONJ
dpc-4137	51	13	interesting	interesting	ADJ
dpc-4137	51	14	findings	finding	NOUN
dpc-4137	51	15	regarding	regard	VERB
dpc-4137	51	16	the	the	DET
dpc-4137	51	17	results	result	NOUN
dpc-4137	51	18	of	of	ADP
dpc-4137	51	19	its	its	PRON
dpc-4137	51	20	mutation	mutation	NOUN
dpc-4137	51	21	,	,	PUNCT
dpc-4137	51	22	we	we	PRON
dpc-4137	51	23	wanted	want	VERB
dpc-4137	51	24	to	to	PART
dpc-4137	51	25	study	study	VERB
dpc-4137	51	26	its	its	PRON
dpc-4137	51	27	potential	potential	ADJ
dpc-4137	51	28	role	role	NOUN
dpc-4137	51	29	in	in	ADP
dpc-4137	51	30	psoriasis	psoriasis	NOUN
dpc-4137	51	31	,	,	PUNCT
dpc-4137	51	32	which	which	PRON
dpc-4137	51	33	has	have	AUX
dpc-4137	51	34	been	be	AUX
dpc-4137	51	35	proven	prove	VERB
dpc-4137	51	36	to	to	PART
dpc-4137	51	37	be	be	AUX
dpc-4137	51	38	associated	associate	VERB
dpc-4137	51	39	precisely	precisely	ADV
dpc-4137	51	40	with	with	ADP
dpc-4137	51	41	impaired	impaired	ADJ
dpc-4137	51	42	keratinocytes	keratinocyte	NOUN
dpc-4137	51	43	proliferation	proliferation	NOUN
dpc-4137	51	44	and	and	CCONJ
dpc-4137	51	45	differentiation	differentiation	NOUN
dpc-4137	51	46	.	.	PUNCT
dpc-4137	52	1	materials	material	NOUN
dpc-4137	52	2	and	and	CCONJ
dpc-4137	52	3	methods	method	NOUN
dpc-4137	52	4	the	the	DET
dpc-4137	52	5	study	study	NOUN
dpc-4137	52	6	included	include	VERB
dpc-4137	52	7	60	60	NUM
dpc-4137	52	8	patients	patient	NOUN
dpc-4137	52	9	(	(	PUNCT
dpc-4137	52	10	21	21	NUM
dpc-4137	52	11	women	woman	NOUN
dpc-4137	52	12	and	and	CCONJ
dpc-4137	52	13	39	39	NUM
dpc-4137	52	14	men	man	NOUN
dpc-4137	52	15	)	)	PUNCT
dpc-4137	52	16	with	with	ADP
dpc-4137	52	17	active	active	ADJ
dpc-4137	52	18	plaque	plaque	NOUN
dpc-4137	52	19	-	-	PUNCT
dpc-4137	52	20	type	type	NOUN
dpc-4137	52	21	psoriasis	psoriasis	NOUN
dpc-4137	52	22	,	,	PUNCT
dpc-4137	52	23	at	at	ADP
dpc-4137	52	24	the	the	DET
dpc-4137	52	25	mean	mean	ADJ
dpc-4137	52	26	age	age	NOUN
dpc-4137	52	27	of	of	ADP
dpc-4137	52	28	50±2.34	50±2.34	NUM
dpc-4137	52	29	years	year	NOUN
dpc-4137	52	30	and	and	CCONJ
dpc-4137	52	31	30	30	NUM
dpc-4137	52	32	sexand	sexand	NOUN
dpc-4137	52	33	age	age	NOUN
dpc-4137	52	34	-	-	PUNCT
dpc-4137	52	35	matched	match	VERB
dpc-4137	52	36	volunteers	volunteer	NOUN
dpc-4137	52	37	without	without	ADP
dpc-4137	52	38	dermatoses	dermatosis	NOUN
dpc-4137	52	39	and	and	CCONJ
dpc-4137	52	40	negative	negative	ADJ
dpc-4137	52	41	family	family	NOUN
dpc-4137	52	42	history	history	NOUN
dpc-4137	52	43	of	of	ADP
dpc-4137	52	44	psoriasis	psoriasis	NOUN
dpc-4137	52	45	.	.	PUNCT
dpc-4137	53	1	the	the	DET
dpc-4137	53	2	following	follow	VERB
dpc-4137	53	3	exclusion	exclusion	NOUN
dpc-4137	53	4	criteria	criterion	NOUN
dpc-4137	53	5	from	from	ADP
dpc-4137	53	6	the	the	DET
dpc-4137	53	7	study	study	NOUN
dpc-4137	53	8	were	be	AUX
dpc-4137	53	9	applied	apply	VERB
dpc-4137	53	10	:	:	PUNCT
dpc-4137	53	11	age	age	NOUN
dpc-4137	53	12	under	under	ADP
dpc-4137	53	13	18	18	NUM
dpc-4137	53	14	years	year	NOUN
dpc-4137	53	15	,	,	PUNCT
dpc-4137	53	16	pregnancy	pregnancy	NOUN
dpc-4137	53	17	,	,	PUNCT
dpc-4137	53	18	types	type	NOUN
dpc-4137	53	19	of	of	ADP
dpc-4137	53	20	psoriasis	psoriasis	NOUN
dpc-4137	53	21	other	other	ADJ
dpc-4137	53	22	than	than	ADP
dpc-4137	53	23	plaque	plaque	NOUN
dpc-4137	53	24	psoriasis	psoriasis	NOUN
dpc-4137	53	25	,	,	PUNCT
dpc-4137	53	26	dietary	dietary	ADJ
dpc-4137	53	27	restrictions	restriction	NOUN
dpc-4137	53	28	and	and	CCONJ
dpc-4137	53	29	intake	intake	NOUN
dpc-4137	53	30	of	of	ADP
dpc-4137	53	31	oral	oral	ADJ
dpc-4137	53	32	medications	medication	NOUN
dpc-4137	53	33	at	at	ADV
dpc-4137	53	34	least	least	ADV
dpc-4137	53	35	three	three	NUM
dpc-4137	53	36	months	month	NOUN
dpc-4137	53	37	prior	prior	ADV
dpc-4137	53	38	to	to	ADP
dpc-4137	53	39	the	the	DET
dpc-4137	53	40	study	study	NOUN
dpc-4137	53	41	,	,	PUNCT
dpc-4137	53	42	application	application	NOUN
dpc-4137	53	43	of	of	ADP
dpc-4137	53	44	topical	topical	ADJ
dpc-4137	53	45	agents	agent	NOUN
dpc-4137	53	46	at	at	ADP
dpc-4137	53	47	least	least	ADV
dpc-4137	53	48	one	one	NUM
dpc-4137	53	49	month	month	NOUN
dpc-4137	53	50	prior	prior	ADV
dpc-4137	53	51	to	to	ADP
dpc-4137	53	52	the	the	DET
dpc-4137	53	53	study	study	NOUN
dpc-4137	53	54	,	,	PUNCT
dpc-4137	53	55	malignancies	malignancy	NOUN
dpc-4137	53	56	,	,	PUNCT
dpc-4137	53	57	and	and	CCONJ
dpc-4137	53	58	renal	renal	ADJ
dpc-4137	53	59	dysfunction	dysfunction	NOUN
dpc-4137	53	60	.	.	PUNCT
dpc-4137	54	1	the	the	DET
dpc-4137	54	2	severity	severity	NOUN
dpc-4137	54	3	of	of	ADP
dpc-4137	54	4	psoriatic	psoriatic	ADJ
dpc-4137	54	5	skin	skin	NOUN
dpc-4137	54	6	lesions	lesion	NOUN
dpc-4137	54	7	was	be	AUX
dpc-4137	54	8	assessed	assess	VERB
dpc-4137	54	9	using	use	VERB
dpc-4137	54	10	the	the	DET
dpc-4137	54	11	psoriasis	psoriasis	NOUN
dpc-4137	54	12	area	area	NOUN
dpc-4137	54	13	and	and	CCONJ
dpc-4137	54	14	severity	severity	NOUN
dpc-4137	54	15	index	index	NOUN
dpc-4137	54	16	(	(	PUNCT
dpc-4137	54	17	pasi	pasi	NOUN
dpc-4137	54	18	)	)	PUNCT
dpc-4137	54	19	and	and	CCONJ
dpc-4137	54	20	was	be	AUX
dpc-4137	54	21	always	always	ADV
dpc-4137	54	22	performed	perform	VERB
dpc-4137	54	23	by	by	ADP
dpc-4137	54	24	the	the	DET
dpc-4137	54	25	same	same	ADJ
dpc-4137	54	26	dermatologist	dermatologist	NOUN
dpc-4137	54	27	in	in	ADP
dpc-4137	54	28	all	all	DET
dpc-4137	54	29	patients	patient	NOUN
dpc-4137	54	30	.	.	PUNCT
dpc-4137	55	1	the	the	DET
dpc-4137	55	2	study	study	NOUN
dpc-4137	55	3	group	group	NOUN
dpc-4137	55	4	of	of	ADP
dpc-4137	55	5	patients	patient	NOUN
dpc-4137	55	6	was	be	AUX
dpc-4137	55	7	divided	divide	VERB
dpc-4137	55	8	into	into	ADP
dpc-4137	55	9	three	three	NUM
dpc-4137	55	10	subgroups	subgroup	NOUN
dpc-4137	55	11	depending	depend	VERB
dpc-4137	55	12	on	on	ADP
dpc-4137	55	13	the	the	DET
dpc-4137	55	14	severity	severity	NOUN
dpc-4137	55	15	of	of	ADP
dpc-4137	55	16	their	their	PRON
dpc-4137	55	17	disease	disease	NOUN
dpc-4137	55	18	:	:	PUNCT
dpc-4137	55	19	pasi	pasi	NOUN
dpc-4137	55	20	i	i	PRON
dpc-4137	55	21	(	(	PUNCT
dpc-4137	55	22	pasi	pasi	NOUN
dpc-4137	55	23	<	<	NOUN
dpc-4137	55	24	10	10	NUM
dpc-4137	55	25	)	)	PUNCT
dpc-4137	55	26	mild	mild	ADJ
dpc-4137	55	27	psoriasis	psoriasis	NOUN
dpc-4137	55	28	,	,	PUNCT
dpc-4137	55	29	pasi	pasi	PROPN
dpc-4137	55	30	ii	ii	PROPN
dpc-4137	55	31	(	(	PUNCT
dpc-4137	55	32	pasi	pasi	NOUN
dpc-4137	55	33	10	10	NUM
dpc-4137	55	34	-	-	SYM
dpc-4137	55	35	20	20	NUM
dpc-4137	55	36	)	)	PUNCT
dpc-4137	55	37	moderate	moderate	ADJ
dpc-4137	55	38	psoriasis	psoriasis	NOUN
dpc-4137	55	39	,	,	PUNCT
dpc-4137	55	40	and	and	CCONJ
dpc-4137	55	41	pasi	pasi	PROPN
dpc-4137	55	42	iii	iii	PROPN
dpc-4137	55	43	(	(	PUNCT
dpc-4137	55	44	pasi	pasi	NOUN
dpc-4137	55	45	>	>	X
dpc-4137	55	46	20	20	NUM
dpc-4137	55	47	)	)	PUNCT
dpc-4137	55	48	severe	severe	ADJ
dpc-4137	55	49	psoriasis	psoriasis	NOUN
dpc-4137	55	50	.	.	PUNCT
dpc-4137	56	1	body	body	NOUN
dpc-4137	56	2	mass	mass	PROPN
dpc-4137	56	3	index	index	NOUN
dpc-4137	56	4	(	(	PUNCT
dpc-4137	56	5	bmi	bmi	PROPN
dpc-4137	56	6	)	)	PUNCT
dpc-4137	56	7	was	be	AUX
dpc-4137	56	8	calculated	calculate	VERB
dpc-4137	56	9	as	as	ADP
dpc-4137	56	10	weight	weight	NOUN
dpc-4137	56	11	/	/	PUNCT
dpc-4137	56	12	height2	height2	PROPN
dpc-4137	56	13	.	.	PUNCT
dpc-4137	57	1	laboratory	laboratory	NOUN
dpc-4137	57	2	tests	test	NOUN
dpc-4137	57	3	,	,	PUNCT
dpc-4137	57	4	including	include	VERB
dpc-4137	57	5	c	c	NOUN
dpc-4137	57	6	-	-	PUNCT
dpc-4137	57	7	reactive	reactive	ADJ
dpc-4137	57	8	protein	protein	NOUN
dpc-4137	57	9	(	(	PUNCT
dpc-4137	57	10	crp	crp	PROPN
dpc-4137	57	11	)	)	PUNCT
dpc-4137	57	12	,	,	PUNCT
dpc-4137	57	13	complete	complete	ADJ
dpc-4137	57	14	conclusions	conclusion	NOUN
dpc-4137	57	15	:	:	PUNCT
dpc-4137	57	16	obtained	obtain	VERB
dpc-4137	57	17	results	result	NOUN
dpc-4137	57	18	point	point	VERB
dpc-4137	57	19	to	to	ADP
dpc-4137	57	20	the	the	DET
dpc-4137	57	21	probable	probable	ADJ
dpc-4137	57	22	involvement	involvement	NOUN
dpc-4137	57	23	of	of	ADP
dpc-4137	57	24	gsdma	gsdma	NOUN
dpc-4137	57	25	in	in	ADP
dpc-4137	57	26	psoriasis	psoriasis	NOUN
dpc-4137	57	27	.	.	PUNCT
dpc-4137	58	1	gsdma	gsdma	NOUN
dpc-4137	58	2	overexpression	overexpression	NOUN
dpc-4137	58	3	may	may	AUX
dpc-4137	58	4	probably	probably	ADV
dpc-4137	58	5	lead	lead	VERB
dpc-4137	58	6	to	to	ADP
dpc-4137	58	7	keratinocytes	keratinocyte	NOUN
dpc-4137	58	8	hyperproliferation	hyperproliferation	NOUN
dpc-4137	58	9	and	and	CCONJ
dpc-4137	58	10	be	be	AUX
dpc-4137	58	11	responsible	responsible	ADJ
dpc-4137	58	12	for	for	ADP
dpc-4137	58	13	triggering	trigger	VERB
dpc-4137	58	14	inflammation	inflammation	NOUN
dpc-4137	58	15	in	in	ADP
dpc-4137	58	16	psoriatic	psoriatic	ADJ
dpc-4137	58	17	skin	skin	NOUN
dpc-4137	58	18	.	.	PUNCT
dpc-4137	59	1	serum	serum	NOUN
dpc-4137	59	2	gsdma	gsdma	PROPN
dpc-4137	59	3	could	could	AUX
dpc-4137	59	4	become	become	VERB
dpc-4137	59	5	psoriasis	psoriasis	NOUN
dpc-4137	59	6	biomarker	biomarker	NOUN
dpc-4137	59	7	,	,	PUNCT
dpc-4137	59	8	whereas	whereas	SCONJ
dpc-4137	59	9	urinary	urinary	ADJ
dpc-4137	59	10	gsdma	gsdma	NOUN
dpc-4137	59	11	,	,	PUNCT
dpc-4137	59	12	not	not	PART
dpc-4137	59	13	at	at	ADP
dpc-4137	59	14	this	this	DET
dpc-4137	59	15	point	point	NOUN
dpc-4137	59	16	.	.	PUNCT
dpc-4137	60	1	original	original	ADJ
dpc-4137	60	2	article	article	NOUN
dpc-4137	60	3	|	|	ADV
dpc-4137	60	4	dermatol	dermatol	ADJ
dpc-4137	60	5	pract	pract	NOUN
dpc-4137	60	6	concept	concept	NOUN
dpc-4137	60	7	.	.	PUNCT
dpc-4137	61	1	2024;14(3):e2024177	2024;14(3):e2024177	NUM
dpc-4137	61	2	3	3	NUM
dpc-4137	61	3	blood	blood	NOUN
dpc-4137	61	4	count	count	NOUN
dpc-4137	61	5	,	,	PUNCT
dpc-4137	61	6	fasting	fast	VERB
dpc-4137	61	7	serum	serum	NOUN
dpc-4137	61	8	glucose	glucose	NOUN
dpc-4137	61	9	,	,	PUNCT
dpc-4137	61	10	lipid	lipid	NOUN
dpc-4137	61	11	profile	profile	NOUN
dpc-4137	61	12	,	,	PUNCT
dpc-4137	61	13	and	and	CCONJ
dpc-4137	61	14	markers	marker	NOUN
dpc-4137	61	15	of	of	ADP
dpc-4137	61	16	liver	liver	NOUN
dpc-4137	61	17	and	and	CCONJ
dpc-4137	61	18	kidney	kidney	NOUN
dpc-4137	61	19	function	function	NOUN
dpc-4137	61	20	,	,	PUNCT
dpc-4137	61	21	were	be	AUX
dpc-4137	61	22	performed	perform	VERB
dpc-4137	61	23	.	.	PUNCT
dpc-4137	62	1	the	the	DET
dpc-4137	62	2	study	study	NOUN
dpc-4137	62	3	was	be	AUX
dpc-4137	62	4	approved	approve	VERB
dpc-4137	62	5	by	by	ADP
dpc-4137	62	6	the	the	DET
dpc-4137	62	7	bioethics	bioethics	PROPN
dpc-4137	62	8	committee	committee	NOUN
dpc-4137	62	9	of	of	ADP
dpc-4137	62	10	the	the	DET
dpc-4137	62	11	medical	medical	ADJ
dpc-4137	62	12	university	university	PROPN
dpc-4137	62	13	of	of	ADP
dpc-4137	62	14	bialystok	bialystok	PROPN
dpc-4137	62	15	(	(	PUNCT
dpc-4137	62	16	number	number	NOUN
dpc-4137	62	17	:	:	PUNCT
dpc-4137	62	18	apk.002.303.2022	apk.002.303.2022	NOUN
dpc-4137	62	19	and	and	CCONJ
dpc-4137	62	20	apk.002.19.2020	apk.002.19.2020	VERB
dpc-4137	62	21	)	)	PUNCT
dpc-4137	62	22	and	and	CCONJ
dpc-4137	62	23	was	be	AUX
dpc-4137	62	24	conducted	conduct	VERB
dpc-4137	62	25	in	in	ADP
dpc-4137	62	26	accordance	accordance	NOUN
dpc-4137	62	27	with	with	ADP
dpc-4137	62	28	the	the	DET
dpc-4137	62	29	principles	principle	NOUN
dpc-4137	62	30	of	of	ADP
dpc-4137	62	31	the	the	DET
dpc-4137	62	32	helsinki	helsinki	PROPN
dpc-4137	62	33	declaration	declaration	PROPN
dpc-4137	62	34	.	.	PUNCT
dpc-4137	63	1	each	each	DET
dpc-4137	63	2	participant	participant	NOUN
dpc-4137	63	3	provided	provide	VERB
dpc-4137	63	4	written	write	VERB
dpc-4137	63	5	consent	consent	NOUN
dpc-4137	63	6	before	before	SCONJ
dpc-4137	63	7	the	the	DET
dpc-4137	63	8	study	study	NOUN
dpc-4137	63	9	commenced	commence	VERB
dpc-4137	63	10	.	.	PUNCT
dpc-4137	64	1	serum	serum	NOUN
dpc-4137	64	2	and	and	CCONJ
dpc-4137	64	3	urine	urine	NOUN
dpc-4137	64	4	fasting	fast	VERB
dpc-4137	64	5	blood	blood	NOUN
dpc-4137	64	6	samples	sample	NOUN
dpc-4137	64	7	were	be	AUX
dpc-4137	64	8	taken	take	VERB
dpc-4137	64	9	using	use	VERB
dpc-4137	64	10	vacuum	vacuum	NOUN
dpc-4137	64	11	tubes	tube	NOUN
dpc-4137	64	12	.	.	PUNCT
dpc-4137	65	1	they	they	PRON
dpc-4137	65	2	were	be	AUX
dpc-4137	65	3	left	leave	VERB
dpc-4137	65	4	to	to	PART
dpc-4137	65	5	clot	clot	VERB
dpc-4137	65	6	for	for	ADP
dpc-4137	65	7	30	30	NUM
dpc-4137	65	8	minutes	minute	NOUN
dpc-4137	65	9	before	before	ADP
dpc-4137	65	10	centrifuging	centrifuge	VERB
dpc-4137	65	11	for	for	ADP
dpc-4137	65	12	15	15	NUM
dpc-4137	65	13	minutes	minute	NOUN
dpc-4137	65	14	at	at	ADP
dpc-4137	65	15	2000	2000	NUM
dpc-4137	65	16	g.	g.	NOUN
dpc-4137	65	17	urine	urine	NOUN
dpc-4137	65	18	samples	sample	NOUN
dpc-4137	65	19	were	be	AUX
dpc-4137	65	20	taken	take	VERB
dpc-4137	65	21	as	as	ADP
dpc-4137	65	22	first	first	ADJ
dpc-4137	65	23	morning	morning	NOUN
dpc-4137	65	24	specimens	specimen	VERB
dpc-4137	65	25	from	from	ADP
dpc-4137	65	26	a	a	DET
dpc-4137	65	27	mid	mid	NOUN
dpc-4137	65	28	-	-	NOUN
dpc-4137	65	29	stream	stream	NOUN
dpc-4137	65	30	;	;	PUNCT
dpc-4137	65	31	they	they	PRON
dpc-4137	65	32	were	be	AUX
dpc-4137	65	33	centrifugated	centrifugate	VERB
dpc-4137	65	34	for	for	ADP
dpc-4137	65	35	10	10	NUM
dpc-4137	65	36	minutes	minute	NOUN
dpc-4137	65	37	at	at	ADP
dpc-4137	65	38	2000	2000	NUM
dpc-4137	65	39	g.	g.	NOUN
dpc-4137	65	40	the	the	PRON
dpc-4137	65	41	obtained	obtain	VERB
dpc-4137	65	42	serum	serum	NOUN
dpc-4137	65	43	and	and	CCONJ
dpc-4137	65	44	urine	urine	NOUN
dpc-4137	65	45	were	be	AUX
dpc-4137	65	46	stored	store	VERB
dpc-4137	65	47	at	at	ADP
dpc-4137	65	48	-80	-80	NOUN
dpc-4137	65	49	°	°	ADP
dpc-4137	65	50	c	c	NOUN
dpc-4137	65	51	until	until	ADP
dpc-4137	65	52	further	further	ADJ
dpc-4137	65	53	analysis	analysis	NOUN
dpc-4137	65	54	.	.	PUNCT
dpc-4137	66	1	laboratory	laboratory	NOUN
dpc-4137	66	2	parameters	parameter	NOUN
dpc-4137	66	3	were	be	AUX
dpc-4137	66	4	measured	measure	VERB
dpc-4137	66	5	using	use	VERB
dpc-4137	66	6	routine	routine	ADJ
dpc-4137	66	7	techniques	technique	NOUN
dpc-4137	66	8	.	.	PUNCT
dpc-4137	67	1	gsdma	gsdma	NOUN
dpc-4137	67	2	concentrations	concentration	NOUN
dpc-4137	67	3	were	be	AUX
dpc-4137	67	4	measured	measure	VERB
dpc-4137	67	5	with	with	ADP
dpc-4137	67	6	an	an	DET
dpc-4137	67	7	enzyme	enzyme	NOUN
dpc-4137	67	8	-	-	PUNCT
dpc-4137	67	9	linked	link	VERB
dpc-4137	67	10	immunosorbent	immunosorbent	NOUN
dpc-4137	67	11	assay	assay	PROPN
dpc-4137	67	12	(	(	PUNCT
dpc-4137	67	13	elisa	elisa	NOUN
dpc-4137	67	14	)	)	PUNCT
dpc-4137	67	15	provided	provide	VERB
dpc-4137	67	16	by	by	ADP
dpc-4137	67	17	eiaab	eiaab	PROPN
dpc-4137	67	18	®	®	NOUN
dpc-4137	67	19	(	(	PUNCT
dpc-4137	67	20	e11790h	e11790h	PROPN
dpc-4137	67	21	)	)	PUNCT
dpc-4137	67	22	with	with	ADP
dpc-4137	67	23	a	a	DET
dpc-4137	67	24	minimum	minimum	ADJ
dpc-4137	67	25	detectable	detectable	ADJ
dpc-4137	67	26	dose	dose	NOUN
dpc-4137	67	27	of	of	ADP
dpc-4137	67	28	0.156	0.156	NUM
dpc-4137	67	29	-	-	SYM
dpc-4137	67	30	10	10	NUM
dpc-4137	67	31	ng	ng	PROPN
dpc-4137	67	32	/	/	SYM
dpc-4137	67	33	ml	ml	PROPN
dpc-4137	67	34	.	.	PUNCT
dpc-4137	68	1	the	the	DET
dpc-4137	68	2	concentrations	concentration	NOUN
dpc-4137	68	3	were	be	AUX
dpc-4137	68	4	assessed	assess	VERB
dpc-4137	68	5	by	by	ADP
dpc-4137	68	6	interpolation	interpolation	NOUN
dpc-4137	68	7	from	from	ADP
dpc-4137	68	8	calibration	calibration	NOUN
dpc-4137	68	9	curves	curve	NOUN
dpc-4137	68	10	prepared	prepare	VERB
dpc-4137	68	11	with	with	ADP
dpc-4137	68	12	standard	standard	ADJ
dpc-4137	68	13	samples	sample	NOUN
dpc-4137	68	14	provided	provide	VERB
dpc-4137	68	15	by	by	ADP
dpc-4137	68	16	the	the	DET
dpc-4137	68	17	manufacturer	manufacturer	NOUN
dpc-4137	68	18	.	.	PUNCT
dpc-4137	69	1	all	all	DET
dpc-4137	69	2	the	the	DET
dpc-4137	69	3	tests	test	NOUN
dpc-4137	69	4	were	be	AUX
dpc-4137	69	5	performed	perform	VERB
dpc-4137	69	6	by	by	ADP
dpc-4137	69	7	the	the	DET
dpc-4137	69	8	same	same	ADJ
dpc-4137	69	9	person	person	NOUN
dpc-4137	69	10	in	in	ADP
dpc-4137	69	11	standardized	standardized	ADJ
dpc-4137	69	12	laboratory	laboratory	NOUN
dpc-4137	69	13	settings	setting	NOUN
dpc-4137	69	14	.	.	PUNCT
dpc-4137	70	1	tissue	tissue	NOUN
dpc-4137	70	2	tissue	tissue	NOUN
dpc-4137	70	3	samples	sample	NOUN
dpc-4137	70	4	were	be	AUX
dpc-4137	70	5	collected	collect	VERB
dpc-4137	70	6	from	from	ADP
dpc-4137	70	7	33	33	NUM
dpc-4137	70	8	patients	patient	NOUN
dpc-4137	70	9	with	with	ADP
dpc-4137	70	10	psoriasis	psoriasis	NOUN
dpc-4137	70	11	and	and	CCONJ
dpc-4137	70	12	20	20	NUM
dpc-4137	70	13	sexand	sexand	NOUN
dpc-4137	70	14	age	age	NOUN
dpc-4137	70	15	-	-	PUNCT
dpc-4137	70	16	matched	match	VERB
dpc-4137	70	17	volunteers	volunteer	NOUN
dpc-4137	70	18	without	without	ADP
dpc-4137	70	19	skin	skin	NOUN
dpc-4137	70	20	diseases	disease	NOUN
dpc-4137	70	21	.	.	PUNCT
dpc-4137	71	1	all	all	DET
dpc-4137	71	2	participants	participant	NOUN
dpc-4137	71	3	did	do	AUX
dpc-4137	71	4	not	not	PART
dpc-4137	71	5	apply	apply	VERB
dpc-4137	71	6	any	any	DET
dpc-4137	71	7	topical	topical	ADJ
dpc-4137	71	8	agents	agent	NOUN
dpc-4137	71	9	on	on	ADP
dpc-4137	71	10	the	the	DET
dpc-4137	71	11	skin	skin	NOUN
dpc-4137	71	12	at	at	ADV
dpc-4137	71	13	least	least	ADJ
dpc-4137	71	14	a	a	PRON
dpc-4137	71	15	month	month	NOUN
dpc-4137	71	16	before	before	ADP
dpc-4137	71	17	the	the	DET
dpc-4137	71	18	biopsy	biopsy	NOUN
dpc-4137	71	19	.	.	PUNCT
dpc-4137	72	1	biopsies	biopsy	NOUN
dpc-4137	72	2	,	,	PUNCT
dpc-4137	72	3	obtained	obtain	VERB
dpc-4137	72	4	from	from	ADP
dpc-4137	72	5	the	the	DET
dpc-4137	72	6	trunk	trunk	NOUN
dpc-4137	72	7	using	use	VERB
dpc-4137	72	8	a	a	DET
dpc-4137	72	9	4	4	NUM
dpc-4137	72	10	mm	mm	NOUN
dpc-4137	72	11	punch	punch	NOUN
dpc-4137	72	12	after	after	ADP
dpc-4137	72	13	local	local	ADJ
dpc-4137	72	14	anesthesia	anesthesia	NOUN
dpc-4137	72	15	,	,	PUNCT
dpc-4137	72	16	included	include	VERB
dpc-4137	72	17	one	one	NUM
dpc-4137	72	18	each	each	PRON
dpc-4137	72	19	from	from	ADP
dpc-4137	72	20	psoriatic	psoriatic	ADJ
dpc-4137	72	21	plaque	plaque	NOUN
dpc-4137	72	22	and	and	CCONJ
dpc-4137	72	23	non	non	ADJ
dpc-4137	72	24	-	-	ADJ
dpc-4137	72	25	lesional	lesional	ADJ
dpc-4137	72	26	skin	skin	NOUN
dpc-4137	72	27	in	in	ADP
dpc-4137	72	28	patients	patient	NOUN
dpc-4137	72	29	and	and	CCONJ
dpc-4137	72	30	one	one	NUM
dpc-4137	72	31	from	from	ADP
dpc-4137	72	32	non	non	ADJ
dpc-4137	72	33	-	-	ADJ
dpc-4137	72	34	lesional	lesional	ADJ
dpc-4137	72	35	skin	skin	NOUN
dpc-4137	72	36	in	in	ADP
dpc-4137	72	37	controls	control	NOUN
dpc-4137	72	38	performed	perform	VERB
dpc-4137	72	39	during	during	ADP
dpc-4137	72	40	the	the	DET
dpc-4137	72	41	surgical	surgical	ADJ
dpc-4137	72	42	removal	removal	NOUN
dpc-4137	72	43	of	of	ADP
dpc-4137	72	44	benign	benign	ADJ
dpc-4137	72	45	skin	skin	NOUN
dpc-4137	72	46	lesions	lesion	NOUN
dpc-4137	72	47	.	.	PUNCT
dpc-4137	73	1	tissue	tissue	NOUN
dpc-4137	73	2	samples	sample	NOUN
dpc-4137	73	3	were	be	AUX
dpc-4137	73	4	then	then	ADV
dpc-4137	73	5	fixed	fix	VERB
dpc-4137	73	6	in	in	ADP
dpc-4137	73	7	10	10	NUM
dpc-4137	73	8	%	%	NOUN
dpc-4137	73	9	buffered	buffer	VERB
dpc-4137	73	10	formalin	formalin	NOUN
dpc-4137	73	11	solution	solution	NOUN
dpc-4137	73	12	.	.	PUNCT
dpc-4137	74	1	after	after	ADP
dpc-4137	74	2	preservation	preservation	NOUN
dpc-4137	74	3	,	,	PUNCT
dpc-4137	74	4	they	they	PRON
dpc-4137	74	5	were	be	AUX
dpc-4137	74	6	embedded	embed	VERB
dpc-4137	74	7	in	in	ADP
dpc-4137	74	8	the	the	DET
dpc-4137	74	9	paraffin	paraffin	NOUN
dpc-4137	74	10	blocks	block	NOUN
dpc-4137	74	11	,	,	PUNCT
dpc-4137	74	12	and	and	CCONJ
dpc-4137	74	13	cut	cut	VERB
dpc-4137	74	14	into	into	ADP
dpc-4137	74	15	4	4	NUM
dpc-4137	74	16	µm	µm	NOUN
dpc-4137	74	17	sections	section	NOUN
dpc-4137	74	18	on	on	ADP
dpc-4137	74	19	silanized	silanize	VERB
dpc-4137	74	20	slides	slide	NOUN
dpc-4137	74	21	.	.	PUNCT
dpc-4137	75	1	the	the	DET
dpc-4137	75	2	next	next	ADJ
dpc-4137	75	3	step	step	NOUN
dpc-4137	75	4	was	be	AUX
dpc-4137	75	5	an	an	DET
dpc-4137	75	6	overnight	overnight	ADJ
dpc-4137	75	7	incubation	incubation	NOUN
dpc-4137	75	8	at	at	ADP
dpc-4137	75	9	60	60	NUM
dpc-4137	75	10	°	°	NOUN
dpc-4137	75	11	c	c	NOUN
dpc-4137	75	12	,	,	PUNCT
dpc-4137	75	13	deparaffinization	deparaffinization	NOUN
dpc-4137	75	14	,	,	PUNCT
dpc-4137	75	15	and	and	CCONJ
dpc-4137	75	16	rehydration	rehydration	NOUN
dpc-4137	75	17	of	of	ADP
dpc-4137	75	18	tissues	tissue	NOUN
dpc-4137	75	19	.	.	PUNCT
dpc-4137	76	1	slides	slide	NOUN
dpc-4137	76	2	were	be	AUX
dpc-4137	76	3	then	then	ADV
dpc-4137	76	4	incubated	incubate	VERB
dpc-4137	76	5	with	with	ADP
dpc-4137	76	6	3	3	NUM
dpc-4137	76	7	%	%	NOUN
dpc-4137	76	8	hydrogen	hydrogen	NOUN
dpc-4137	76	9	peroxide	peroxide	NOUN
dpc-4137	76	10	solution	solution	NOUN
dpc-4137	76	11	to	to	PART
dpc-4137	76	12	block	block	VERB
dpc-4137	76	13	endogenous	endogenous	ADJ
dpc-4137	76	14	peroxidase	peroxidase	NOUN
dpc-4137	76	15	and	and	CCONJ
dpc-4137	76	16	with	with	ADP
dpc-4137	76	17	protein	protein	NOUN
dpc-4137	76	18	block	block	NOUN
dpc-4137	76	19	to	to	PART
dpc-4137	76	20	avoid	avoid	VERB
dpc-4137	76	21	nonspecific	nonspecific	ADJ
dpc-4137	76	22	antibody	antibody	NOUN
dpc-4137	76	23	binding	bind	VERB
dpc-4137	76	24	.	.	PUNCT
dpc-4137	77	1	next	next	ADV
dpc-4137	77	2	,	,	PUNCT
dpc-4137	77	3	tissues	tissue	NOUN
dpc-4137	77	4	were	be	AUX
dpc-4137	77	5	incubated	incubate	VERB
dpc-4137	77	6	with	with	ADP
dpc-4137	77	7	rabbit	rabbit	NOUN
dpc-4137	77	8	polyclonal	polyclonal	ADJ
dpc-4137	77	9	anti	anti	ADJ
dpc-4137	77	10	-	-	ADJ
dpc-4137	77	11	human	human	ADJ
dpc-4137	77	12	gsdma	gsdma	NOUN
dpc-4137	77	13	antibody	antibody	NOUN
dpc-4137	77	14	(	(	PUNCT
dpc-4137	77	15	hpa023313	hpa023313	NOUN
dpc-4137	77	16	,	,	PUNCT
dpc-4137	77	17	dilution	dilution	NOUN
dpc-4137	77	18	1:50	1:50	NUM
dpc-4137	77	19	,	,	PUNCT
dpc-4137	77	20	clone	clone	NOUN
dpc-4137	77	21	oti1	oti1	NOUN
dpc-4137	77	22	,	,	PUNCT
dpc-4137	77	23	sigma	sigma	PROPN
dpc-4137	77	24	-	-	PUNCT
dpc-4137	77	25	aldrich	aldrich	PROPN
dpc-4137	77	26	®	®	NOUN
dpc-4137	77	27	)	)	PUNCT
dpc-4137	77	28	for	for	ADP
dpc-4137	77	29	30	30	NUM
dpc-4137	77	30	minutes	minute	NOUN
dpc-4137	77	31	at	at	ADP
dpc-4137	77	32	room	room	NOUN
dpc-4137	77	33	temperature	temperature	NOUN
dpc-4137	77	34	.	.	PUNCT
dpc-4137	78	1	then	then	ADV
dpc-4137	78	2	,	,	PUNCT
dpc-4137	78	3	post	post	VERB
dpc-4137	78	4	primary	primary	ADJ
dpc-4137	78	5	block	block	NOUN
dpc-4137	78	6	and	and	CCONJ
dpc-4137	78	7	novolink	novolink	VERB
dpc-4137	78	8	polymer	polymer	NOUN
dpc-4137	78	9	were	be	AUX
dpc-4137	78	10	used	use	VERB
dpc-4137	78	11	(	(	PUNCT
dpc-4137	78	12	leica	leica	PROPN
dpc-4137	78	13	novolink	novolink	VERB
dpc-4137	78	14	polymer	polymer	NOUN
dpc-4137	78	15	detection	detection	NOUN
dpc-4137	78	16	system	system	NOUN
dpc-4137	78	17	®	®	PROPN
dpc-4137	78	18	,	,	PUNCT
dpc-4137	78	19	united	united	PROPN
dpc-4137	78	20	states	states	PROPN
dpc-4137	78	21	)	)	PUNCT
dpc-4137	78	22	.	.	PUNCT
dpc-4137	79	1	protein	protein	NOUN
dpc-4137	79	2	expression	expression	NOUN
dpc-4137	79	3	was	be	AUX
dpc-4137	79	4	visualized	visualize	VERB
dpc-4137	79	5	with	with	ADP
dpc-4137	79	6	novolink	novolink	ADJ
dpc-4137	79	7	dab	dab	NOUN
dpc-4137	79	8	solution	solution	NOUN
dpc-4137	79	9	and	and	CCONJ
dpc-4137	79	10	cell	cell	NOUN
dpc-4137	79	11	nuclei	nucleus	NOUN
dpc-4137	79	12	with	with	ADP
dpc-4137	79	13	hematoxylin	hematoxylin	PROPN
dpc-4137	79	14	(	(	PUNCT
dpc-4137	79	15	leica	leica	PROPN
dpc-4137	79	16	novolink	novolink	VERB
dpc-4137	79	17	polymer	polymer	NOUN
dpc-4137	79	18	detection	detection	NOUN
dpc-4137	79	19	system	system	NOUN
dpc-4137	79	20	®	®	PROPN
dpc-4137	79	21	,	,	PUNCT
dpc-4137	79	22	united	united	PROPN
dpc-4137	79	23	states	states	PROPN
dpc-4137	79	24	)	)	PUNCT
dpc-4137	79	25	.	.	PUNCT
dpc-4137	80	1	positive	positive	ADJ
dpc-4137	80	2	control	control	NOUN
dpc-4137	80	3	of	of	ADP
dpc-4137	80	4	immunostaining	immunostaining	NOUN
dpc-4137	80	5	was	be	AUX
dpc-4137	80	6	sebaceous	sebaceous	ADJ
dpc-4137	80	7	cells	cell	NOUN
dpc-4137	80	8	in	in	ADP
dpc-4137	80	9	normal	normal	ADJ
dpc-4137	80	10	skin	skin	NOUN
dpc-4137	80	11	(	(	PUNCT
dpc-4137	80	12	figure	figure	NOUN
dpc-4137	80	13	1a	1a	NOUN
dpc-4137	80	14	)	)	PUNCT
dpc-4137	80	15	.	.	PUNCT
dpc-4137	81	1	the	the	DET
dpc-4137	81	2	presence	presence	NOUN
dpc-4137	81	3	of	of	ADP
dpc-4137	81	4	gsdma	gsdma	NOUN
dpc-4137	81	5	was	be	AUX
dpc-4137	81	6	presented	present	VERB
dpc-4137	81	7	using	use	VERB
dpc-4137	81	8	a	a	DET
dpc-4137	81	9	semi	semi	ADJ
dpc-4137	81	10	-	-	ADJ
dpc-4137	81	11	quantitative	quantitative	ADJ
dpc-4137	81	12	method	method	NOUN
dpc-4137	81	13	.	.	PUNCT
dpc-4137	82	1	intensity	intensity	NOUN
dpc-4137	82	2	and	and	CCONJ
dpc-4137	82	3	localization	localization	NOUN
dpc-4137	82	4	of	of	ADP
dpc-4137	82	5	immunostaining	immunostaining	NOUN
dpc-4137	82	6	were	be	AUX
dpc-4137	82	7	analyzed	analyze	VERB
dpc-4137	82	8	and	and	CCONJ
dpc-4137	82	9	defined	define	VERB
dpc-4137	82	10	as	as	ADP
dpc-4137	82	11	follow	follow	NOUN
dpc-4137	82	12	:	:	PUNCT
dpc-4137	82	13	low	low	ADJ
dpc-4137	82	14	expression	expression	NOUN
dpc-4137	82	15	–	–	PUNCT
dpc-4137	82	16	weak	weak	ADJ
dpc-4137	82	17	/	/	SYM
dpc-4137	82	18	medium	medium	ADJ
dpc-4137	82	19	staining	stain	VERB
dpc-4137	82	20	intensity	intensity	NOUN
dpc-4137	82	21	in	in	ADP
dpc-4137	82	22	stratum	stratum	NOUN
dpc-4137	82	23	corneum	corneum	NOUN
dpc-4137	82	24	of	of	ADP
dpc-4137	82	25	epidermis	epidermis	NOUN
dpc-4137	82	26	;	;	PUNCT
dpc-4137	82	27	medium	medium	ADJ
dpc-4137	82	28	expression	expression	NOUN
dpc-4137	82	29	–	–	PUNCT
dpc-4137	82	30	weak	weak	ADJ
dpc-4137	82	31	/	/	SYM
dpc-4137	82	32	medium	medium	ADJ
dpc-4137	82	33	staining	stain	VERB
dpc-4137	82	34	intensity	intensity	NOUN
dpc-4137	82	35	in	in	ADP
dpc-4137	82	36	stratum	stratum	PROPN
dpc-4137	82	37	corneum	corneum	NOUN
dpc-4137	82	38	,	,	PUNCT
dpc-4137	82	39	granulosum	granulosum	NOUN
dpc-4137	82	40	and	and	CCONJ
dpc-4137	82	41	spinosum	spinosum	VERB
dpc-4137	82	42	,	,	PUNCT
dpc-4137	82	43	up	up	ADP
dpc-4137	82	44	to	to	ADP
dpc-4137	82	45	2/3	2/3	NUM
dpc-4137	82	46	of	of	ADP
dpc-4137	82	47	the	the	DET
dpc-4137	82	48	epidermis	epidermis	NOUN
dpc-4137	82	49	;	;	PUNCT
dpc-4137	82	50	strong	strong	ADJ
dpc-4137	82	51	expression	expression	NOUN
dpc-4137	82	52	–	–	PUNCT
dpc-4137	82	53	strong	strong	ADJ
dpc-4137	82	54	staining	staining	ADJ
dpc-4137	82	55	intensity	intensity	NOUN
dpc-4137	82	56	in	in	ADP
dpc-4137	82	57	more	more	ADJ
dpc-4137	82	58	than	than	ADP
dpc-4137	82	59	2/3	2/3	NUM
dpc-4137	82	60	of	of	ADP
dpc-4137	82	61	the	the	DET
dpc-4137	82	62	epidermis	epidermis	NOUN
dpc-4137	82	63	or	or	CCONJ
dpc-4137	82	64	in	in	ADP
dpc-4137	82	65	the	the	DET
dpc-4137	82	66	whole	whole	ADJ
dpc-4137	82	67	epidermis	epidermis	NOUN
dpc-4137	82	68	.	.	PUNCT
dpc-4137	83	1	staining	stain	VERB
dpc-4137	83	2	was	be	AUX
dpc-4137	83	3	observed	observe	VERB
dpc-4137	83	4	mostly	mostly	ADV
dpc-4137	83	5	in	in	ADP
dpc-4137	83	6	cytoplasm	cytoplasm	NOUN
dpc-4137	83	7	of	of	ADP
dpc-4137	83	8	epithelial	epithelial	ADJ
dpc-4137	83	9	cells	cell	NOUN
dpc-4137	83	10	,	,	PUNCT
dpc-4137	83	11	but	but	CCONJ
dpc-4137	83	12	nuclear	nuclear	ADJ
dpc-4137	83	13	staining	stain	VERB
dpc-4137	83	14	in	in	ADP
dpc-4137	83	15	cases	case	NOUN
dpc-4137	83	16	with	with	ADP
dpc-4137	83	17	strong	strong	ADJ
dpc-4137	83	18	expression	expression	NOUN
dpc-4137	83	19	was	be	AUX
dpc-4137	83	20	also	also	ADV
dpc-4137	83	21	noted	note	VERB
dpc-4137	83	22	.	.	PUNCT
dpc-4137	84	1	figure	figure	NOUN
dpc-4137	84	2	1	1	NUM
dpc-4137	84	3	(	(	PUNCT
dpc-4137	84	4	a	a	DET
dpc-4137	84	5	-	-	PUNCT
dpc-4137	84	6	l	l	NOUN
dpc-4137	84	7	)	)	PUNCT
dpc-4137	84	8	presents	present	VERB
dpc-4137	84	9	the	the	DET
dpc-4137	84	10	expression	expression	NOUN
dpc-4137	84	11	of	of	ADP
dpc-4137	84	12	gsdma	gsdma	NOUN
dpc-4137	84	13	in	in	ADP
dpc-4137	84	14	patients	patient	NOUN
dpc-4137	84	15	and	and	CCONJ
dpc-4137	84	16	controls	control	NOUN
dpc-4137	84	17	.	.	PUNCT
dpc-4137	85	1	statistical	statistical	ADJ
dpc-4137	85	2	analysis	analysis	NOUN
dpc-4137	85	3	all	all	DET
dpc-4137	85	4	analyses	analysis	NOUN
dpc-4137	85	5	were	be	AUX
dpc-4137	85	6	performed	perform	VERB
dpc-4137	85	7	in	in	ADP
dpc-4137	85	8	graphpad	graphpad	NOUN
dpc-4137	85	9	9.4	9.4	NUM
dpc-4137	85	10	prism	prism	NOUN
dpc-4137	85	11	.	.	PUNCT
dpc-4137	86	1	the	the	DET
dpc-4137	86	2	normally	normally	ADV
dpc-4137	86	3	distributed	distribute	VERB
dpc-4137	86	4	data	datum	NOUN
dpc-4137	86	5	were	be	AUX
dpc-4137	86	6	analyzed	analyze	VERB
dpc-4137	86	7	using	use	VERB
dpc-4137	86	8	a	a	DET
dpc-4137	86	9	one	one	NUM
dpc-4137	86	10	-	-	PUNCT
dpc-4137	86	11	way	way	NOUN
dpc-4137	86	12	analysis	analysis	NOUN
dpc-4137	86	13	of	of	ADP
dpc-4137	86	14	variance	variance	NOUN
dpc-4137	86	15	(	(	PUNCT
dpc-4137	86	16	anova	anova	PROPN
dpc-4137	86	17	)	)	PUNCT
dpc-4137	86	18	and	and	CCONJ
dpc-4137	86	19	shown	show	VERB
dpc-4137	86	20	as	as	ADP
dpc-4137	86	21	mean	mean	PROPN
dpc-4137	86	22	±	±	NUM
dpc-4137	86	23	sd	sd	NOUN
dpc-4137	86	24	.	.	PUNCT
dpc-4137	87	1	the	the	DET
dpc-4137	87	2	non	non	ADJ
dpc-4137	87	3	-	-	ADJ
dpc-4137	87	4	gaussian	gaussian	ADJ
dpc-4137	87	5	data	datum	NOUN
dpc-4137	87	6	were	be	AUX
dpc-4137	87	7	presented	present	VERB
dpc-4137	87	8	as	as	ADP
dpc-4137	87	9	median	median	PROPN
dpc-4137	87	10	(	(	PUNCT
dpc-4137	87	11	full	full	ADJ
dpc-4137	87	12	range	range	NOUN
dpc-4137	87	13	)	)	PUNCT
dpc-4137	87	14	and	and	CCONJ
dpc-4137	87	15	analyzed	analyze	VERB
dpc-4137	87	16	using	use	VERB
dpc-4137	87	17	non	non	ADJ
dpc-4137	87	18	-	-	ADJ
dpc-4137	87	19	parametric	parametric	ADJ
dpc-4137	87	20	mann	mann	PROPN
dpc-4137	87	21	–	–	PUNCT
dpc-4137	87	22	whitney	whitney	PROPN
dpc-4137	87	23	.	.	PUNCT
dpc-4137	88	1	the	the	DET
dpc-4137	88	2	chi	chi	ADJ
dpc-4137	88	3	-	-	PUNCT
dpc-4137	88	4	square	square	ADJ
dpc-4137	88	5	test	test	NOUN
dpc-4137	88	6	of	of	ADP
dpc-4137	88	7	independence	independence	NOUN
dpc-4137	88	8	was	be	AUX
dpc-4137	88	9	used	use	VERB
dpc-4137	88	10	to	to	PART
dpc-4137	88	11	assess	assess	VERB
dpc-4137	88	12	the	the	DET
dpc-4137	88	13	relationship	relationship	NOUN
dpc-4137	88	14	between	between	ADP
dpc-4137	88	15	two	two	NUM
dpc-4137	88	16	nominal	nominal	ADJ
dpc-4137	88	17	variables	variable	NOUN
dpc-4137	88	18	.	.	PUNCT
dpc-4137	89	1	the	the	DET
dpc-4137	89	2	correlations	correlation	NOUN
dpc-4137	89	3	between	between	ADP
dpc-4137	89	4	the	the	DET
dpc-4137	89	5	examined	examine	VERB
dpc-4137	89	6	parameters	parameter	NOUN
dpc-4137	89	7	were	be	AUX
dpc-4137	89	8	evaluated	evaluate	VERB
dpc-4137	89	9	with	with	ADP
dpc-4137	89	10	spearman	spearman	NOUN
dpc-4137	89	11	’s	’s	PART
dpc-4137	89	12	rank	rank	PROPN
dpc-4137	89	13	test	test	NOUN
dpc-4137	89	14	.	.	PUNCT
dpc-4137	90	1	the	the	DET
dpc-4137	90	2	differences	difference	NOUN
dpc-4137	90	3	were	be	AUX
dpc-4137	90	4	deemed	deem	VERB
dpc-4137	90	5	statistically	statistically	ADV
dpc-4137	90	6	significant	significant	ADJ
dpc-4137	90	7	when	when	SCONJ
dpc-4137	90	8	p	p	NOUN
dpc-4137	90	9	<	<	X
dpc-4137	90	10	0.05	0.05	NUM
dpc-4137	90	11	.	.	PUNCT
dpc-4137	91	1	results	result	VERB
dpc-4137	91	2	the	the	DET
dpc-4137	91	3	basic	basic	ADJ
dpc-4137	91	4	information	information	NOUN
dpc-4137	91	5	on	on	ADP
dpc-4137	91	6	patients	patient	NOUN
dpc-4137	91	7	and	and	CCONJ
dpc-4137	91	8	controls	control	NOUN
dpc-4137	91	9	is	be	AUX
dpc-4137	91	10	presented	present	VERB
dpc-4137	91	11	in	in	ADP
dpc-4137	91	12	table	table	NOUN
dpc-4137	91	13	1	1	NUM
dpc-4137	91	14	.	.	PUNCT
dpc-4137	92	1	we	we	PRON
dpc-4137	92	2	enrolled	enrol	VERB
dpc-4137	92	3	60	60	NUM
dpc-4137	92	4	psoriatic	psoriatic	ADJ
dpc-4137	92	5	patients	patient	NOUN
dpc-4137	92	6	(	(	PUNCT
dpc-4137	92	7	39	39	NUM
dpc-4137	92	8	men	man	NOUN
dpc-4137	92	9	and	and	CCONJ
dpc-4137	92	10	21	21	NUM
dpc-4137	92	11	women	woman	NOUN
dpc-4137	92	12	)	)	PUNCT
dpc-4137	92	13	and	and	CCONJ
dpc-4137	92	14	30	30	NUM
dpc-4137	92	15	controls	control	NOUN
dpc-4137	92	16	(	(	PUNCT
dpc-4137	92	17	20	20	NUM
dpc-4137	92	18	men	man	NOUN
dpc-4137	92	19	and	and	CCONJ
dpc-4137	92	20	10	10	NUM
dpc-4137	92	21	women	woman	NOUN
dpc-4137	92	22	)	)	PUNCT
dpc-4137	92	23	in	in	ADP
dpc-4137	92	24	total	total	NOUN
dpc-4137	92	25	.	.	PUNCT
dpc-4137	93	1	there	there	PRON
dpc-4137	93	2	was	be	VERB
dpc-4137	93	3	no	no	DET
dpc-4137	93	4	statistically	statistically	ADV
dpc-4137	93	5	significant	significant	ADJ
dpc-4137	93	6	difference	difference	NOUN
dpc-4137	93	7	between	between	ADP
dpc-4137	93	8	patients	patient	NOUN
dpc-4137	93	9	and	and	CCONJ
dpc-4137	93	10	controls	control	NOUN
dpc-4137	93	11	in	in	ADP
dpc-4137	93	12	terms	term	NOUN
dpc-4137	93	13	of	of	ADP
dpc-4137	93	14	age	age	NOUN
dpc-4137	93	15	,	,	PUNCT
dpc-4137	93	16	sex	sex	NOUN
dpc-4137	93	17	,	,	PUNCT
dpc-4137	93	18	or	or	CCONJ
dpc-4137	93	19	bmi	bmi	NOUN
dpc-4137	93	20	(	(	PUNCT
dpc-4137	93	21	ns	ns	NUM
dpc-4137	93	22	)	)	PUNCT
dpc-4137	93	23	.	.	PUNCT
dpc-4137	94	1	serum	serum	NOUN
dpc-4137	94	2	and	and	CCONJ
dpc-4137	94	3	urine	urine	NOUN
dpc-4137	94	4	serum	serum	NOUN
dpc-4137	94	5	and	and	CCONJ
dpc-4137	94	6	urine	urine	NOUN
dpc-4137	94	7	were	be	AUX
dpc-4137	94	8	assessed	assess	VERB
dpc-4137	94	9	in	in	ADP
dpc-4137	94	10	60	60	NUM
dpc-4137	94	11	patients	patient	NOUN
dpc-4137	94	12	and	and	CCONJ
dpc-4137	94	13	30	30	NUM
dpc-4137	94	14	controls	control	NOUN
dpc-4137	94	15	.	.	PUNCT
dpc-4137	95	1	the	the	DET
dpc-4137	95	2	median	median	ADJ
dpc-4137	95	3	gsdma	gsdma	NOUN
dpc-4137	95	4	serum	serum	NOUN
dpc-4137	95	5	concentration	concentration	NOUN
dpc-4137	95	6	in	in	ADP
dpc-4137	95	7	patients	patient	NOUN
dpc-4137	95	8	was	be	AUX
dpc-4137	95	9	0.5437	0.5437	NUM
dpc-4137	95	10	(	(	PUNCT
dpc-4137	95	11	0.03–1.407	0.03–1.407	NUM
dpc-4137	95	12	)	)	PUNCT
dpc-4137	95	13	ng	ng	PROPN
dpc-4137	95	14	/	/	SYM
dpc-4137	95	15	ml	ml	PROPN
dpc-4137	95	16	,	,	PUNCT
dpc-4137	95	17	whereas	whereas	SCONJ
dpc-4137	95	18	in	in	ADP
dpc-4137	95	19	the	the	DET
dpc-4137	95	20	controls	control	NOUN
dpc-4137	95	21	it	it	PRON
dpc-4137	95	22	was	be	AUX
dpc-4137	95	23	–	–	PUNCT
dpc-4137	95	24	0.3622	0.3622	NUM
dpc-4137	95	25	(	(	PUNCT
dpc-4137	95	26	0.031–0.793	0.031–0.793	ADJ
dpc-4137	95	27	)	)	PUNCT
dpc-4137	95	28	ng	ng	PROPN
dpc-4137	95	29	/	/	SYM
dpc-4137	95	30	ml	ml	PROPN
dpc-4137	95	31	.	.	PUNCT
dpc-4137	96	1	the	the	DET
dpc-4137	96	2	median	median	ADJ
dpc-4137	96	3	urinary	urinary	ADJ
dpc-4137	96	4	concentration	concentration	NOUN
dpc-4137	96	5	of	of	ADP
dpc-4137	96	6	gsdma	gsdma	NOUN
dpc-4137	96	7	in	in	ADP
dpc-4137	96	8	patients	patient	NOUN
dpc-4137	96	9	was	be	AUX
dpc-4137	96	10	0.138	0.138	NUM
dpc-4137	96	11	(	(	PUNCT
dpc-4137	96	12	0.012–0.779	0.012–0.779	PROPN
dpc-4137	96	13	)	)	PUNCT
dpc-4137	96	14	ng	ng	PROPN
dpc-4137	96	15	/	/	SYM
dpc-4137	96	16	ml	ml	PROPN
dpc-4137	96	17	,	,	PUNCT
dpc-4137	96	18	whereas	whereas	SCONJ
dpc-4137	96	19	in	in	ADP
dpc-4137	96	20	the	the	DET
dpc-4137	96	21	controls	control	NOUN
dpc-4137	96	22	it	it	PRON
dpc-4137	96	23	was	be	AUX
dpc-4137	96	24	–	–	PUNCT
dpc-4137	96	25	0.1235	0.1235	NUM
dpc-4137	96	26	(	(	PUNCT
dpc-4137	96	27	0.027	0.027	NUM
dpc-4137	96	28	-	-	SYM
dpc-4137	96	29	0.285	0.285	NUM
dpc-4137	96	30	)	)	PUNCT
dpc-4137	96	31	ng	ng	PROPN
dpc-4137	96	32	/	/	SYM
dpc-4137	96	33	ml	ml	PROPN
dpc-4137	96	34	.	.	PUNCT
dpc-4137	97	1	the	the	DET
dpc-4137	97	2	median	median	ADJ
dpc-4137	97	3	ratio	ratio	NOUN
dpc-4137	97	4	between	between	ADP
dpc-4137	97	5	urinary	urinary	ADJ
dpc-4137	97	6	gsdma	gsdma	NOUN
dpc-4137	97	7	and	and	CCONJ
dpc-4137	97	8	urinary	urinary	ADJ
dpc-4137	97	9	creatinine	creatinine	NOUN
dpc-4137	97	10	in	in	ADP
dpc-4137	97	11	patients	patient	NOUN
dpc-4137	97	12	was	be	AUX
dpc-4137	97	13	0.00295	0.00295	NUM
dpc-4137	97	14	(	(	PUNCT
dpc-4137	97	15	0.0005–0.0243	0.0005–0.0243	NUM
dpc-4137	97	16	)	)	PUNCT
dpc-4137	97	17	,	,	PUNCT
dpc-4137	97	18	whereas	whereas	SCONJ
dpc-4137	97	19	in	in	ADP
dpc-4137	97	20	the	the	DET
dpc-4137	97	21	controls	control	NOUN
dpc-4137	97	22	it	it	PRON
dpc-4137	97	23	was	be	AUX
dpc-4137	97	24	0.00345	0.00345	NUM
dpc-4137	97	25	(	(	PUNCT
dpc-4137	97	26	0.0006–0.0316	0.0006–0.0316	ADJ
dpc-4137	97	27	)	)	PUNCT
dpc-4137	97	28	.	.	PUNCT
dpc-4137	98	1	the	the	DET
dpc-4137	98	2	serum	serum	NOUN
dpc-4137	98	3	concentration	concentration	NOUN
dpc-4137	98	4	(	(	PUNCT
dpc-4137	98	5	figure	figure	NOUN
dpc-4137	98	6	2a	2a	NUM
dpc-4137	98	7	)	)	PUNCT
dpc-4137	98	8	and	and	CCONJ
dpc-4137	98	9	absolute	absolute	ADJ
dpc-4137	98	10	urinary	urinary	ADJ
dpc-4137	98	11	concentration	concentration	NOUN
dpc-4137	98	12	(	(	PUNCT
dpc-4137	98	13	figure	figure	NOUN
dpc-4137	98	14	2b	2b	NOUN
dpc-4137	98	15	)	)	PUNCT
dpc-4137	98	16	of	of	ADP
dpc-4137	98	17	gsdma	gsdma	NOUN
dpc-4137	98	18	were	be	AUX
dpc-4137	98	19	significantly	significantly	ADV
dpc-4137	98	20	higher	high	ADJ
dpc-4137	98	21	in	in	ADP
dpc-4137	98	22	psoriatic	psoriatic	ADJ
dpc-4137	98	23	patients	patient	NOUN
dpc-4137	98	24	than	than	ADP
dpc-4137	98	25	in	in	ADP
dpc-4137	98	26	controls	control	NOUN
dpc-4137	98	27	without	without	ADP
dpc-4137	98	28	skin	skin	NOUN
dpc-4137	98	29	diseases	disease	NOUN
dpc-4137	98	30	(	(	PUNCT
dpc-4137	98	31	p	p	X
dpc-4137	98	32	<	<	X
dpc-4137	98	33	0.05	0.05	NUM
dpc-4137	98	34	)	)	PUNCT
dpc-4137	98	35	,	,	PUNCT
dpc-4137	98	36	whereas	whereas	SCONJ
dpc-4137	98	37	the	the	DET
dpc-4137	98	38	urinary	urinary	ADJ
dpc-4137	98	39	gsdma	gsdma	NOUN
dpc-4137	98	40	/	/	SYM
dpc-4137	98	41	creatinine	creatinine	NOUN
dpc-4137	98	42	ratio	ratio	NOUN
dpc-4137	98	43	was	be	AUX
dpc-4137	98	44	insignificantly	insignificantly	ADV
dpc-4137	98	45	lower	low	ADJ
dpc-4137	98	46	(	(	PUNCT
dpc-4137	98	47	figure	figure	NOUN
dpc-4137	98	48	2c	2c	NUM
dpc-4137	98	49	)	)	PUNCT
dpc-4137	98	50	.	.	PUNCT
dpc-4137	99	1	after	after	ADP
dpc-4137	99	2	the	the	DET
dpc-4137	99	3	division	division	NOUN
dpc-4137	99	4	of	of	ADP
dpc-4137	99	5	patients	patient	NOUN
dpc-4137	99	6	into	into	ADP
dpc-4137	99	7	three	three	NUM
dpc-4137	99	8	groups	group	NOUN
dpc-4137	99	9	depending	depend	VERB
dpc-4137	99	10	on	on	ADP
dpc-4137	99	11	psoriasis	psoriasis	NOUN
dpc-4137	99	12	severity	severity	NOUN
dpc-4137	99	13	on	on	ADP
dpc-4137	99	14	pasi	pasi	NOUN
dpc-4137	99	15	,	,	PUNCT
dpc-4137	99	16	gsdma	gsdma	NOUN
dpc-4137	99	17	serum	serum	NOUN
dpc-4137	99	18	concentrations	concentration	NOUN
dpc-4137	99	19	were	be	AUX
dpc-4137	99	20	higher	high	ADJ
dpc-4137	99	21	in	in	ADP
dpc-4137	99	22	subjects	subject	NOUN
dpc-4137	99	23	with	with	ADP
dpc-4137	99	24	higher	high	ADJ
dpc-4137	99	25	pasi	pasi	NOUN
dpc-4137	99	26	;	;	PUNCT
dpc-4137	99	27	however	however	ADV
dpc-4137	99	28	,	,	PUNCT
dpc-4137	99	29	there	there	PRON
dpc-4137	99	30	was	be	VERB
dpc-4137	99	31	no	no	DET
dpc-4137	99	32	significant	significant	ADJ
dpc-4137	99	33	difference	difference	NOUN
dpc-4137	99	34	between	between	ADP
dpc-4137	99	35	the	the	DET
dpc-4137	99	36	groups	group	NOUN
dpc-4137	99	37	(	(	PUNCT
dpc-4137	99	38	ns	ns	ADJ
dpc-4137	99	39	)	)	PUNCT
dpc-4137	99	40	(	(	PUNCT
dpc-4137	99	41	figure	figure	NOUN
dpc-4137	99	42	  	  	SPACE
dpc-4137	99	43	3a	3a	NUM
dpc-4137	99	44	.	.	PUNCT
dpc-4137	99	45	)	)	PUNCT
dpc-4137	99	46	.	.	PUNCT
dpc-4137	100	1	after	after	ADP
dpc-4137	100	2	the	the	DET
dpc-4137	100	3	division	division	NOUN
dpc-4137	100	4	of	of	ADP
dpc-4137	100	5	patients	patient	NOUN
dpc-4137	100	6	into	into	ADP
dpc-4137	100	7	subgroups	subgroup	NOUN
dpc-4137	100	8	depending	depend	VERB
dpc-4137	100	9	on	on	ADP
dpc-4137	100	10	the	the	DET
dpc-4137	100	11	psoriasis	psoriasis	NOUN
dpc-4137	100	12	duration	duration	NOUN
dpc-4137	100	13	(	(	PUNCT
dpc-4137	100	14	figure	figure	NOUN
dpc-4137	100	15	3b	3b	NUM
dpc-4137	100	16	)	)	PUNCT
dpc-4137	100	17	or	or	CCONJ
dpc-4137	100	18	by	by	ADP
dpc-4137	100	19	sex	sex	NOUN
dpc-4137	100	20	4	4	NUM
dpc-4137	100	21	original	original	ADJ
dpc-4137	100	22	article	article	NOUN
dpc-4137	100	23	|	|	ADV
dpc-4137	100	24	dermatol	dermatol	ADJ
dpc-4137	100	25	pract	pract	NOUN
dpc-4137	100	26	concept	concept	NOUN
dpc-4137	100	27	.	.	PUNCT
dpc-4137	101	1	2024;14(3):e2024177	2024;14(3):e2024177	NUM
dpc-4137	101	2	figure	figure	NOUN
dpc-4137	101	3	1	1	NUM
dpc-4137	101	4	.	.	PUNCT
dpc-4137	101	5	immunohistochemical	immunohistochemical	ADJ
dpc-4137	101	6	expression	expression	NOUN
dpc-4137	101	7	of	of	ADP
dpc-4137	101	8	gsdma	gsdma	NOUN
dpc-4137	101	9	in	in	ADP
dpc-4137	101	10	healthy	healthy	ADJ
dpc-4137	101	11	group	group	NOUN
dpc-4137	101	12	and	and	CCONJ
dpc-4137	101	13	patients	patient	NOUN
dpc-4137	101	14	with	with	ADP
dpc-4137	101	15	psoriasis	psoriasis	NOUN
dpc-4137	101	16	.	.	PUNCT
dpc-4137	102	1	healthy	healthy	ADJ
dpc-4137	102	2	skin	skin	NOUN
dpc-4137	102	3	–	–	PUNCT
dpc-4137	102	4	gsdma	gsdma	NOUN
dpc-4137	102	5	weak	weak	ADJ
dpc-4137	102	6	expression	expression	NOUN
dpc-4137	102	7	in	in	ADP
dpc-4137	102	8	stratum	stratum	PROPN
dpc-4137	102	9	corneum	corneum	NOUN
dpc-4137	102	10	,	,	PUNCT
dpc-4137	102	11	also	also	ADV
dpc-4137	102	12	positive	positive	ADJ
dpc-4137	102	13	staining	stain	VERB
dpc-4137	102	14	in	in	ADP
dpc-4137	102	15	the	the	DET
dpc-4137	102	16	sebaceous	sebaceous	ADJ
dpc-4137	102	17	glands	gland	NOUN
dpc-4137	102	18	(	(	PUNCT
dpc-4137	102	19	a	a	DET
dpc-4137	102	20	,	,	PUNCT
dpc-4137	102	21	b	b	NOUN
dpc-4137	102	22	)	)	PUNCT
dpc-4137	102	23	;	;	PUNCT
dpc-4137	102	24	non	non	ADJ
dpc-4137	102	25	-	-	ADJ
dpc-4137	102	26	lesional	lesional	ADJ
dpc-4137	102	27	skin	skin	NOUN
dpc-4137	102	28	(	(	PUNCT
dpc-4137	102	29	patients	patient	NOUN
dpc-4137	102	30	with	with	ADP
dpc-4137	102	31	psoriasis	psoriasis	NOUN
dpc-4137	102	32	)	)	PUNCT
dpc-4137	102	33	–	–	PUNCT
dpc-4137	102	34	weak	weak	ADJ
dpc-4137	102	35	expression	expression	NOUN
dpc-4137	102	36	in	in	ADP
dpc-4137	102	37	stratum	stratum	NOUN
dpc-4137	102	38	corneum	corneum	NOUN
dpc-4137	102	39	(	(	PUNCT
dpc-4137	102	40	c	c	X
dpc-4137	102	41	,	,	PUNCT
dpc-4137	102	42	d	d	NOUN
dpc-4137	102	43	)	)	PUNCT
dpc-4137	102	44	,	,	PUNCT
dpc-4137	102	45	medium	medium	NOUN
dpc-4137	102	46	(	(	PUNCT
dpc-4137	102	47	e	e	NOUN
dpc-4137	102	48	,	,	PUNCT
dpc-4137	102	49	f	f	NOUN
dpc-4137	102	50	)	)	PUNCT
dpc-4137	102	51	and	and	CCONJ
dpc-4137	102	52	high	high	ADJ
dpc-4137	102	53	(	(	PUNCT
dpc-4137	102	54	g	g	NOUN
dpc-4137	102	55	,	,	PUNCT
dpc-4137	102	56	h	h	NOUN
dpc-4137	102	57	)	)	PUNCT
dpc-4137	102	58	expression	expression	NOUN
dpc-4137	102	59	in	in	ADP
dpc-4137	102	60	stratum	stratum	PROPN
dpc-4137	102	61	corneum	corneum	NOUN
dpc-4137	102	62	,	,	PUNCT
dpc-4137	102	63	granulosum	granulosum	NOUN
dpc-4137	102	64	,	,	PUNCT
dpc-4137	102	65	and	and	CCONJ
dpc-4137	102	66	spinosum	spinosum	NOUN
dpc-4137	102	67	,	,	PUNCT
dpc-4137	102	68	up	up	ADP
dpc-4137	102	69	to	to	ADP
dpc-4137	102	70	2/3	2/3	NUM
dpc-4137	102	71	of	of	ADP
dpc-4137	102	72	the	the	DET
dpc-4137	102	73	epidermis	epidermis	NOUN
dpc-4137	102	74	;	;	PUNCT
dpc-4137	102	75	lesional	lesional	ADJ
dpc-4137	102	76	skin	skin	NOUN
dpc-4137	102	77	(	(	PUNCT
dpc-4137	102	78	psoriasis	psoriasis	NOUN
dpc-4137	102	79	)	)	PUNCT
dpc-4137	102	80	–	–	PUNCT
dpc-4137	102	81	medium	medium	NOUN
dpc-4137	102	82	expression	expression	NOUN
dpc-4137	102	83	in	in	ADP
dpc-4137	102	84	stratum	stratum	PROPN
dpc-4137	102	85	corneum	corneum	NOUN
dpc-4137	102	86	,	,	PUNCT
dpc-4137	102	87	granulosum	granulosum	NOUN
dpc-4137	102	88	and	and	CCONJ
dpc-4137	102	89	spinosum	spinosum	VERB
dpc-4137	102	90	,	,	PUNCT
dpc-4137	102	91	up	up	ADP
dpc-4137	102	92	to	to	ADP
dpc-4137	102	93	2/3	2/3	NUM
dpc-4137	102	94	of	of	ADP
dpc-4137	102	95	the	the	DET
dpc-4137	102	96	epidermis	epidermis	NOUN
dpc-4137	102	97	(	(	PUNCT
dpc-4137	102	98	i	i	PROPN
dpc-4137	102	99	,	,	PUNCT
dpc-4137	102	100	j	j	PROPN
dpc-4137	102	101	)	)	PUNCT
dpc-4137	102	102	;	;	PUNCT
dpc-4137	102	103	lesional	lesional	ADJ
dpc-4137	102	104	skin	skin	NOUN
dpc-4137	102	105	(	(	PUNCT
dpc-4137	102	106	psoriasis	psoriasis	NOUN
dpc-4137	102	107	)	)	PUNCT
dpc-4137	102	108	–	–	PUNCT
dpc-4137	102	109	strong	strong	ADJ
dpc-4137	102	110	expression	expression	NOUN
dpc-4137	102	111	in	in	ADP
dpc-4137	102	112	more	more	ADJ
dpc-4137	102	113	than	than	ADP
dpc-4137	102	114	2/3	2/3	NUM
dpc-4137	102	115	of	of	ADP
dpc-4137	102	116	the	the	DET
dpc-4137	102	117	epidermis	epidermis	NOUN
dpc-4137	102	118	or	or	CCONJ
dpc-4137	102	119	in	in	ADP
dpc-4137	102	120	the	the	DET
dpc-4137	102	121	whole	whole	ADJ
dpc-4137	102	122	epidermis	epidermis	NOUN
dpc-4137	102	123	(	(	PUNCT
dpc-4137	102	124	k	k	NOUN
dpc-4137	102	125	,	,	PUNCT
dpc-4137	102	126	l	l	NOUN
dpc-4137	102	127	)	)	PUNCT
dpc-4137	102	128	.	.	PUNCT
dpc-4137	103	1	magnifications	magnification	NOUN
dpc-4137	103	2	x	x	SYM
dpc-4137	103	3	100	100	NUM
dpc-4137	103	4	and	and	CCONJ
dpc-4137	103	5	x	x	SYM
dpc-4137	103	6	400	400	NUM
dpc-4137	103	7	.	.	PUNCT
dpc-4137	103	8	original	original	ADJ
dpc-4137	103	9	article	article	NOUN
dpc-4137	103	10	|	|	ADV
dpc-4137	103	11	dermatol	dermatol	ADJ
dpc-4137	103	12	pract	pract	NOUN
dpc-4137	103	13	concept	concept	NOUN
dpc-4137	103	14	.	.	PUNCT
dpc-4137	104	1	2024;14(3):e2024177	2024;14(3):e2024177	NUM
dpc-4137	104	2	5	5	NUM
dpc-4137	104	3	expression	expression	NOUN
dpc-4137	104	4	,	,	PUNCT
dpc-4137	104	5	11	11	NUM
dpc-4137	104	6	samples	sample	NOUN
dpc-4137	104	7	had	have	VERB
dpc-4137	104	8	moderate	moderate	ADJ
dpc-4137	104	9	expression	expression	NOUN
dpc-4137	104	10	,	,	PUNCT
dpc-4137	104	11	and	and	CCONJ
dpc-4137	104	12	only	only	ADV
dpc-4137	104	13	one	one	NUM
dpc-4137	104	14	sample	sample	NOUN
dpc-4137	104	15	had	have	VERB
dpc-4137	104	16	low	low	ADJ
dpc-4137	104	17	expression	expression	NOUN
dpc-4137	104	18	.	.	PUNCT
dpc-4137	105	1	among	among	ADP
dpc-4137	105	2	the	the	DET
dpc-4137	105	3	samples	sample	NOUN
dpc-4137	105	4	taken	take	VERB
dpc-4137	105	5	from	from	ADP
dpc-4137	105	6	the	the	DET
dpc-4137	105	7	non	non	ADJ
dpc-4137	105	8	-	-	ADJ
dpc-4137	105	9	lesional	lesional	ADJ
dpc-4137	105	10	skin	skin	NOUN
dpc-4137	105	11	of	of	ADP
dpc-4137	105	12	patients	patient	NOUN
dpc-4137	105	13	,	,	PUNCT
dpc-4137	105	14	seven	seven	NUM
dpc-4137	105	15	samples	sample	NOUN
dpc-4137	105	16	exhibited	exhibit	VERB
dpc-4137	105	17	strong	strong	ADJ
dpc-4137	105	18	gsdma	gsdma	NOUN
dpc-4137	105	19	expression	expression	NOUN
dpc-4137	105	20	,	,	PUNCT
dpc-4137	105	21	13	13	NUM
dpc-4137	105	22	samples	sample	NOUN
dpc-4137	105	23	had	have	VERB
dpc-4137	105	24	moderate	moderate	ADJ
dpc-4137	105	25	expression	expression	NOUN
dpc-4137	105	26	,	,	PUNCT
dpc-4137	105	27	and	and	CCONJ
dpc-4137	105	28	13	13	NUM
dpc-4137	105	29	samples	sample	NOUN
dpc-4137	105	30	had	have	VERB
dpc-4137	105	31	low	low	ADJ
dpc-4137	105	32	expression	expression	NOUN
dpc-4137	105	33	.	.	PUNCT
dpc-4137	106	1	among	among	ADP
dpc-4137	106	2	the	the	DET
dpc-4137	106	3	control	control	NOUN
dpc-4137	106	4	group	group	NOUN
dpc-4137	106	5	,	,	PUNCT
dpc-4137	106	6	all	all	DET
dpc-4137	106	7	samples	sample	NOUN
dpc-4137	106	8	exhibited	exhibit	VERB
dpc-4137	106	9	low	low	ADJ
dpc-4137	106	10	gsdma	gsdma	NOUN
dpc-4137	106	11	samples	sample	NOUN
dpc-4137	106	12	,	,	PUNCT
dpc-4137	106	13	and	and	CCONJ
dpc-4137	106	14	only	only	ADV
dpc-4137	106	15	1	1	NUM
dpc-4137	106	16	with	with	ADP
dpc-4137	106	17	strong	strong	ADJ
dpc-4137	106	18	gsdma	gsdma	NOUN
dpc-4137	106	19	expression	expression	NOUN
dpc-4137	106	20	.	.	PUNCT
dpc-4137	107	1	the	the	DET
dpc-4137	107	2	majority	majority	NOUN
dpc-4137	107	3	of	of	ADP
dpc-4137	107	4	the	the	DET
dpc-4137	107	5	samples	sample	NOUN
dpc-4137	107	6	taken	take	VERB
dpc-4137	107	7	from	from	ADP
dpc-4137	107	8	the	the	DET
dpc-4137	107	9	psoriatic	psoriatic	ADJ
dpc-4137	107	10	plaque	plaque	NOUN
dpc-4137	107	11	exhibited	exhibit	VERB
dpc-4137	107	12	strong	strong	ADJ
dpc-4137	107	13	gsdma	gsdma	NOUN
dpc-4137	107	14	expression	expression	NOUN
dpc-4137	107	15	,	,	PUNCT
dpc-4137	107	16	whereas	whereas	SCONJ
dpc-4137	107	17	the	the	DET
dpc-4137	107	18	majority	majority	NOUN
dpc-4137	107	19	of	of	ADP
dpc-4137	107	20	samples	sample	NOUN
dpc-4137	107	21	from	from	ADP
dpc-4137	107	22	the	the	DET
dpc-4137	107	23	healthy	healthy	ADJ
dpc-4137	107	24	skin	skin	NOUN
dpc-4137	107	25	of	of	ADP
dpc-4137	107	26	controls	control	NOUN
dpc-4137	107	27	exhibited	exhibit	VERB
dpc-4137	107	28	low	low	ADJ
dpc-4137	107	29	gsdma	gsdma	NOUN
dpc-4137	107	30	expression	expression	NOUN
dpc-4137	107	31	.	.	PUNCT
dpc-4137	108	1	strong	strong	ADJ
dpc-4137	108	2	expression	expression	NOUN
dpc-4137	108	3	of	of	ADP
dpc-4137	108	4	gsdma	gsdma	NOUN
dpc-4137	108	5	was	be	AUX
dpc-4137	108	6	significantly	significantly	ADV
dpc-4137	108	7	more	more	ADV
dpc-4137	108	8	prevalent	prevalent	ADJ
dpc-4137	108	9	in	in	ADP
dpc-4137	108	10	psoriatic	psoriatic	ADJ
dpc-4137	108	11	plaques	plaque	NOUN
dpc-4137	108	12	compared	compare	VERB
dpc-4137	108	13	to	to	ADP
dpc-4137	108	14	non	non	ADJ
dpc-4137	108	15	-	-	ADJ
dpc-4137	108	16	lesional	lesional	ADJ
dpc-4137	108	17	patients	patient	NOUN
dpc-4137	108	18	’	'	PUNCT
dpc-4137	108	19	skin	skin	NOUN
dpc-4137	108	20	and	and	CCONJ
dpc-4137	108	21	healthy	healthy	ADJ
dpc-4137	108	22	skin	skin	NOUN
dpc-4137	108	23	of	of	ADP
dpc-4137	108	24	controls	control	NOUN
dpc-4137	108	25	(	(	PUNCT
dpc-4137	108	26	p	p	X
dpc-4137	108	27	<	<	X
dpc-4137	108	28	0.01	0.01	NUM
dpc-4137	108	29	and	and	CCONJ
dpc-4137	108	30	p	p	X
dpc-4137	108	31	<	<	X
dpc-4137	108	32	0.001	0.001	NUM
dpc-4137	108	33	,	,	PUNCT
dpc-4137	108	34	respectively	respectively	ADV
dpc-4137	108	35	)	)	PUNCT
dpc-4137	108	36	.	.	PUNCT
dpc-4137	109	1	low	low	ADJ
dpc-4137	109	2	expression	expression	NOUN
dpc-4137	109	3	of	of	ADP
dpc-4137	109	4	gsdma	gsdma	NOUN
dpc-4137	109	5	was	be	AUX
dpc-4137	109	6	significantly	significantly	ADV
dpc-4137	109	7	more	more	ADV
dpc-4137	109	8	prevalent	prevalent	ADJ
dpc-4137	109	9	in	in	ADP
dpc-4137	109	10	the	the	DET
dpc-4137	109	11	healthy	healthy	ADJ
dpc-4137	109	12	skin	skin	NOUN
dpc-4137	109	13	of	of	ADP
dpc-4137	109	14	controls	control	NOUN
dpc-4137	109	15	than	than	ADP
dpc-4137	109	16	in	in	ADP
dpc-4137	109	17	non	non	ADJ
dpc-4137	109	18	-	-	ADJ
dpc-4137	109	19	lesional	lesional	ADJ
dpc-4137	109	20	patients	patient	NOUN
dpc-4137	109	21	’	’	PART
dpc-4137	109	22	skin	skin	NOUN
dpc-4137	109	23	and	and	CCONJ
dpc-4137	109	24	psoriatic	psoriatic	ADJ
dpc-4137	109	25	plaques	plaque	NOUN
dpc-4137	109	26	(	(	PUNCT
dpc-4137	109	27	p	p	X
dpc-4137	109	28	<	<	X
dpc-4137	109	29	0.001	0.001	NUM
dpc-4137	109	30	and	and	CCONJ
dpc-4137	109	31	p	p	X
dpc-4137	109	32	<	<	X
dpc-4137	109	33	0.01	0.01	NUM
dpc-4137	109	34	,	,	PUNCT
dpc-4137	109	35	respectively	respectively	ADV
dpc-4137	109	36	)	)	PUNCT
dpc-4137	109	37	.	.	PUNCT
dpc-4137	110	1	there	there	PRON
dpc-4137	110	2	was	be	VERB
dpc-4137	110	3	no	no	DET
dpc-4137	110	4	sample	sample	NOUN
dpc-4137	110	5	with	with	ADP
dpc-4137	110	6	moderate	moderate	ADJ
dpc-4137	110	7	expression	expression	NOUN
dpc-4137	110	8	of	of	ADP
dpc-4137	110	9	gsdma	gsdma	NOUN
dpc-4137	110	10	in	in	ADP
dpc-4137	110	11	healthy	healthy	ADJ
dpc-4137	110	12	controls	control	NOUN
dpc-4137	110	13	(	(	PUNCT
dpc-4137	110	14	figure	figure	NOUN
dpc-4137	110	15	5	5	NUM
dpc-4137	110	16	)	)	PUNCT
dpc-4137	110	17	.	.	PUNCT
dpc-4137	111	1	after	after	ADP
dpc-4137	111	2	the	the	DET
dpc-4137	111	3	division	division	NOUN
dpc-4137	111	4	of	of	ADP
dpc-4137	111	5	patients	patient	NOUN
dpc-4137	111	6	according	accord	VERB
dpc-4137	111	7	to	to	ADP
dpc-4137	111	8	psoriasis	psoriasis	NOUN
dpc-4137	111	9	severity	severity	NOUN
dpc-4137	111	10	on	on	ADP
dpc-4137	111	11	pasi	pasi	NOUN
dpc-4137	111	12	,	,	PUNCT
dpc-4137	111	13	in	in	ADP
dpc-4137	111	14	subjects	subject	NOUN
dpc-4137	111	15	with	with	ADP
dpc-4137	111	16	mild	mild	ADJ
dpc-4137	111	17	psoriasis	psoriasis	NOUN
dpc-4137	111	18	(	(	PUNCT
dpc-4137	111	19	pasi	pasi	NOUN
dpc-4137	111	20	i	i	PROPN
dpc-4137	111	21	)	)	PUNCT
dpc-4137	111	22	,	,	PUNCT
dpc-4137	111	23	we	we	PRON
dpc-4137	111	24	observed	observe	VERB
dpc-4137	111	25	samples	sample	NOUN
dpc-4137	111	26	only	only	ADV
dpc-4137	111	27	with	with	ADP
dpc-4137	111	28	low	low	ADJ
dpc-4137	111	29	gsmda	gsmda	ADJ
dpc-4137	111	30	expression	expression	NOUN
dpc-4137	111	31	.	.	PUNCT
dpc-4137	112	1	the	the	DET
dpc-4137	112	2	highest	high	ADJ
dpc-4137	112	3	number	number	NOUN
dpc-4137	112	4	of	of	ADP
dpc-4137	112	5	samples	sample	NOUN
dpc-4137	112	6	with	with	ADP
dpc-4137	112	7	strong	strong	ADJ
dpc-4137	112	8	gsdma	gsdma	NOUN
dpc-4137	112	9	expression	expression	NOUN
dpc-4137	112	10	was	be	AUX
dpc-4137	112	11	found	find	VERB
dpc-4137	112	12	in	in	ADP
dpc-4137	112	13	the	the	DET
dpc-4137	112	14	subgroup	subgroup	NOUN
dpc-4137	112	15	of	of	ADP
dpc-4137	112	16	severe	severe	ADJ
dpc-4137	112	17	psoriasis	psoriasis	NOUN
dpc-4137	112	18	(	(	PUNCT
dpc-4137	112	19	pasi	pasi	NOUN
dpc-4137	112	20	iii	iii	PROPN
dpc-4137	112	21	)	)	PUNCT
dpc-4137	112	22	(	(	PUNCT
dpc-4137	112	23	figure	figure	NOUN
dpc-4137	112	24	6	6	NUM
dpc-4137	112	25	)	)	PUNCT
dpc-4137	112	26	.	.	PUNCT
dpc-4137	113	1	conclusions	conclusion	NOUN
dpc-4137	113	2	we	we	PRON
dpc-4137	113	3	here	here	ADV
dpc-4137	113	4	report	report	VERB
dpc-4137	113	5	on	on	ADP
dpc-4137	113	6	the	the	DET
dpc-4137	113	7	possible	possible	ADJ
dpc-4137	113	8	role	role	NOUN
dpc-4137	113	9	of	of	ADP
dpc-4137	113	10	gsdma	gsdma	NOUN
dpc-4137	113	11	in	in	ADP
dpc-4137	113	12	psoriasis	psoriasis	NOUN
dpc-4137	113	13	.	.	PUNCT
dpc-4137	114	1	unfortunately	unfortunately	ADV
dpc-4137	114	2	,	,	PUNCT
dpc-4137	114	3	gsdma	gsdma	NOUN
dpc-4137	114	4	seems	seem	VERB
dpc-4137	114	5	to	to	PART
dpc-4137	114	6	be	be	AUX
dpc-4137	114	7	understudied	understudy	VERB
dpc-4137	114	8	so	so	ADV
dpc-4137	114	9	far	far	ADV
dpc-4137	114	10	,	,	PUNCT
dpc-4137	114	11	and	and	CCONJ
dpc-4137	114	12	the	the	DET
dpc-4137	114	13	data	datum	NOUN
dpc-4137	114	14	on	on	ADP
dpc-4137	114	15	its	its	PRON
dpc-4137	114	16	biological	biological	ADJ
dpc-4137	114	17	role	role	NOUN
dpc-4137	114	18	and	and	CCONJ
dpc-4137	114	19	involvement	involvement	NOUN
dpc-4137	114	20	in	in	ADP
dpc-4137	114	21	other	other	ADJ
dpc-4137	114	22	diseases	disease	NOUN
dpc-4137	114	23	are	be	AUX
dpc-4137	114	24	scarce	scarce	ADJ
dpc-4137	114	25	.	.	PUNCT
dpc-4137	115	1	that	that	PRON
dpc-4137	115	2	makes	make	VERB
dpc-4137	115	3	our	our	PRON
dpc-4137	115	4	results	result	NOUN
dpc-4137	115	5	challenging	challenge	VERB
dpc-4137	115	6	to	to	PART
dpc-4137	115	7	interpret	interpret	VERB
dpc-4137	115	8	at	at	ADP
dpc-4137	115	9	this	this	DET
dpc-4137	115	10	point	point	NOUN
dpc-4137	115	11	.	.	PUNCT
dpc-4137	116	1	nevertheless	nevertheless	ADV
dpc-4137	116	2	,	,	PUNCT
dpc-4137	116	3	as	as	ADP
dpc-4137	116	4	for	for	ADP
dpc-4137	116	5	dermatoses	dermatosis	NOUN
dpc-4137	116	6	,	,	PUNCT
dpc-4137	116	7	a	a	DET
dpc-4137	116	8	very	very	ADV
dpc-4137	116	9	recent	recent	ADJ
dpc-4137	116	10	publication	publication	NOUN
dpc-4137	116	11	investigated	investigate	VERB
dpc-4137	116	12	gsdma	gsdma	NOUN
dpc-4137	116	13	in	in	ADP
dpc-4137	116	14	atopic	atopic	NOUN
dpc-4137	116	15	dermatitis	dermatitis	NOUN
dpc-4137	116	16	(	(	PUNCT
dpc-4137	116	17	ad	ad	NOUN
dpc-4137	116	18	)	)	PUNCT
dpc-4137	116	19	.	.	PUNCT
dpc-4137	117	1	surprisingly	surprisingly	ADV
dpc-4137	117	2	,	,	PUNCT
dpc-4137	117	3	gsdma	gsdma	PROPN
dpc-4137	117	4	had	have	VERB
dpc-4137	117	5	lower	low	ADJ
dpc-4137	117	6	expression	expression	NOUN
dpc-4137	117	7	in	in	ADP
dpc-4137	117	8	the	the	DET
dpc-4137	117	9	ad	ad	NOUN
dpc-4137	117	10	(	(	PUNCT
dpc-4137	117	11	figure	figure	NOUN
dpc-4137	117	12	3c	3c	NUM
dpc-4137	117	13	)	)	PUNCT
dpc-4137	117	14	,	,	PUNCT
dpc-4137	117	15	there	there	PRON
dpc-4137	117	16	was	be	VERB
dpc-4137	117	17	no	no	DET
dpc-4137	117	18	significant	significant	ADJ
dpc-4137	117	19	difference	difference	NOUN
dpc-4137	117	20	between	between	ADP
dpc-4137	117	21	the	the	DET
dpc-4137	117	22	groups	group	NOUN
dpc-4137	117	23	(	(	PUNCT
dpc-4137	117	24	ns	ns	ADJ
dpc-4137	117	25	)	)	PUNCT
dpc-4137	117	26	.	.	PUNCT
dpc-4137	118	1	after	after	ADP
dpc-4137	118	2	the	the	DET
dpc-4137	118	3	division	division	NOUN
dpc-4137	118	4	of	of	ADP
dpc-4137	118	5	patients	patient	NOUN
dpc-4137	118	6	according	accord	VERB
dpc-4137	118	7	to	to	ADP
dpc-4137	118	8	bmi	bmi	PROPN
dpc-4137	118	9	,	,	PUNCT
dpc-4137	118	10	there	there	PRON
dpc-4137	118	11	was	be	VERB
dpc-4137	118	12	no	no	DET
dpc-4137	118	13	significant	significant	ADJ
dpc-4137	118	14	difference	difference	NOUN
dpc-4137	118	15	between	between	ADP
dpc-4137	118	16	the	the	DET
dpc-4137	118	17	subgroups	subgroup	NOUN
dpc-4137	118	18	(	(	PUNCT
dpc-4137	118	19	ns	ns	INTJ
dpc-4137	118	20	,	,	PUNCT
dpc-4137	118	21	data	datum	NOUN
dpc-4137	118	22	not	not	PART
dpc-4137	118	23	shown	show	VERB
dpc-4137	118	24	)	)	PUNCT
dpc-4137	118	25	.	.	PUNCT
dpc-4137	119	1	there	there	PRON
dpc-4137	119	2	was	be	VERB
dpc-4137	119	3	no	no	DET
dpc-4137	119	4	significant	significant	ADJ
dpc-4137	119	5	correlation	correlation	NOUN
dpc-4137	119	6	between	between	ADP
dpc-4137	119	7	serum	serum	NOUN
dpc-4137	119	8	concentration	concentration	NOUN
dpc-4137	119	9	of	of	ADP
dpc-4137	119	10	gsdma	gsdma	NOUN
dpc-4137	119	11	and	and	CCONJ
dpc-4137	119	12	pasi	pasi	NOUN
dpc-4137	119	13	,	,	PUNCT
dpc-4137	119	14	bmi	bmi	PROPN
dpc-4137	119	15	,	,	PUNCT
dpc-4137	119	16	age	age	NOUN
dpc-4137	119	17	,	,	PUNCT
dpc-4137	119	18	sex	sex	NOUN
dpc-4137	119	19	of	of	ADP
dpc-4137	119	20	patients	patient	NOUN
dpc-4137	119	21	,	,	PUNCT
dpc-4137	119	22	or	or	CCONJ
dpc-4137	119	23	psoriasis	psoriasis	NOUN
dpc-4137	119	24	duration	duration	NOUN
dpc-4137	119	25	(	(	PUNCT
dpc-4137	119	26	ns	ns	NUM
dpc-4137	119	27	)	)	PUNCT
dpc-4137	119	28	.	.	PUNCT
dpc-4137	120	1	among	among	ADP
dpc-4137	120	2	the	the	DET
dpc-4137	120	3	laboratory	laboratory	NOUN
dpc-4137	120	4	investigations	investigation	NOUN
dpc-4137	120	5	,	,	PUNCT
dpc-4137	120	6	there	there	PRON
dpc-4137	120	7	was	be	VERB
dpc-4137	120	8	a	a	DET
dpc-4137	120	9	strong	strong	ADJ
dpc-4137	120	10	significant	significant	ADJ
dpc-4137	120	11	negative	negative	ADJ
dpc-4137	120	12	correlation	correlation	NOUN
dpc-4137	120	13	between	between	ADP
dpc-4137	120	14	gsdma	gsdma	NOUN
dpc-4137	120	15	serum	serum	NOUN
dpc-4137	120	16	concentration	concentration	NOUN
dpc-4137	120	17	and	and	CCONJ
dpc-4137	120	18	alt	alt	VERB
dpc-4137	120	19	activity	activity	NOUN
dpc-4137	120	20	(	(	PUNCT
dpc-4137	120	21	r	r	NOUN
dpc-4137	120	22	=	=	PUNCT
dpc-4137	120	23	-0.38	-0.38	ADJ
dpc-4137	120	24	;	;	PUNCT
dpc-4137	120	25	p	p	X
dpc-4137	120	26	=	=	PROPN
dpc-4137	120	27	0.0026	0.0026	NUM
dpc-4137	120	28	)	)	PUNCT
dpc-4137	120	29	(	(	PUNCT
dpc-4137	120	30	figure	figure	NOUN
dpc-4137	120	31	4	4	NUM
dpc-4137	120	32	)	)	PUNCT
dpc-4137	120	33	.	.	PUNCT
dpc-4137	121	1	tissue	tissue	NOUN
dpc-4137	121	2	tissue	tissue	NOUN
dpc-4137	121	3	gsdma	gsdma	NOUN
dpc-4137	121	4	expression	expression	NOUN
dpc-4137	121	5	was	be	AUX
dpc-4137	121	6	assessed	assess	VERB
dpc-4137	121	7	in	in	ADP
dpc-4137	121	8	33	33	NUM
dpc-4137	121	9	patients	patient	NOUN
dpc-4137	121	10	and	and	CCONJ
dpc-4137	121	11	20	20	NUM
dpc-4137	121	12	controls	control	NOUN
dpc-4137	121	13	.	.	PUNCT
dpc-4137	122	1	the	the	DET
dpc-4137	122	2	presence	presence	NOUN
dpc-4137	122	3	of	of	ADP
dpc-4137	122	4	gsdma	gsdma	NOUN
dpc-4137	122	5	was	be	AUX
dpc-4137	122	6	presented	present	VERB
dpc-4137	122	7	as	as	ADP
dpc-4137	122	8	low	low	ADJ
dpc-4137	122	9	expression	expression	NOUN
dpc-4137	122	10	(	(	PUNCT
dpc-4137	122	11	in	in	ADP
dpc-4137	122	12	stratum	stratum	PROPN
dpc-4137	122	13	corneum	corneum	NOUN
dpc-4137	122	14	)	)	PUNCT
dpc-4137	122	15	,	,	PUNCT
dpc-4137	122	16	moderate	moderate	ADJ
dpc-4137	122	17	expression	expression	NOUN
dpc-4137	122	18	(	(	PUNCT
dpc-4137	122	19	in	in	ADP
dpc-4137	122	20	stratum	stratum	PROPN
dpc-4137	122	21	corneum	corneum	NOUN
dpc-4137	122	22	,	,	PUNCT
dpc-4137	122	23	granulosum	granulosum	NOUN
dpc-4137	122	24	,	,	PUNCT
dpc-4137	122	25	and	and	CCONJ
dpc-4137	122	26	spinosum	spinosum	NOUN
dpc-4137	122	27	,	,	PUNCT
dpc-4137	122	28	up	up	ADP
dpc-4137	122	29	to	to	ADP
dpc-4137	122	30	2/3	2/3	NUM
dpc-4137	122	31	of	of	ADP
dpc-4137	122	32	the	the	DET
dpc-4137	122	33	epidermis	epidermis	NOUN
dpc-4137	122	34	)	)	PUNCT
dpc-4137	122	35	,	,	PUNCT
dpc-4137	122	36	or	or	CCONJ
dpc-4137	122	37	strong	strong	ADJ
dpc-4137	122	38	expression	expression	NOUN
dpc-4137	122	39	(	(	PUNCT
dpc-4137	122	40	in	in	ADP
dpc-4137	122	41	more	more	ADJ
dpc-4137	122	42	than	than	ADP
dpc-4137	122	43	2/3	2/3	NUM
dpc-4137	122	44	of	of	ADP
dpc-4137	122	45	the	the	DET
dpc-4137	122	46	epidermis	epidermis	NOUN
dpc-4137	122	47	or	or	CCONJ
dpc-4137	122	48	in	in	ADP
dpc-4137	122	49	the	the	DET
dpc-4137	122	50	whole	whole	ADJ
dpc-4137	122	51	epidermis	epidermis	NOUN
dpc-4137	122	52	)	)	PUNCT
dpc-4137	122	53	.	.	PUNCT
dpc-4137	123	1	twenty	twenty	NUM
dpc-4137	123	2	-	-	PUNCT
dpc-4137	123	3	one	one	NUM
dpc-4137	123	4	samples	sample	NOUN
dpc-4137	123	5	taken	take	VERB
dpc-4137	123	6	from	from	ADP
dpc-4137	123	7	the	the	DET
dpc-4137	123	8	psoriatic	psoriatic	ADJ
dpc-4137	123	9	plaques	plaque	NOUN
dpc-4137	123	10	exhibited	exhibit	VERB
dpc-4137	123	11	strong	strong	ADJ
dpc-4137	123	12	gsdma	gsdma	NOUN
dpc-4137	123	13	table	table	NOUN
dpc-4137	123	14	1	1	NUM
dpc-4137	123	15	.	.	PUNCT
dpc-4137	124	1	the	the	DET
dpc-4137	124	2	basic	basic	ADJ
dpc-4137	124	3	information	information	NOUN
dpc-4137	124	4	on	on	ADP
dpc-4137	124	5	patients	patient	NOUN
dpc-4137	124	6	and	and	CCONJ
dpc-4137	124	7	controls	control	NOUN
dpc-4137	124	8	.	.	PUNCT
dpc-4137	125	1	parameter	parameter	PROPN
dpc-4137	125	2	controls	control	NOUN
dpc-4137	125	3	(	(	PUNCT
dpc-4137	125	4	n=30	n=30	NOUN
dpc-4137	125	5	)	)	PUNCT
dpc-4137	125	6	psoriatic	psoriatic	ADJ
dpc-4137	125	7	patients	patient	NOUN
dpc-4137	125	8	(	(	PUNCT
dpc-4137	125	9	n=60	n=60	NOUN
dpc-4137	125	10	)	)	PUNCT
dpc-4137	125	11	sex	sex	NOUN
dpc-4137	125	12	(	(	PUNCT
dpc-4137	125	13	m	m	NOUN
dpc-4137	125	14	/	/	SYM
dpc-4137	125	15	f	f	NOUN
dpc-4137	125	16	)	)	PUNCT
dpc-4137	125	17	20/10	20/10	NUM
dpc-4137	125	18	39/21	39/21	NUM
dpc-4137	125	19	ns	ns	NUM
dpc-4137	125	20	age	age	NOUN
dpc-4137	125	21	[	[	X
dpc-4137	125	22	years	year	NOUN
dpc-4137	125	23	]	]	X
dpc-4137	125	24	48±2.45	48±2.45	NUM
dpc-4137	125	25	50±2.34	50±2.34	NUM
dpc-4137	125	26	ns	ns	NUM
dpc-4137	125	27	height	height	NOUN
dpc-4137	126	1	[	[	X
dpc-4137	126	2	cm	cm	X
dpc-4137	126	3	]	]	X
dpc-4137	126	4	1.75	1.75	NUM
dpc-4137	126	5	(	(	PUNCT
dpc-4137	126	6	1.5	1.5	NUM
dpc-4137	126	7	-	-	SYM
dpc-4137	126	8	1.9	1.9	NUM
dpc-4137	126	9	)	)	PUNCT
dpc-4137	126	10	1.71	1.71	NUM
dpc-4137	126	11	(	(	PUNCT
dpc-4137	126	12	1.5	1.5	NUM
dpc-4137	126	13	-	-	SYM
dpc-4137	126	14	1.9	1.9	NUM
dpc-4137	126	15	)	)	PUNCT
dpc-4137	126	16	ns	ns	NUM
dpc-4137	126	17	weight	weight	NOUN
dpc-4137	127	1	[	[	X
dpc-4137	127	2	kg	kg	X
dpc-4137	127	3	]	]	X
dpc-4137	128	1	78.40±2.9	78.40±2.9	NUM
dpc-4137	128	2	85.43±2.5	85.43±2.5	NUM
dpc-4137	128	3	ns	ns	NUM
dpc-4137	128	4	bmi	bmi	NOUN
dpc-4137	128	5	25.85±0.77	25.85±0.77	NUM
dpc-4137	128	6	27.85±0.64	27.85±0.64	NUM
dpc-4137	128	7	ns	ns	NUM
dpc-4137	128	8	ns	ns	PROPN
dpc-4137	128	9	,	,	PUNCT
dpc-4137	128	10	non	non	ADJ
dpc-4137	128	11	-	-	ADJ
dpc-4137	128	12	significant	significant	ADJ
dpc-4137	128	13	.	.	PUNCT
dpc-4137	129	1	figure	figure	NOUN
dpc-4137	129	2	2	2	NUM
dpc-4137	129	3	.	.	PUNCT
dpc-4137	129	4	serum	serum	NOUN
dpc-4137	129	5	gsdma	gsdma	PROPN
dpc-4137	129	6	concentration	concentration	NOUN
dpc-4137	129	7	(	(	PUNCT
dpc-4137	129	8	a	a	X
dpc-4137	129	9	)	)	PUNCT
dpc-4137	129	10	,	,	PUNCT
dpc-4137	129	11	absolute	absolute	ADJ
dpc-4137	129	12	urinary	urinary	ADJ
dpc-4137	129	13	gsdma	gsdma	NOUN
dpc-4137	129	14	concentration	concentration	NOUN
dpc-4137	129	15	(	(	PUNCT
dpc-4137	129	16	b	b	NOUN
dpc-4137	129	17	)	)	PUNCT
dpc-4137	129	18	,	,	PUNCT
dpc-4137	129	19	and	and	CCONJ
dpc-4137	129	20	urinary	urinary	ADJ
dpc-4137	129	21	gsdma	gsdma	NOUN
dpc-4137	129	22	/	/	SYM
dpc-4137	129	23	creatinine	creatinine	NOUN
dpc-4137	129	24	concentration	concentration	NOUN
dpc-4137	129	25	ratio	ratio	NOUN
dpc-4137	129	26	(	(	PUNCT
dpc-4137	129	27	c	c	NOUN
dpc-4137	129	28	)	)	PUNCT
dpc-4137	129	29	in	in	ADP
dpc-4137	129	30	patients	patient	NOUN
dpc-4137	129	31	and	and	CCONJ
dpc-4137	129	32	controls	control	NOUN
dpc-4137	129	33	;	;	PUNCT
dpc-4137	129	34	serum	serum	NOUN
dpc-4137	129	35	gsdma	gsdma	NOUN
dpc-4137	129	36	concentration	concentration	NOUN
dpc-4137	129	37	after	after	ADP
dpc-4137	129	38	the	the	DET
dpc-4137	129	39	division	division	NOUN
dpc-4137	129	40	of	of	ADP
dpc-4137	129	41	patients	patient	NOUN
dpc-4137	129	42	depending	depend	VERB
dpc-4137	129	43	on	on	ADP
dpc-4137	129	44	pasi	pasi	NOUN
dpc-4137	129	45	,	,	PUNCT
dpc-4137	129	46	psoriasis	psoriasis	NOUN
dpc-4137	129	47	duration	duration	NOUN
dpc-4137	129	48	,	,	PUNCT
dpc-4137	129	49	and	and	CCONJ
dpc-4137	129	50	sex	sex	NOUN
dpc-4137	129	51	compared	compare	VERB
dpc-4137	129	52	to	to	ADP
dpc-4137	129	53	controls	control	NOUN
dpc-4137	129	54	.	.	PUNCT
dpc-4137	130	1	*	*	PUNCT
dpc-4137	130	2	means	mean	VERB
dpc-4137	130	3	a	a	DET
dpc-4137	130	4	statistically	statistically	ADV
dpc-4137	130	5	significant	significant	ADJ
dpc-4137	130	6	difference	difference	NOUN
dpc-4137	130	7	with	with	ADP
dpc-4137	130	8	p	p	NOUN
dpc-4137	130	9	<	<	X
dpc-4137	130	10	0.05	0.05	NUM
dpc-4137	130	11	.	.	PUNCT
dpc-4137	130	12	6	6	NUM
dpc-4137	130	13	original	original	ADJ
dpc-4137	130	14	article	article	NOUN
dpc-4137	130	15	|	|	ADV
dpc-4137	130	16	dermatol	dermatol	ADJ
dpc-4137	130	17	pract	pract	NOUN
dpc-4137	130	18	concept	concept	NOUN
dpc-4137	130	19	.	.	PUNCT
dpc-4137	131	1	2024;14(3):e2024177	2024;14(3):e2024177	NUM
dpc-4137	131	2	one	one	NUM
dpc-4137	131	3	of	of	ADP
dpc-4137	131	4	the	the	DET
dpc-4137	131	5	key	key	ADJ
dpc-4137	131	6	yet	yet	CCONJ
dpc-4137	131	7	few	few	ADJ
dpc-4137	131	8	studies	study	NOUN
dpc-4137	131	9	shedding	shed	VERB
dpc-4137	131	10	some	some	DET
dpc-4137	131	11	light	light	NOUN
dpc-4137	131	12	on	on	ADP
dpc-4137	131	13	gsdma	gsdma	NOUN
dpc-4137	131	14	role	role	NOUN
dpc-4137	131	15	which	which	PRON
dpc-4137	131	16	could	could	AUX
dpc-4137	131	17	be	be	AUX
dpc-4137	131	18	applied	apply	VERB
dpc-4137	131	19	in	in	ADP
dpc-4137	131	20	psoriasis	psoriasis	NOUN
dpc-4137	131	21	is	be	AUX
dpc-4137	131	22	that	that	SCONJ
dpc-4137	131	23	by	by	ADP
dpc-4137	131	24	tanaka	tanaka	PROPN
dpc-4137	131	25	et	et	PROPN
dpc-4137	131	26	al	al	PROPN
dpc-4137	131	27	.	.	PROPN
dpc-4137	131	28	in	in	ADP
dpc-4137	131	29	the	the	DET
dpc-4137	131	30	mice	mouse	NOUN
dpc-4137	131	31	with	with	ADP
dpc-4137	131	32	gsdma3	gsdma3	PROPN
dpc-4137	131	33	mutation	mutation	NOUN
dpc-4137	131	34	,	,	PUNCT
dpc-4137	131	35	they	they	PRON
dpc-4137	131	36	observed	observe	VERB
dpc-4137	131	37	epidermal	epidermal	ADJ
dpc-4137	131	38	hyperplasia	hyperplasia	NOUN
dpc-4137	132	1	[	[	X
dpc-4137	132	2	21	21	NUM
dpc-4137	132	3	]	]	X
dpc-4137	132	4	,	,	PUNCT
dpc-4137	132	5	which	which	PRON
dpc-4137	132	6	is	be	AUX
dpc-4137	132	7	interesting	interesting	ADJ
dpc-4137	132	8	considering	consider	VERB
dpc-4137	132	9	histopathological	histopathological	ADJ
dpc-4137	132	10	findings	finding	NOUN
dpc-4137	132	11	in	in	ADP
dpc-4137	132	12	psoriasis	psoriasis	NOUN
dpc-4137	132	13	.	.	PUNCT
dpc-4137	133	1	however	however	ADV
dpc-4137	133	2	,	,	PUNCT
dpc-4137	133	3	in	in	ADP
dpc-4137	133	4	the	the	DET
dpc-4137	133	5	opposite	opposite	ADJ
dpc-4137	133	6	experiment	experiment	NOUN
dpc-4137	133	7	on	on	ADP
dpc-4137	133	8	gsdma	gsdma	NOUN
dpc-4137	133	9	knock	knock	VERB
dpc-4137	133	10	-	-	PUNCT
dpc-4137	133	11	out	out	ADP
dpc-4137	133	12	mice	mouse	NOUN
dpc-4137	133	13	,	,	PUNCT
dpc-4137	133	14	there	there	PRON
dpc-4137	133	15	were	be	VERB
dpc-4137	133	16	no	no	DET
dpc-4137	133	17	changes	change	NOUN
dpc-4137	133	18	in	in	ADP
dpc-4137	133	19	their	their	PRON
dpc-4137	133	20	clinical	clinical	ADJ
dpc-4137	133	21	skin	skin	NOUN
dpc-4137	133	22	condition	condition	NOUN
dpc-4137	133	23	[	[	X
dpc-4137	133	24	21	21	NUM
dpc-4137	133	25	]	]	PUNCT
dpc-4137	133	26	.	.	PUNCT
dpc-4137	134	1	the	the	DET
dpc-4137	134	2	authors	author	NOUN
dpc-4137	134	3	suggested	suggest	VERB
dpc-4137	134	4	that	that	SCONJ
dpc-4137	134	5	it	it	PRON
dpc-4137	134	6	might	might	AUX
dpc-4137	134	7	be	be	AUX
dpc-4137	134	8	due	due	ADJ
dpc-4137	134	9	to	to	ADP
dpc-4137	134	10	other	other	ADJ
dpc-4137	134	11	genes	gene	NOUN
dpc-4137	134	12	taking	take	VERB
dpc-4137	134	13	over	over	ADP
dpc-4137	134	14	the	the	DET
dpc-4137	134	15	role	role	NOUN
dpc-4137	134	16	of	of	ADP
dpc-4137	134	17	gsdma	gsdma	NOUN
dpc-4137	134	18	and	and	CCONJ
dpc-4137	134	19	that	that	SCONJ
dpc-4137	134	20	its	its	PRON
dpc-4137	134	21	biological	biological	ADJ
dpc-4137	134	22	role	role	NOUN
dpc-4137	134	23	emerges	emerge	VERB
dpc-4137	134	24	when	when	SCONJ
dpc-4137	134	25	stimulated	stimulate	VERB
dpc-4137	134	26	by	by	ADP
dpc-4137	134	27	external	external	ADJ
dpc-4137	134	28	factors	factor	NOUN
dpc-4137	134	29	[	[	X
dpc-4137	134	30	21	21	NUM
dpc-4137	134	31	]	]	PUNCT
dpc-4137	134	32	.	.	PUNCT
dpc-4137	135	1	nevertheless	nevertheless	ADV
dpc-4137	135	2	,	,	PUNCT
dpc-4137	135	3	these	these	DET
dpc-4137	135	4	observations	observation	NOUN
dpc-4137	135	5	must	must	AUX
dpc-4137	135	6	be	be	AUX
dpc-4137	135	7	approached	approach	VERB
dpc-4137	135	8	with	with	ADP
dpc-4137	135	9	caution	caution	NOUN
dpc-4137	135	10	because	because	SCONJ
dpc-4137	135	11	they	they	PRON
dpc-4137	135	12	are	be	AUX
dpc-4137	135	13	made	make	VERB
dpc-4137	135	14	on	on	ADP
dpc-4137	135	15	mice	mouse	NOUN
dpc-4137	135	16	,	,	PUNCT
dpc-4137	135	17	which	which	PRON
dpc-4137	135	18	have	have	VERB
dpc-4137	135	19	three	three	NUM
dpc-4137	135	20	gsdma	gsdma	NOUN
dpc-4137	135	21	orthologs	ortholog	NOUN
dpc-4137	135	22	(	(	PUNCT
dpc-4137	135	23	gsdma	gsdma	NOUN
dpc-4137	135	24	1	1	NUM
dpc-4137	135	25	-	-	SYM
dpc-4137	135	26	3	3	NUM
dpc-4137	135	27	)	)	PUNCT
dpc-4137	135	28	,	,	PUNCT
dpc-4137	135	29	whereas	whereas	SCONJ
dpc-4137	135	30	humans	human	NOUN
dpc-4137	135	31	have	have	VERB
dpc-4137	135	32	only	only	ADV
dpc-4137	135	33	one	one	NUM
dpc-4137	135	34	[	[	X
dpc-4137	135	35	21	21	NUM
dpc-4137	135	36	]	]	PUNCT
dpc-4137	135	37	,	,	PUNCT
dpc-4137	135	38	so	so	SCONJ
dpc-4137	135	39	results	result	NOUN
dpc-4137	135	40	based	base	VERB
dpc-4137	135	41	on	on	ADP
dpc-4137	135	42	gsdma3	gsdma3	PROPN
dpc-4137	135	43	specifically	specifically	ADV
dpc-4137	135	44	can	can	AUX
dpc-4137	135	45	not	not	PART
dpc-4137	135	46	be	be	AUX
dpc-4137	135	47	directly	directly	ADV
dpc-4137	135	48	extrapolated	extrapolate	VERB
dpc-4137	135	49	on	on	ADP
dpc-4137	135	50	humans	human	NOUN
dpc-4137	135	51	,	,	PUNCT
dpc-4137	135	52	especially	especially	ADV
dpc-4137	135	53	gsdma3	gsdma3	PROPN
dpc-4137	135	54	,	,	PUNCT
dpc-4137	135	55	the	the	DET
dpc-4137	135	56	only	only	ADJ
dpc-4137	135	57	gene	gene	NOUN
dpc-4137	135	58	in	in	ADP
dpc-4137	135	59	which	which	PRON
dpc-4137	135	60	the	the	DET
dpc-4137	135	61	mutation	mutation	NOUN
dpc-4137	135	62	exhibited	exhibit	VERB
dpc-4137	135	63	epidermal	epidermal	ADJ
dpc-4137	135	64	alterations	alteration	NOUN
dpc-4137	135	65	.	.	PUNCT
dpc-4137	136	1	the	the	DET
dpc-4137	136	2	authors	author	NOUN
dpc-4137	136	3	of	of	ADP
dpc-4137	136	4	the	the	DET
dpc-4137	136	5	study	study	NOUN
dpc-4137	136	6	attempted	attempt	VERB
dpc-4137	136	7	to	to	PART
dpc-4137	136	8	explain	explain	VERB
dpc-4137	136	9	the	the	DET
dpc-4137	136	10	mechanism	mechanism	NOUN
dpc-4137	136	11	underlying	underlie	VERB
dpc-4137	136	12	acanthosis	acanthosis	NOUN
dpc-4137	136	13	since	since	SCONJ
dpc-4137	136	14	it	it	PRON
dpc-4137	136	15	is	be	AUX
dpc-4137	136	16	not	not	PART
dpc-4137	136	17	fully	fully	ADV
dpc-4137	136	18	clear	clear	ADJ
dpc-4137	136	19	.	.	PUNCT
dpc-4137	137	1	they	they	PRON
dpc-4137	137	2	suggested	suggest	VERB
dpc-4137	137	3	that	that	SCONJ
dpc-4137	137	4	it	it	PRON
dpc-4137	137	5	is	be	AUX
dpc-4137	137	6	the	the	DET
dpc-4137	137	7	inflammation	inflammation	NOUN
dpc-4137	137	8	in	in	ADP
dpc-4137	137	9	the	the	DET
dpc-4137	137	10	mice	mouse	NOUN
dpc-4137	137	11	’s	’s	PART
dpc-4137	137	12	skin	skin	NOUN
dpc-4137	137	13	that	that	PRON
dpc-4137	137	14	leads	lead	VERB
dpc-4137	137	15	to	to	ADP
dpc-4137	137	16	epidermal	epidermal	ADJ
dpc-4137	137	17	hyperplasia	hyperplasia	NOUN
dpc-4137	138	1	[	[	X
dpc-4137	138	2	21	21	NUM
dpc-4137	138	3	]	]	PUNCT
dpc-4137	138	4	.	.	PUNCT
dpc-4137	139	1	they	they	PRON
dpc-4137	139	2	focused	focus	VERB
dpc-4137	139	3	on	on	ADP
dpc-4137	139	4	tgf	tgf	PROPN
dpc-4137	139	5	-	-	PUNCT
dpc-4137	139	6	β	β	PROPN
dpc-4137	139	7	because	because	SCONJ
dpc-4137	139	8	gsdma	gsdma	NOUN
dpc-4137	139	9	is	be	AUX
dpc-4137	139	10	engaged	engage	VERB
dpc-4137	139	11	in	in	ADP
dpc-4137	139	12	tgf	tgf	PROPN
dpc-4137	139	13	-	-	PUNCT
dpc-4137	139	14	β	β	NOUN
dpc-4137	139	15	-	-	PUNCT
dpc-4137	139	16	mediated	mediate	VERB
dpc-4137	139	17	apoptosis	apoptosis	NOUN
dpc-4137	139	18	,	,	PUNCT
dpc-4137	139	19	and	and	CCONJ
dpc-4137	139	20	overexpression	overexpression	NOUN
dpc-4137	139	21	of	of	ADP
dpc-4137	139	22	tgf	tgf	PROPN
dpc-4137	139	23	-	-	PUNCT
dpc-4137	139	24	β	β	PROPN
dpc-4137	139	25	triggers	trigger	VERB
dpc-4137	139	26	skin	skin	NOUN
dpc-4137	139	27	inflammation	inflammation	NOUN
dpc-4137	139	28	[	[	X
dpc-4137	139	29	21	21	NUM
dpc-4137	139	30	]	]	PUNCT
dpc-4137	139	31	.	.	PUNCT
dpc-4137	140	1	tgf	tgf	PROPN
dpc-4137	140	2	-	-	PUNCT
dpc-4137	140	3	β	β	NOUN
dpc-4137	140	4	up	up	X
dpc-4137	140	5	-	-	PUNCT
dpc-4137	140	6	regulates	regulate	VERB
dpc-4137	140	7	gsdma	gsdma	NOUN
dpc-4137	140	8	and	and	CCONJ
dpc-4137	140	9	therefore	therefore	ADV
dpc-4137	140	10	promotes	promote	VERB
dpc-4137	140	11	apoptosis	apoptosis	NOUN
dpc-4137	140	12	[	[	X
dpc-4137	140	13	12	12	NUM
dpc-4137	140	14	]	]	PUNCT
dpc-4137	140	15	.	.	PUNCT
dpc-4137	141	1	on	on	ADP
dpc-4137	141	2	the	the	DET
dpc-4137	141	3	other	other	ADJ
dpc-4137	141	4	hand	hand	NOUN
dpc-4137	141	5	,	,	PUNCT
dpc-4137	141	6	tgf	tgf	PROPN
dpc-4137	141	7	-	-	PUNCT
dpc-4137	141	8	β	β	PROPN
dpc-4137	141	9	has	have	AUX
dpc-4137	141	10	been	be	AUX
dpc-4137	141	11	investigated	investigate	VERB
dpc-4137	141	12	in	in	ADP
dpc-4137	141	13	psoriasis	psoriasis	NOUN
dpc-4137	141	14	,	,	PUNCT
dpc-4137	141	15	and	and	CCONJ
dpc-4137	141	16	an	an	DET
dpc-4137	141	17	elevated	elevated	ADJ
dpc-4137	141	18	concentration	concentration	NOUN
dpc-4137	141	19	of	of	ADP
dpc-4137	141	20	tgf	tgf	PROPN
dpc-4137	141	21	-	-	PUNCT
dpc-4137	141	22	β	β	PROPN
dpc-4137	141	23	has	have	AUX
dpc-4137	141	24	been	be	AUX
dpc-4137	141	25	observed	observe	VERB
dpc-4137	141	26	in	in	ADP
dpc-4137	141	27	the	the	DET
dpc-4137	141	28	plasma	plasma	NOUN
dpc-4137	141	29	and	and	CCONJ
dpc-4137	141	30	scales	scale	NOUN
dpc-4137	141	31	of	of	ADP
dpc-4137	141	32	psoriatic	psoriatic	ADJ
dpc-4137	141	33	patients	patient	NOUN
dpc-4137	142	1	[	[	X
dpc-4137	142	2	23	23	NUM
dpc-4137	142	3	]	]	PUNCT
dpc-4137	142	4	.	.	PUNCT
dpc-4137	143	1	in	in	ADP
dpc-4137	143	2	addition	addition	NOUN
dpc-4137	143	3	,	,	PUNCT
dpc-4137	143	4	this	this	DET
dpc-4137	143	5	plasma	plasma	NOUN
dpc-4137	143	6	level	level	NOUN
dpc-4137	143	7	was	be	AUX
dpc-4137	143	8	associated	associate	VERB
dpc-4137	143	9	with	with	ADP
dpc-4137	143	10	skin	skin	NOUN
dpc-4137	143	11	lesion	lesion	NOUN
dpc-4137	143	12	severity	severity	NOUN
dpc-4137	143	13	and	and	CCONJ
dpc-4137	143	14	decreased	decrease	VERB
dpc-4137	143	15	after	after	ADP
dpc-4137	143	16	antipsoriatic	antipsoriatic	ADJ
dpc-4137	143	17	therapy	therapy	NOUN
dpc-4137	143	18	[	[	X
dpc-4137	143	19	23,24	23,24	X
dpc-4137	143	20	]	]	PUNCT
dpc-4137	143	21	.	.	PUNCT
dpc-4137	144	1	another	another	DET
dpc-4137	144	2	study	study	NOUN
dpc-4137	144	3	that	that	PRON
dpc-4137	144	4	attempted	attempt	VERB
dpc-4137	144	5	to	to	PART
dpc-4137	144	6	discover	discover	VERB
dpc-4137	144	7	the	the	DET
dpc-4137	144	8	role	role	NOUN
dpc-4137	144	9	of	of	ADP
dpc-4137	144	10	gsdma	gsdma	NOUN
dpc-4137	144	11	in	in	ADP
dpc-4137	144	12	the	the	DET
dpc-4137	144	13	skin	skin	NOUN
dpc-4137	144	14	was	be	AUX
dpc-4137	144	15	that	that	SCONJ
dpc-4137	144	16	by	by	ADP
dpc-4137	144	17	lin	lin	PROPN
dpc-4137	144	18	et	et	PROPN
dpc-4137	144	19	al	al	PROPN
dpc-4137	144	20	.	.	PUNCT
dpc-4137	145	1	their	their	PRON
dpc-4137	145	2	team	team	NOUN
dpc-4137	145	3	observed	observe	VERB
dpc-4137	145	4	that	that	SCONJ
dpc-4137	145	5	induction	induction	NOUN
dpc-4137	145	6	of	of	ADP
dpc-4137	145	7	gsdma3	gsdma3	NOUN
dpc-4137	145	8	expression	expression	NOUN
dpc-4137	145	9	in	in	ADP
dpc-4137	145	10	mice	mouse	NOUN
dpc-4137	145	11	leads	lead	VERB
dpc-4137	145	12	to	to	ADP
dpc-4137	145	13	epidermal	epidermal	ADJ
dpc-4137	145	14	hyperplasia	hyperplasia	NOUN
dpc-4137	145	15	and	and	CCONJ
dpc-4137	145	16	skin	skin	NOUN
dpc-4137	145	17	inflammation	inflammation	NOUN
dpc-4137	146	1	[	[	X
dpc-4137	146	2	20	20	NUM
dpc-4137	146	3	]	]	PUNCT
dpc-4137	146	4	.	.	PUNCT
dpc-4137	147	1	they	they	PRON
dpc-4137	147	2	concluded	conclude	VERB
dpc-4137	147	3	that	that	SCONJ
dpc-4137	147	4	keratinocytes	keratinocyte	NOUN
dpc-4137	147	5	that	that	PRON
dpc-4137	147	6	exhibited	exhibit	VERB
dpc-4137	147	7	gsdma	gsdma	NOUN
dpc-4137	147	8	overexpression	overexpression	NOUN
dpc-4137	147	9	suffered	suffer	VERB
dpc-4137	147	10	from	from	ADP
dpc-4137	147	11	oxidative	oxidative	ADJ
dpc-4137	147	12	stress	stress	NOUN
dpc-4137	147	13	and	and	CCONJ
dpc-4137	147	14	underwent	undergo	VERB
dpc-4137	147	15	spontaneous	spontaneous	ADJ
dpc-4137	147	16	necrosis	necrosis	NOUN
dpc-4137	147	17	followed	follow	VERB
dpc-4137	147	18	by	by	ADP
dpc-4137	147	19	inflammatory	inflammatory	ADJ
dpc-4137	147	20	condition	condition	NOUN
dpc-4137	147	21	lesions	lesion	NOUN
dpc-4137	147	22	than	than	ADP
dpc-4137	147	23	in	in	ADP
dpc-4137	147	24	healthy	healthy	ADJ
dpc-4137	147	25	skin	skin	NOUN
dpc-4137	147	26	,	,	PUNCT
dpc-4137	147	27	and	and	CCONJ
dpc-4137	147	28	gsdma1	gsdma1	NOUN
dpc-4137	147	29	/	/	SYM
dpc-4137	147	30	a3	a3	NOUN
dpc-4137	147	31	-	-	PUNCT
dpc-4137	147	32	deficiency	deficiency	NOUN
dpc-4137	147	33	selectively	selectively	ADV
dpc-4137	147	34	enhanced	enhance	VERB
dpc-4137	147	35	the	the	DET
dpc-4137	147	36	th	th	NUM
dpc-4137	147	37	cells	cell	NOUN
dpc-4137	147	38	type	type	VERB
dpc-4137	147	39	2	2	NUM
dpc-4137	147	40	response	response	NOUN
dpc-4137	147	41	.	.	PUNCT
dpc-4137	148	1	the	the	DET
dpc-4137	148	2	authors	author	NOUN
dpc-4137	148	3	suggested	suggest	VERB
dpc-4137	148	4	that	that	SCONJ
dpc-4137	148	5	gsdma	gsdma	NOUN
dpc-4137	148	6	may	may	AUX
dpc-4137	148	7	be	be	AUX
dpc-4137	148	8	involved	involve	VERB
dpc-4137	148	9	in	in	ADP
dpc-4137	148	10	ad	ad	NOUN
dpc-4137	148	11	pathogenesis	pathogenesis	NOUN
dpc-4137	148	12	due	due	ADP
dpc-4137	148	13	to	to	ADP
dpc-4137	148	14	its	its	PRON
dpc-4137	148	15	influence	influence	NOUN
dpc-4137	148	16	on	on	ADP
dpc-4137	148	17	keratinocytes	keratinocyte	NOUN
dpc-4137	148	18	differentiation	differentiation	NOUN
dpc-4137	148	19	and	and	CCONJ
dpc-4137	148	20	cornification	cornification	NOUN
dpc-4137	149	1	[	[	X
dpc-4137	149	2	22	22	NUM
dpc-4137	149	3	]	]	PUNCT
dpc-4137	149	4	.	.	PUNCT
dpc-4137	150	1	figure	figure	NOUN
dpc-4137	150	2	3	3	NUM
dpc-4137	150	3	.	.	PUNCT
dpc-4137	151	1	the	the	DET
dpc-4137	151	2	division	division	NOUN
dpc-4137	151	3	of	of	ADP
dpc-4137	151	4	patients	patient	NOUN
dpc-4137	151	5	depending	depend	VERB
dpc-4137	151	6	on	on	ADP
dpc-4137	151	7	(	(	PUNCT
dpc-4137	151	8	a	a	PRON
dpc-4137	151	9	)	)	PUNCT
dpc-4137	151	10	pasi	pasi	NOUN
dpc-4137	151	11	,	,	PUNCT
dpc-4137	151	12	(	(	PUNCT
dpc-4137	151	13	b	b	NOUN
dpc-4137	151	14	)	)	PUNCT
dpc-4137	151	15	psoriasis	psoriasis	NOUN
dpc-4137	151	16	duration	duration	NOUN
dpc-4137	151	17	,	,	PUNCT
dpc-4137	151	18	and	and	CCONJ
dpc-4137	151	19	(	(	PUNCT
dpc-4137	151	20	c	c	NOUN
dpc-4137	151	21	)	)	PUNCT
dpc-4137	151	22	gender	gender	NOUN
dpc-4137	151	23	compared	compare	VERB
dpc-4137	151	24	to	to	ADP
dpc-4137	151	25	controls	control	NOUN
dpc-4137	151	26	.	.	PUNCT
dpc-4137	152	1	figure	figure	NOUN
dpc-4137	152	2	4	4	NUM
dpc-4137	152	3	.	.	PUNCT
dpc-4137	153	1	correlations	correlation	NOUN
dpc-4137	153	2	between	between	ADP
dpc-4137	153	3	serum	serum	NOUN
dpc-4137	153	4	gasdermin	gasdermin	NOUN
dpc-4137	153	5	a	a	DET
dpc-4137	153	6	concentration	concentration	NOUN
dpc-4137	153	7	and	and	CCONJ
dpc-4137	153	8	basic	basic	ADJ
dpc-4137	153	9	laboratory	laboratory	NOUN
dpc-4137	153	10	parameters	parameter	NOUN
dpc-4137	153	11	.	.	PUNCT
dpc-4137	154	1	(	(	PUNCT
dpc-4137	154	2	alt	alt	ADJ
dpc-4137	154	3	,	,	PUNCT
dpc-4137	154	4	alanine	alanine	NOUN
dpc-4137	154	5	transaminase	transaminase	NOUN
dpc-4137	154	6	;	;	PUNCT
dpc-4137	154	7	ast	ast	NOUN
dpc-4137	154	8	=	=	NOUN
dpc-4137	154	9	asparagine	asparagine	NOUN
dpc-4137	154	10	transaminase	transaminase	NOUN
dpc-4137	154	11	;	;	PUNCT
dpc-4137	154	12	tg	tg	PROPN
dpc-4137	154	13	=	=	PUNCT
dpc-4137	154	14	triglycerides	triglyceride	NOUN
dpc-4137	154	15	;	;	PUNCT
dpc-4137	154	16	chol	chol	NOUN
dpc-4137	154	17	=	=	SYM
dpc-4137	154	18	total	total	ADJ
dpc-4137	154	19	cholesterol	cholesterol	NOUN
dpc-4137	154	20	;	;	PUNCT
dpc-4137	154	21	hdl	hdl	PROPN
dpc-4137	154	22	=	=	PUNCT
dpc-4137	154	23	high	high	ADJ
dpc-4137	154	24	-	-	PUNCT
dpc-4137	154	25	density	density	NOUN
dpc-4137	154	26	lipoprotein	lipoprotein	NOUN
dpc-4137	154	27	;	;	PUNCT
dpc-4137	154	28	ldl	ldl	NOUN
dpc-4137	154	29	=	=	NOUN
dpc-4137	154	30	low	low	ADJ
dpc-4137	154	31	-	-	PUNCT
dpc-4137	154	32	density	density	NOUN
dpc-4137	154	33	lipoprotein	lipoprotein	NOUN
dpc-4137	154	34	;	;	PUNCT
dpc-4137	154	35	glu	glu	NOUN
dpc-4137	154	36	=	=	SYM
dpc-4137	154	37	fasting	fast	VERB
dpc-4137	154	38	glucose	glucose	NOUN
dpc-4137	154	39	;	;	PUNCT
dpc-4137	154	40	crp	crp	X
dpc-4137	155	1	=	=	SYM
dpc-4137	156	1	c	c	X
dpc-4137	156	2	-	-	PUNCT
dpc-4137	156	3	reactive	reactive	ADJ
dpc-4137	156	4	protein	protein	NOUN
dpc-4137	156	5	;	;	PUNCT
dpc-4137	156	6	cr	cr	PROPN
dpc-4137	156	7	=	=	SYM
dpc-4137	156	8	creatinine	creatinine	NOUN
dpc-4137	156	9	;	;	PUNCT
dpc-4137	156	10	gfr	gfr	NOUN
dpc-4137	156	11	=	=	SYM
dpc-4137	156	12	glomerular	glomerular	ADJ
dpc-4137	156	13	filtration	filtration	NOUN
dpc-4137	156	14	rate	rate	NOUN
dpc-4137	156	15	;	;	PUNCT
dpc-4137	156	16	uac	uac	NOUN
dpc-4137	156	17	=	=	NOUN
dpc-4137	156	18	uric	uric	ADJ
dpc-4137	156	19	acid	acid	NOUN
dpc-4137	156	20	;	;	PUNCT
dpc-4137	156	21	urea	urea	NOUN
dpc-4137	156	22	;	;	PUNCT
dpc-4137	156	23	wbc	wbc	PROPN
dpc-4137	156	24	=	=	SYM
dpc-4137	156	25	white	white	ADJ
dpc-4137	156	26	blood	blood	NOUN
dpc-4137	156	27	cells	cell	NOUN
dpc-4137	156	28	;	;	PUNCT
dpc-4137	156	29	rbc	rbc	PROPN
dpc-4137	156	30	=	=	PROPN
dpc-4137	156	31	red	red	ADJ
dpc-4137	156	32	blood	blood	NOUN
dpc-4137	156	33	cells	cell	NOUN
dpc-4137	156	34	;	;	PUNCT
dpc-4137	156	35	hgb	hgb	PROPN
dpc-4137	156	36	=	=	PUNCT
dpc-4137	156	37	hemoglobin	hemoglobin	NOUN
dpc-4137	156	38	;	;	PUNCT
dpc-4137	156	39	plt	plt	NOUN
dpc-4137	156	40	=	=	NOUN
dpc-4137	156	41	platelets	platelet	VERB
dpc-4137	156	42	.	.	PUNCT
dpc-4137	156	43	)	)	PUNCT
dpc-4137	156	44	.	.	PUNCT
dpc-4137	157	1	original	original	ADJ
dpc-4137	157	2	article	article	NOUN
dpc-4137	157	3	|	|	ADV
dpc-4137	157	4	dermatol	dermatol	ADJ
dpc-4137	157	5	pract	pract	NOUN
dpc-4137	157	6	concept	concept	NOUN
dpc-4137	157	7	.	.	PUNCT
dpc-4137	158	1	2024;14(3):e2024177	2024;14(3):e2024177	NUM
dpc-4137	158	2	7	7	NUM
dpc-4137	158	3	psoriatic	psoriatic	ADJ
dpc-4137	158	4	epidermis	epidermis	NOUN
dpc-4137	158	5	[	[	X
dpc-4137	158	6	27	27	NUM
dpc-4137	158	7	]	]	PUNCT
dpc-4137	158	8	.	.	PUNCT
dpc-4137	159	1	autophagy	autophagy	PROPN
dpc-4137	159	2	promotes	promote	VERB
dpc-4137	159	3	highmobility	highmobility	NOUN
dpc-4137	159	4	group	group	NOUN
dpc-4137	159	5	box	box	PROPN
dpc-4137	159	6	1	1	NUM
dpc-4137	159	7	(	(	PUNCT
dpc-4137	159	8	hmgb-1	hmgb-1	NUM
dpc-4137	159	9	)	)	PUNCT
dpc-4137	159	10	secretion	secretion	NOUN
dpc-4137	159	11	in	in	ADP
dpc-4137	159	12	psoriasis	psoriasis	NOUN
dpc-4137	159	13	and	and	CCONJ
dpc-4137	159	14	leads	lead	VERB
dpc-4137	159	15	to	to	ADP
dpc-4137	159	16	chronically	chronically	ADV
dpc-4137	159	17	sustained	sustain	VERB
dpc-4137	159	18	inflammatory	inflammatory	ADJ
dpc-4137	159	19	condition	condition	NOUN
dpc-4137	159	20	in	in	ADP
dpc-4137	159	21	this	this	DET
dpc-4137	159	22	dermatosis	dermatosis	NOUN
dpc-4137	159	23	[	[	X
dpc-4137	159	24	26	26	NUM
dpc-4137	159	25	]	]	PUNCT
dpc-4137	159	26	.	.	PUNCT
dpc-4137	160	1	another	another	DET
dpc-4137	160	2	piece	piece	NOUN
dpc-4137	160	3	of	of	ADP
dpc-4137	160	4	evidence	evidence	NOUN
dpc-4137	160	5	justifying	justify	VERB
dpc-4137	160	6	this	this	DET
dpc-4137	160	7	hypothesis	hypothesis	NOUN
dpc-4137	160	8	is	be	AUX
dpc-4137	160	9	that	that	SCONJ
dpc-4137	160	10	there	there	PRON
dpc-4137	160	11	are	be	VERB
dpc-4137	160	12	polymorphisms	polymorphism	NOUN
dpc-4137	160	13	in	in	ADP
dpc-4137	160	14	the	the	DET
dpc-4137	160	15	autophagy	autophagy	ADJ
dpc-4137	160	16	gene	gene	NOUN
dpc-4137	160	17	described	describe	VERB
dpc-4137	160	18	which	which	PRON
dpc-4137	160	19	are	be	AUX
dpc-4137	160	20	related	relate	VERB
dpc-4137	160	21	to	to	ADP
dpc-4137	160	22	psoriasis	psoriasis	NOUN
dpc-4137	160	23	[	[	X
dpc-4137	160	24	26	26	NUM
dpc-4137	160	25	]	]	PUNCT
dpc-4137	160	26	.	.	PUNCT
dpc-4137	161	1	herein	herein	PROPN
dpc-4137	161	2	,	,	PUNCT
dpc-4137	161	3	the	the	DET
dpc-4137	161	4	data	datum	NOUN
dpc-4137	161	5	on	on	ADP
dpc-4137	161	6	gsdma	gsdma	NOUN
dpc-4137	161	7	role	role	NOUN
dpc-4137	161	8	in	in	ADP
dpc-4137	161	9	the	the	DET
dpc-4137	161	10	skin	skin	NOUN
dpc-4137	161	11	are	be	AUX
dpc-4137	161	12	scarce	scarce	ADJ
dpc-4137	161	13	and	and	CCONJ
dpc-4137	161	14	also	also	ADV
dpc-4137	161	15	sometimes	sometimes	ADV
dpc-4137	161	16	inconsistent	inconsistent	ADJ
dpc-4137	161	17	.	.	PUNCT
dpc-4137	162	1	apparently	apparently	ADV
dpc-4137	162	2	,	,	PUNCT
dpc-4137	162	3	gsdma	gsdma	NOUN
dpc-4137	162	4	takes	take	VERB
dpc-4137	162	5	part	part	NOUN
dpc-4137	162	6	in	in	ADP
dpc-4137	162	7	cell	cell	NOUN
dpc-4137	162	8	death	death	NOUN
dpc-4137	162	9	in	in	ADP
dpc-4137	162	10	different	different	ADJ
dpc-4137	162	11	mechanisms	mechanism	NOUN
dpc-4137	162	12	but	but	CCONJ
dpc-4137	162	13	surely	surely	ADV
dpc-4137	162	14	its	its	PRON
dpc-4137	162	15	overexpression	overexpression	NOUN
dpc-4137	162	16	exacerbates	exacerbate	VERB
dpc-4137	162	17	inflammation	inflammation	NOUN
dpc-4137	162	18	.	.	PUNCT
dpc-4137	163	1	there	there	PRON
dpc-4137	163	2	are	be	VERB
dpc-4137	163	3	also	also	ADV
dpc-4137	163	4	many	many	ADJ
dpc-4137	163	5	connections	connection	NOUN
dpc-4137	163	6	between	between	ADP
dpc-4137	163	7	gsdma	gsdma	NOUN
dpc-4137	163	8	and	and	CCONJ
dpc-4137	163	9	already	already	ADV
dpc-4137	163	10	recognized	recognize	VERB
dpc-4137	163	11	links	link	NOUN
dpc-4137	163	12	in	in	ADP
dpc-4137	163	13	the	the	DET
dpc-4137	163	14	epidermis	epidermis	NOUN
dpc-4137	164	1	[	[	X
dpc-4137	164	2	20	20	NUM
dpc-4137	164	3	]	]	PUNCT
dpc-4137	164	4	.	.	PUNCT
dpc-4137	165	1	oxidative	oxidative	ADJ
dpc-4137	165	2	stress	stress	NOUN
dpc-4137	165	3	plays	play	VERB
dpc-4137	165	4	a	a	DET
dpc-4137	165	5	major	major	ADJ
dpc-4137	165	6	role	role	NOUN
dpc-4137	165	7	in	in	ADP
dpc-4137	165	8	psoriasis	psoriasis	NOUN
dpc-4137	165	9	pathology	pathology	NOUN
dpc-4137	165	10	[	[	X
dpc-4137	165	11	25	25	NUM
dpc-4137	165	12	]	]	PUNCT
dpc-4137	165	13	.	.	PUNCT
dpc-4137	166	1	although	although	SCONJ
dpc-4137	166	2	the	the	DET
dpc-4137	166	3	data	datum	NOUN
dpc-4137	166	4	on	on	ADP
dpc-4137	166	5	gsdma	gsdma	NOUN
dpc-4137	166	6	are	be	AUX
dpc-4137	166	7	poor	poor	ADJ
dpc-4137	166	8	,	,	PUNCT
dpc-4137	166	9	there	there	PRON
dpc-4137	166	10	are	be	VERB
dpc-4137	166	11	more	more	ADJ
dpc-4137	166	12	rationales	rationale	NOUN
dpc-4137	166	13	that	that	PRON
dpc-4137	166	14	could	could	AUX
dpc-4137	166	15	support	support	VERB
dpc-4137	166	16	gsdma	gsdma	NOUN
dpc-4137	166	17	’s	’s	PART
dpc-4137	166	18	engagement	engagement	NOUN
dpc-4137	166	19	in	in	ADP
dpc-4137	166	20	psoriasis	psoriasis	NOUN
dpc-4137	166	21	and	and	CCONJ
dpc-4137	166	22	point	point	VERB
dpc-4137	166	23	to	to	ADP
dpc-4137	166	24	its	its	PRON
dpc-4137	166	25	role	role	NOUN
dpc-4137	166	26	in	in	ADP
dpc-4137	166	27	its	its	PRON
dpc-4137	166	28	pathogenesis	pathogenesis	NOUN
dpc-4137	166	29	.	.	PUNCT
dpc-4137	167	1	activation	activation	NOUN
dpc-4137	167	2	of	of	ADP
dpc-4137	167	3	gsdma	gsdma	NOUN
dpc-4137	167	4	leads	lead	VERB
dpc-4137	167	5	to	to	ADP
dpc-4137	167	6	stimulation	stimulation	NOUN
dpc-4137	167	7	of	of	ADP
dpc-4137	167	8	caspase	caspase	PROPN
dpc-4137	167	9	3	3	NUM
dpc-4137	167	10	and	and	CCONJ
dpc-4137	167	11	further	far	ADV
dpc-4137	167	12	to	to	ADP
dpc-4137	167	13	induction	induction	NOUN
dpc-4137	167	14	of	of	ADP
dpc-4137	167	15	autophagy	autophagy	NOUN
dpc-4137	167	16	[	[	X
dpc-4137	167	17	12	12	NUM
dpc-4137	167	18	]	]	PUNCT
dpc-4137	167	19	.	.	PUNCT
dpc-4137	168	1	wang	wang	PROPN
dpc-4137	168	2	et	et	PROPN
dpc-4137	168	3	al	al	PROPN
dpc-4137	168	4	.	.	PROPN
dpc-4137	168	5	suggested	suggest	VERB
dpc-4137	168	6	that	that	SCONJ
dpc-4137	168	7	autophagy	autophagy	NOUN
dpc-4137	168	8	is	be	AUX
dpc-4137	168	9	activated	activate	VERB
dpc-4137	168	10	in	in	ADP
dpc-4137	168	11	psoriatic	psoriatic	ADJ
dpc-4137	168	12	epidermis	epidermis	NOUN
dpc-4137	168	13	and	and	CCONJ
dpc-4137	168	14	is	be	AUX
dpc-4137	168	15	probably	probably	ADV
dpc-4137	168	16	important	important	ADJ
dpc-4137	168	17	in	in	ADP
dpc-4137	168	18	the	the	DET
dpc-4137	168	19	proliferation	proliferation	NOUN
dpc-4137	168	20	and	and	CCONJ
dpc-4137	168	21	differentiation	differentiation	NOUN
dpc-4137	168	22	of	of	ADP
dpc-4137	168	23	keratinocytes	keratinocyte	NOUN
dpc-4137	168	24	in	in	ADP
dpc-4137	168	25	psoriasis	psoriasis	NOUN
dpc-4137	168	26	[	[	X
dpc-4137	168	27	26	26	NUM
dpc-4137	168	28	]	]	PUNCT
dpc-4137	168	29	.	.	PUNCT
dpc-4137	169	1	overexpression	overexpression	NOUN
dpc-4137	169	2	of	of	ADP
dpc-4137	169	3	the	the	DET
dpc-4137	169	4	autophagy	autophagy	ADV
dpc-4137	169	5	-	-	PUNCT
dpc-4137	169	6	related	relate	VERB
dpc-4137	169	7	protein	protein	NOUN
dpc-4137	169	8	,	,	PUNCT
dpc-4137	169	9	sqstm1	sqstm1	NOUN
dpc-4137	169	10	has	have	AUX
dpc-4137	169	11	been	be	AUX
dpc-4137	169	12	observed	observe	VERB
dpc-4137	169	13	in	in	ADP
dpc-4137	169	14	figure	figure	NOUN
dpc-4137	169	15	5	5	NUM
dpc-4137	169	16	.	.	PUNCT
dpc-4137	170	1	the	the	DET
dpc-4137	170	2	expression	expression	NOUN
dpc-4137	170	3	of	of	ADP
dpc-4137	170	4	gsdma	gsdma	NOUN
dpc-4137	170	5	(	(	PUNCT
dpc-4137	170	6	strong	strong	ADJ
dpc-4137	170	7	,	,	PUNCT
dpc-4137	170	8	moderate	moderate	ADJ
dpc-4137	170	9	,	,	PUNCT
dpc-4137	170	10	low	low	ADJ
dpc-4137	170	11	)	)	PUNCT
dpc-4137	170	12	depending	depend	VERB
dpc-4137	170	13	on	on	ADP
dpc-4137	170	14	the	the	DET
dpc-4137	170	15	site	site	NOUN
dpc-4137	170	16	of	of	ADP
dpc-4137	170	17	biopsy	biopsy	NOUN
dpc-4137	170	18	(	(	PUNCT
dpc-4137	170	19	psoriatic	psoriatic	ADJ
dpc-4137	170	20	plaque	plaque	NOUN
dpc-4137	170	21	,	,	PUNCT
dpc-4137	170	22	non	non	ADJ
dpc-4137	170	23	-	-	ADJ
dpc-4137	170	24	lesional	lesional	ADJ
dpc-4137	170	25	patients	patient	NOUN
dpc-4137	170	26	’	'	PUNCT
dpc-4137	170	27	skin	skin	NOUN
dpc-4137	170	28	or	or	CCONJ
dpc-4137	170	29	healthy	healthy	ADJ
dpc-4137	170	30	skin	skin	NOUN
dpc-4137	170	31	of	of	ADP
dpc-4137	170	32	controls	control	NOUN
dpc-4137	170	33	)	)	PUNCT
dpc-4137	170	34	.	.	PUNCT
dpc-4137	171	1	*	*	PUNCT
dpc-4137	171	2	*	*	PUNCT
dpc-4137	171	3	*	*	PUNCT
dpc-4137	171	4	vs	vs	ADP
dpc-4137	171	5	low	low	ADJ
dpc-4137	171	6	expression	expression	NOUN
dpc-4137	171	7	with	with	ADP
dpc-4137	171	8	p<0.001	p<0.001	PROPN
dpc-4137	171	9	,	,	PUNCT
dpc-4137	171	10	^^/^^^	^^/^^^	ADV
dpc-4137	171	11	vs	vs	ADP
dpc-4137	171	12	moderate	moderate	ADJ
dpc-4137	171	13	expression	expression	NOUN
dpc-4137	171	14	with	with	ADP
dpc-4137	171	15	p<0.01/0.001	p<0.01/0.001	NOUN
dpc-4137	171	16	respectively	respectively	ADV
dpc-4137	171	17	,	,	PUNCT
dpc-4137	172	1	#	#	SYM
dpc-4137	172	2	#	#	SYM
dpc-4137	172	3	/	/	SYM
dpc-4137	172	4	#	#	SYM
dpc-4137	172	5	#	#	SYM
dpc-4137	172	6	#	#	NOUN
dpc-4137	172	7	vs	vs	ADP
dpc-4137	172	8	strong	strong	ADJ
dpc-4137	172	9	expression	expression	NOUN
dpc-4137	172	10	with	with	ADP
dpc-4137	172	11	p<0.01	p<0.01	PROPN
dpc-4137	172	12	/	/	SYM
dpc-4137	172	13	p<0.001	p<0.001	NOUN
dpc-4137	172	14	,	,	PUNCT
dpc-4137	172	15	respectively	respectively	ADV
dpc-4137	172	16	.	.	PUNCT
dpc-4137	173	1	figure	figure	NOUN
dpc-4137	173	2	6	6	NUM
dpc-4137	173	3	.	.	PUNCT
dpc-4137	174	1	the	the	DET
dpc-4137	174	2	extent	extent	NOUN
dpc-4137	174	3	of	of	ADP
dpc-4137	174	4	expression	expression	NOUN
dpc-4137	174	5	of	of	ADP
dpc-4137	174	6	gsdma	gsdma	NOUN
dpc-4137	174	7	in	in	ADP
dpc-4137	174	8	psoriatic	psoriatic	ADJ
dpc-4137	174	9	plaque	plaque	NOUN
dpc-4137	174	10	depending	depend	VERB
dpc-4137	174	11	on	on	ADP
dpc-4137	174	12	the	the	DET
dpc-4137	174	13	psoriasis	psoriasis	NOUN
dpc-4137	174	14	severity	severity	NOUN
dpc-4137	174	15	in	in	ADP
dpc-4137	174	16	pasi	pasi	NOUN
dpc-4137	174	17	.	.	PUNCT
dpc-4137	174	18	8	8	NUM
dpc-4137	174	19	original	original	ADJ
dpc-4137	174	20	article	article	NOUN
dpc-4137	174	21	|	|	ADV
dpc-4137	174	22	dermatol	dermatol	ADJ
dpc-4137	174	23	pract	pract	NOUN
dpc-4137	174	24	concept	concept	NOUN
dpc-4137	174	25	.	.	PUNCT
dpc-4137	175	1	2024;14(3):e2024177	2024;14(3):e2024177	NUM
dpc-4137	175	2	in	in	ADP
dpc-4137	175	3	our	our	PRON
dpc-4137	175	4	study	study	NOUN
dpc-4137	175	5	,	,	PUNCT
dpc-4137	175	6	we	we	PRON
dpc-4137	175	7	obtained	obtain	VERB
dpc-4137	175	8	a	a	DET
dpc-4137	175	9	negative	negative	ADJ
dpc-4137	175	10	correlation	correlation	NOUN
dpc-4137	175	11	between	between	ADP
dpc-4137	175	12	gsdma	gsdma	NOUN
dpc-4137	175	13	and	and	CCONJ
dpc-4137	175	14	alt	alt	ADJ
dpc-4137	175	15	,	,	PUNCT
dpc-4137	175	16	which	which	PRON
dpc-4137	175	17	could	could	AUX
dpc-4137	175	18	serve	serve	VERB
dpc-4137	175	19	as	as	ADP
dpc-4137	175	20	an	an	DET
dpc-4137	175	21	interesting	interesting	ADJ
dpc-4137	175	22	starting	starting	NOUN
dpc-4137	175	23	point	point	NOUN
dpc-4137	175	24	for	for	ADP
dpc-4137	175	25	more	more	ADJ
dpc-4137	175	26	in	in	ADP
dpc-4137	175	27	-	-	PUNCT
dpc-4137	175	28	depth	depth	NOUN
dpc-4137	175	29	future	future	ADJ
dpc-4137	175	30	studies	study	NOUN
dpc-4137	175	31	.	.	PUNCT
dpc-4137	176	1	therefore	therefore	ADV
dpc-4137	176	2	,	,	PUNCT
dpc-4137	176	3	we	we	PRON
dpc-4137	176	4	can	can	AUX
dpc-4137	176	5	hypothesize	hypothesize	VERB
dpc-4137	176	6	that	that	SCONJ
dpc-4137	176	7	gsdma	gsdma	NOUN
dpc-4137	176	8	may	may	AUX
dpc-4137	176	9	exert	exert	VERB
dpc-4137	176	10	a	a	DET
dpc-4137	176	11	protective	protective	ADJ
dpc-4137	176	12	influence	influence	NOUN
dpc-4137	176	13	on	on	ADP
dpc-4137	176	14	the	the	DET
dpc-4137	176	15	liver	liver	NOUN
dpc-4137	176	16	.	.	PUNCT
dpc-4137	177	1	knorr	knorr	PROPN
dpc-4137	177	2	et	et	PROPN
dpc-4137	177	3	al	al	PROPN
dpc-4137	177	4	.	.	PROPN
dpc-4137	177	5	reviewed	review	VERB
dpc-4137	177	6	the	the	DET
dpc-4137	177	7	role	role	NOUN
dpc-4137	177	8	of	of	ADP
dpc-4137	177	9	pyroptosis	pyroptosis	NOUN
dpc-4137	177	10	(	(	PUNCT
dpc-4137	177	11	thus	thus	ADV
dpc-4137	177	12	gasdermins	gasdermin	VERB
dpc-4137	177	13	)	)	PUNCT
dpc-4137	177	14	in	in	ADP
dpc-4137	177	15	different	different	ADJ
dpc-4137	177	16	liver	liver	NOUN
dpc-4137	177	17	diseases	disease	NOUN
dpc-4137	177	18	,	,	PUNCT
dpc-4137	177	19	but	but	CCONJ
dpc-4137	177	20	they	they	PRON
dpc-4137	177	21	did	do	AUX
dpc-4137	177	22	not	not	PART
dpc-4137	177	23	mention	mention	VERB
dpc-4137	177	24	any	any	DET
dpc-4137	177	25	engagement	engagement	NOUN
dpc-4137	177	26	of	of	ADP
dpc-4137	177	27	gsdma	gsdma	NOUN
dpc-4137	177	28	in	in	ADP
dpc-4137	177	29	this	this	DET
dpc-4137	177	30	matter	matter	NOUN
dpc-4137	177	31	[	[	X
dpc-4137	177	32	29	29	NUM
dpc-4137	177	33	]	]	PUNCT
dpc-4137	177	34	.	.	PUNCT
dpc-4137	178	1	on	on	ADP
dpc-4137	178	2	the	the	DET
dpc-4137	178	3	other	other	ADJ
dpc-4137	178	4	hand	hand	NOUN
dpc-4137	178	5	,	,	PUNCT
dpc-4137	178	6	gsdma	gsdma	NOUN
dpc-4137	178	7	gene	gene	NOUN
dpc-4137	178	8	was	be	AUX
dpc-4137	178	9	included	include	VERB
dpc-4137	178	10	in	in	ADP
dpc-4137	178	11	the	the	DET
dpc-4137	178	12	set	set	NOUN
dpc-4137	178	13	of	of	ADP
dpc-4137	178	14	pyroptosis	pyroptosis	NOUN
dpc-4137	178	15	-	-	PUNCT
dpc-4137	178	16	related	relate	VERB
dpc-4137	178	17	genes	gene	NOUN
dpc-4137	178	18	that	that	PRON
dpc-4137	178	19	have	have	AUX
dpc-4137	178	20	been	be	AUX
dpc-4137	178	21	found	find	VERB
dpc-4137	178	22	useful	useful	ADJ
dpc-4137	178	23	to	to	PART
dpc-4137	178	24	assess	assess	VERB
dpc-4137	178	25	the	the	DET
dpc-4137	178	26	risk	risk	NOUN
dpc-4137	178	27	score	score	NOUN
dpc-4137	178	28	of	of	ADP
dpc-4137	178	29	hepatocellular	hepatocellular	ADJ
dpc-4137	178	30	carcinoma	carcinoma	NOUN
dpc-4137	178	31	(	(	PUNCT
dpc-4137	178	32	hcc	hcc	PROPN
dpc-4137	178	33	)	)	PUNCT
dpc-4137	179	1	[	[	X
dpc-4137	179	2	30	30	NUM
dpc-4137	179	3	]	]	PUNCT
dpc-4137	179	4	.	.	PUNCT
dpc-4137	180	1	apart	apart	ADV
dpc-4137	180	2	from	from	ADP
dpc-4137	180	3	research	research	NOUN
dpc-4137	180	4	on	on	ADP
dpc-4137	180	5	gsdma	gsdma	NOUN
dpc-4137	180	6	in	in	ADP
dpc-4137	180	7	hcc	hcc	PROPN
dpc-4137	180	8	,	,	PUNCT
dpc-4137	180	9	we	we	PRON
dpc-4137	180	10	were	be	AUX
dpc-4137	180	11	not	not	PART
dpc-4137	180	12	able	able	ADJ
dpc-4137	180	13	to	to	PART
dpc-4137	180	14	find	find	VERB
dpc-4137	180	15	any	any	DET
dpc-4137	180	16	information	information	NOUN
dpc-4137	180	17	on	on	ADP
dpc-4137	180	18	its	its	PRON
dpc-4137	180	19	role	role	NOUN
dpc-4137	180	20	in	in	ADP
dpc-4137	180	21	liver	liver	NOUN
dpc-4137	180	22	disorders	disorder	NOUN
dpc-4137	180	23	,	,	PUNCT
dpc-4137	180	24	so	so	SCONJ
dpc-4137	180	25	we	we	PRON
dpc-4137	180	26	have	have	VERB
dpc-4137	180	27	no	no	DET
dpc-4137	180	28	data	datum	NOUN
dpc-4137	180	29	for	for	ADP
dpc-4137	180	30	comparison	comparison	NOUN
dpc-4137	180	31	with	with	ADP
dpc-4137	180	32	our	our	PRON
dpc-4137	180	33	results	result	NOUN
dpc-4137	180	34	.	.	PUNCT
dpc-4137	181	1	study	study	NOUN
dpc-4137	181	2	limitations	limitation	NOUN
dpc-4137	181	3	include	include	VERB
dpc-4137	181	4	a	a	DET
dpc-4137	181	5	small	small	ADJ
dpc-4137	181	6	,	,	PUNCT
dpc-4137	181	7	predominantly	predominantly	ADV
dpc-4137	181	8	caucasian	caucasian	ADJ
dpc-4137	181	9	sample	sample	NOUN
dpc-4137	181	10	and	and	CCONJ
dpc-4137	181	11	a	a	DET
dpc-4137	181	12	scarcity	scarcity	NOUN
dpc-4137	181	13	of	of	ADP
dpc-4137	181	14	relevant	relevant	ADJ
dpc-4137	181	15	gsdma	gsdma	NOUN
dpc-4137	181	16	studies	study	NOUN
dpc-4137	181	17	.	.	PUNCT
dpc-4137	182	1	our	our	PRON
dpc-4137	182	2	study	study	NOUN
dpc-4137	182	3	comprehensively	comprehensively	ADV
dpc-4137	182	4	examined	examine	VERB
dpc-4137	182	5	the	the	DET
dpc-4137	182	6	role	role	NOUN
dpc-4137	182	7	of	of	ADP
dpc-4137	182	8	gsdma	gsdma	NOUN
dpc-4137	182	9	in	in	ADP
dpc-4137	182	10	psoriasis	psoriasis	NOUN
dpc-4137	182	11	.	.	PUNCT
dpc-4137	183	1	we	we	PRON
dpc-4137	183	2	report	report	VERB
dpc-4137	183	3	on	on	ADP
dpc-4137	183	4	its	its	PRON
dpc-4137	183	5	increased	increase	VERB
dpc-4137	183	6	concentrations	concentration	NOUN
dpc-4137	183	7	in	in	ADP
dpc-4137	183	8	psoriatic	psoriatic	ADJ
dpc-4137	183	9	patients	patient	NOUN
dpc-4137	183	10	’	'	PUNCT
dpc-4137	183	11	sera	sera	NOUN
dpc-4137	183	12	.	.	PUNCT
dpc-4137	184	1	moreover	moreover	ADV
dpc-4137	184	2	,	,	PUNCT
dpc-4137	184	3	we	we	PRON
dpc-4137	184	4	found	find	VERB
dpc-4137	184	5	its	its	PRON
dpc-4137	184	6	more	more	ADV
dpc-4137	184	7	prominent	prominent	ADJ
dpc-4137	184	8	expression	expression	NOUN
dpc-4137	184	9	in	in	ADP
dpc-4137	184	10	plaque	plaque	NOUN
dpc-4137	184	11	psoriasis	psoriasis	NOUN
dpc-4137	184	12	compared	compare	VERB
dpc-4137	184	13	to	to	ADP
dpc-4137	184	14	non	non	ADJ
dpc-4137	184	15	-	-	ADJ
dpc-4137	184	16	lesional	lesional	ADJ
dpc-4137	184	17	patients	patient	NOUN
dpc-4137	184	18	’	'	PUNCT
dpc-4137	184	19	skin	skin	NOUN
dpc-4137	184	20	and	and	CCONJ
dpc-4137	184	21	healthy	healthy	ADJ
dpc-4137	184	22	skin	skin	NOUN
dpc-4137	184	23	of	of	ADP
dpc-4137	184	24	subjects	subject	NOUN
dpc-4137	184	25	without	without	ADP
dpc-4137	184	26	dermatoses	dermatosis	NOUN
dpc-4137	184	27	.	.	PUNCT
dpc-4137	185	1	our	our	PRON
dpc-4137	185	2	study	study	NOUN
dpc-4137	185	3	shows	show	VERB
dpc-4137	185	4	that	that	SCONJ
dpc-4137	185	5	gsdma	gsdma	NOUN
dpc-4137	185	6	is	be	AUX
dpc-4137	185	7	probably	probably	ADV
dpc-4137	185	8	engaged	engage	VERB
dpc-4137	185	9	in	in	ADP
dpc-4137	185	10	psoriasis	psoriasis	NOUN
dpc-4137	185	11	pathogenesis	pathogenesis	NOUN
dpc-4137	185	12	,	,	PUNCT
dpc-4137	185	13	and	and	CCONJ
dpc-4137	185	14	its	its	PRON
dpc-4137	185	15	overexpression	overexpression	NOUN
dpc-4137	185	16	may	may	AUX
dpc-4137	185	17	probably	probably	ADV
dpc-4137	185	18	lead	lead	VERB
dpc-4137	185	19	to	to	ADP
dpc-4137	185	20	keratinocytes	keratinocyte	NOUN
dpc-4137	185	21	hyperproliferation	hyperproliferation	NOUN
dpc-4137	185	22	and	and	CCONJ
dpc-4137	185	23	be	be	AUX
dpc-4137	185	24	responsible	responsible	ADJ
dpc-4137	185	25	for	for	ADP
dpc-4137	185	26	triggering	trigger	VERB
dpc-4137	185	27	inflammation	inflammation	NOUN
dpc-4137	185	28	in	in	ADP
dpc-4137	185	29	psoriatic	psoriatic	ADJ
dpc-4137	185	30	skin	skin	NOUN
dpc-4137	185	31	.	.	PUNCT
dpc-4137	186	1	gsdma	gsdma	NOUN
dpc-4137	186	2	serum	serum	NOUN
dpc-4137	186	3	concentration	concentration	NOUN
dpc-4137	186	4	could	could	AUX
dpc-4137	186	5	be	be	AUX
dpc-4137	186	6	used	use	VERB
dpc-4137	186	7	as	as	ADP
dpc-4137	186	8	its	its	PRON
dpc-4137	186	9	biomarker	biomarker	NOUN
dpc-4137	186	10	but	but	CCONJ
dpc-4137	186	11	not	not	PART
dpc-4137	186	12	of	of	ADP
dpc-4137	186	13	skin	skin	NOUN
dpc-4137	186	14	lesion	lesion	NOUN
dpc-4137	186	15	severity	severity	NOUN
dpc-4137	186	16	.	.	PUNCT
dpc-4137	187	1	urinary	urinary	ADJ
dpc-4137	187	2	gsdma	gsdma	NOUN
dpc-4137	187	3	is	be	AUX
dpc-4137	187	4	probably	probably	ADV
dpc-4137	187	5	not	not	PART
dpc-4137	187	6	useful	useful	ADJ
dpc-4137	187	7	as	as	ADP
dpc-4137	187	8	a	a	DET
dpc-4137	187	9	biomarker	biomarker	NOUN
dpc-4137	187	10	.	.	PUNCT
dpc-4137	188	1	considering	consider	VERB
dpc-4137	188	2	that	that	SCONJ
dpc-4137	188	3	the	the	DET
dpc-4137	188	4	data	datum	NOUN
dpc-4137	188	5	on	on	ADP
dpc-4137	188	6	gsdma	gsdma	NOUN
dpc-4137	188	7	are	be	AUX
dpc-4137	188	8	sparse	sparse	ADJ
dpc-4137	188	9	and	and	CCONJ
dpc-4137	188	10	that	that	SCONJ
dpc-4137	188	11	its	its	PRON
dpc-4137	188	12	role	role	NOUN
dpc-4137	188	13	in	in	ADP
dpc-4137	188	14	the	the	DET
dpc-4137	188	15	skin	skin	NOUN
dpc-4137	188	16	is	be	AUX
dpc-4137	188	17	unclear	unclear	ADJ
dpc-4137	188	18	,	,	PUNCT
dpc-4137	188	19	further	further	ADJ
dpc-4137	188	20	studies	study	NOUN
dpc-4137	188	21	are	be	AUX
dpc-4137	188	22	needed	need	VERB
dpc-4137	188	23	to	to	PART
dpc-4137	188	24	understand	understand	VERB
dpc-4137	188	25	gsdma	gsdma	NOUN
dpc-4137	188	26	function	function	NOUN
dpc-4137	188	27	,	,	PUNCT
dpc-4137	188	28	including	include	VERB
dpc-4137	188	29	in	in	ADP
dpc-4137	188	30	psoriasis	psoriasis	NOUN
dpc-4137	188	31	.	.	PUNCT
dpc-4137	189	1	further	further	ADJ
dpc-4137	189	2	research	research	NOUN
dpc-4137	189	3	on	on	ADP
dpc-4137	189	4	gsdma	gsdma	NOUN
dpc-4137	189	5	as	as	ADP
dpc-4137	189	6	a	a	DET
dpc-4137	189	7	potential	potential	ADJ
dpc-4137	189	8	drug	drug	NOUN
dpc-4137	189	9	target	target	NOUN
dpc-4137	189	10	would	would	AUX
dpc-4137	189	11	be	be	AUX
dpc-4137	189	12	of	of	ADP
dpc-4137	189	13	high	high	ADJ
dpc-4137	189	14	value	value	NOUN
dpc-4137	189	15	.	.	PUNCT
dpc-4137	190	1	references	reference	NOUN
dpc-4137	190	2	1	1	NUM
dpc-4137	190	3	.	.	PUNCT
dpc-4137	190	4	farley	farley	PROPN
dpc-4137	190	5	e	e	PROPN
dpc-4137	190	6	,	,	PUNCT
dpc-4137	190	7	menter	menter	ADJ
dpc-4137	190	8	a.	a.	NOUN
dpc-4137	190	9	psoriasis	psoriasis	NOUN
dpc-4137	190	10	:	:	PUNCT
dpc-4137	190	11	comorbidities	comorbiditie	NOUN
dpc-4137	190	12	and	and	CCONJ
dpc-4137	190	13	associations	association	NOUN
dpc-4137	190	14	.	.	PUNCT
dpc-4137	191	1	g.	g.	PROPN
dpc-4137	191	2	ital	ital	PROPN
dpc-4137	191	3	.	.	PUNCT
dpc-4137	192	1	dermatol	dermatol	NOUN
dpc-4137	192	2	.	.	PUNCT
dpc-4137	193	1	veneorol	veneorol	NOUN
dpc-4137	193	2	.	.	PUNCT
dpc-4137	194	1	2011;146:9–15	2011;146:9–15	NUM
dpc-4137	194	2	.	.	PUNCT
dpc-4137	195	1	2	2	X
dpc-4137	195	2	.	.	X
dpc-4137	195	3	hirotsu	hirotsu	PROPN
dpc-4137	195	4	c	c	PROPN
dpc-4137	195	5	,	,	PUNCT
dpc-4137	195	6	rydlewski	rydlewski	PROPN
dpc-4137	195	7	m	m	PROPN
dpc-4137	195	8	,	,	PUNCT
dpc-4137	195	9	araújo	araújo	PROPN
dpc-4137	195	10	ms	ms	PROPN
dpc-4137	195	11	,	,	PUNCT
dpc-4137	195	12	et	et	PROPN
dpc-4137	195	13	al	al	PROPN
dpc-4137	195	14	.	.	PROPN
dpc-4137	196	1	sleep	sleep	NOUN
dpc-4137	196	2	loss	loss	NOUN
dpc-4137	196	3	and	and	CCONJ
dpc-4137	196	4	cytokines	cytokine	VERB
dpc-4137	196	5	levels	level	NOUN
dpc-4137	196	6	in	in	ADP
dpc-4137	196	7	an	an	DET
dpc-4137	196	8	experimental	experimental	ADJ
dpc-4137	196	9	model	model	NOUN
dpc-4137	196	10	of	of	ADP
dpc-4137	196	11	psoriasis	psoriasis	NOUN
dpc-4137	196	12	.	.	PUNCT
dpc-4137	197	1	plos	plos	PROPN
dpc-4137	197	2	one	one	NUM
dpc-4137	197	3	.	.	PUNCT
dpc-4137	197	4	2012	2012	NUM
dpc-4137	197	5	;	;	PUNCT
dpc-4137	197	6	7	7	NUM
dpc-4137	197	7	:	:	SYM
dpc-4137	197	8	e51183	e51183	NOUN
dpc-4137	197	9	.	.	NOUN
dpc-4137	198	1	3	3	NUM
dpc-4137	198	2	.	.	X
dpc-4137	198	3	lanna	lanna	PROPN
dpc-4137	198	4	c	c	PROPN
dpc-4137	198	5	,	,	PUNCT
dpc-4137	198	6	mancini	mancini	PROPN
dpc-4137	198	7	m	m	PROPN
dpc-4137	198	8	,	,	PUNCT
dpc-4137	198	9	gaziano	gaziano	PROPN
dpc-4137	198	10	r	r	PROPN
dpc-4137	198	11	,	,	PUNCT
dpc-4137	198	12	et	et	PROPN
dpc-4137	198	13	al	al	PROPN
dpc-4137	198	14	.	.	PROPN
dpc-4137	199	1	skin	skin	NOUN
dpc-4137	199	2	immunity	immunity	NOUN
dpc-4137	199	3	and	and	CCONJ
dpc-4137	199	4	its	its	PRON
dpc-4137	199	5	dysregulation	dysregulation	NOUN
dpc-4137	199	6	in	in	ADP
dpc-4137	199	7	psoriasis	psoriasis	NOUN
dpc-4137	199	8	.	.	PUNCT
dpc-4137	200	1	cell	cell	NOUN
dpc-4137	200	2	cycle	cycle	NOUN
dpc-4137	200	3	.	.	PUNCT
dpc-4137	201	1	2019;18:2581	2019;18:2581	NUM
dpc-4137	201	2	-	-	SYM
dpc-4137	201	3	2589	2589	NUM
dpc-4137	201	4	.	.	PUNCT
dpc-4137	202	1	4	4	X
dpc-4137	202	2	.	.	PUNCT
dpc-4137	202	3	rendon	rendon	PROPN
dpc-4137	202	4	a	a	PRON
dpc-4137	202	5	,	,	PUNCT
dpc-4137	202	6	schäkel	schäkel	PROPN
dpc-4137	202	7	k.	k.	PROPN
dpc-4137	202	8	psoriasis	psoriasis	NOUN
dpc-4137	202	9	pathogenesis	pathogenesis	NOUN
dpc-4137	202	10	and	and	CCONJ
dpc-4137	202	11	treatment	treatment	NOUN
dpc-4137	202	12	.	.	PUNCT
dpc-4137	203	1	int	int	PROPN
dpc-4137	203	2	j	j	PROPN
dpc-4137	203	3	mol	mol	ADP
dpc-4137	203	4	sci	sci	PROPN
dpc-4137	203	5	.	.	PROPN
dpc-4137	203	6	2019	2019	NUM
dpc-4137	203	7	;	;	PUNCT
dpc-4137	203	8	20:1475	20:1475	NUM
dpc-4137	203	9	.	.	X
dpc-4137	204	1	5	5	NUM
dpc-4137	204	2	.	.	NOUN
dpc-4137	204	3	nabieva	nabieva	PROPN
dpc-4137	204	4	k	k	PROPN
dpc-4137	204	5	,	,	PUNCT
dpc-4137	204	6	vender	vender	PROPN
dpc-4137	204	7	r.	r.	PROPN
dpc-4137	204	8	quality	quality	PROPN
dpc-4137	204	9	of	of	ADP
dpc-4137	204	10	life	life	NOUN
dpc-4137	204	11	and	and	CCONJ
dpc-4137	204	12	body	body	NOUN
dpc-4137	204	13	region	region	NOUN
dpc-4137	204	14	affected	affect	VERB
dpc-4137	204	15	by	by	ADP
dpc-4137	204	16	psoriasis	psoriasis	NOUN
dpc-4137	204	17	:	:	PUNCT
dpc-4137	204	18	a	a	DET
dpc-4137	204	19	systematic	systematic	ADJ
dpc-4137	204	20	review	review	NOUN
dpc-4137	204	21	.	.	PUNCT
dpc-4137	204	22	actas	actas	PROPN
dpc-4137	204	23	dermosifiliogr	dermosifiliogr	NOUN
dpc-4137	204	24	.	.	PUNCT
dpc-4137	205	1	2023	2023	NUM
dpc-4137	205	2	;	;	PUNCT
dpc-4137	205	3	114:33	114:33	NUM
dpc-4137	205	4	-	-	SYM
dpc-4137	205	5	38	38	NUM
dpc-4137	205	6	.	.	NOUN
dpc-4137	206	1	6	6	NUM
dpc-4137	206	2	.	.	PUNCT
dpc-4137	206	3	saeki	saeki	PROPN
dpc-4137	206	4	h	h	PROPN
dpc-4137	206	5	,	,	PUNCT
dpc-4137	206	6	kanai	kanai	PROPN
dpc-4137	206	7	y	y	PROPN
dpc-4137	206	8	,	,	PUNCT
dpc-4137	206	9	murotani	murotani	PROPN
dpc-4137	206	10	k	k	PROPN
dpc-4137	206	11	,	,	PUNCT
dpc-4137	206	12	et	et	PROPN
dpc-4137	206	13	al	al	PROPN
dpc-4137	206	14	.	.	PROPN
dpc-4137	207	1	work	work	NOUN
dpc-4137	207	2	productivity	productivity	NOUN
dpc-4137	207	3	in	in	ADP
dpc-4137	207	4	real	real	ADJ
dpc-4137	207	5	-	-	PUNCT
dpc-4137	207	6	life	life	NOUN
dpc-4137	207	7	employed	employ	VERB
dpc-4137	207	8	patients	patient	NOUN
dpc-4137	207	9	with	with	ADP
dpc-4137	207	10	plaque	plaque	NOUN
dpc-4137	207	11	psoriasis	psoriasis	NOUN
dpc-4137	207	12	:	:	PUNCT
dpc-4137	207	13	results	result	VERB
dpc-4137	207	14	from	from	ADP
dpc-4137	207	15	the	the	DET
dpc-4137	207	16	prologue	prologue	NOUN
dpc-4137	207	17	study	study	NOUN
dpc-4137	207	18	.	.	PUNCT
dpc-4137	208	1	j	j	PROPN
dpc-4137	208	2	dermatol	dermatol	NOUN
dpc-4137	208	3	.	.	PUNCT
dpc-4137	209	1	2022;49:970	2022;49:970	NOUN
dpc-4137	209	2	-	-	SYM
dpc-4137	209	3	978	978	NUM
dpc-4137	209	4	.	.	PUNCT
dpc-4137	210	1	7	7	X
dpc-4137	210	2	.	.	X
dpc-4137	210	3	information	information	NOUN
dpc-4137	210	4	about	about	ADP
dpc-4137	210	5	psoriasis	psoriasis	NOUN
dpc-4137	210	6	,	,	PUNCT
dpc-4137	210	7	available	available	ADJ
dpc-4137	210	8	at	at	ADP
dpc-4137	210	9	:	:	PUNCT
dpc-4137	210	10	https://www.psoriasis	https://www.psoriasis	NOUN
dpc-4137	210	11	.org	.org	PUNCT
dpc-4137	210	12	/	/	SYM
dpc-4137	210	13	about	about	ADV
dpc-4137	210	14	-	-	PUNCT
dpc-4137	210	15	psoriasis/	psoriasis/	PROPN
dpc-4137	210	16	accessed	access	VERB
dpc-4137	210	17	on	on	ADP
dpc-4137	210	18	august	august	PROPN
dpc-4137	210	19	7	7	NUM
dpc-4137	210	20	,	,	PUNCT
dpc-4137	210	21	2023	2023	NUM
dpc-4137	210	22	.	.	PUNCT
dpc-4137	211	1	8	8	NUM
dpc-4137	211	2	.	.	X
dpc-4137	212	1	armstrong	armstrong	PROPN
dpc-4137	212	2	aw	aw	PROPN
dpc-4137	212	3	,	,	PUNCT
dpc-4137	212	4	read	read	VERB
dpc-4137	212	5	c.	c.	PROPN
dpc-4137	212	6	pathophysiology	pathophysiology	NOUN
dpc-4137	212	7	,	,	PUNCT
dpc-4137	212	8	clinical	clinical	ADJ
dpc-4137	212	9	presentation	presentation	NOUN
dpc-4137	212	10	,	,	PUNCT
dpc-4137	212	11	and	and	CCONJ
dpc-4137	212	12	treatment	treatment	NOUN
dpc-4137	212	13	of	of	ADP
dpc-4137	212	14	psoriasis	psoriasis	NOUN
dpc-4137	212	15	:	:	PUNCT
dpc-4137	212	16	a	a	DET
dpc-4137	212	17	review	review	NOUN
dpc-4137	212	18	.	.	PUNCT
dpc-4137	213	1	jama	jama	PROPN
dpc-4137	213	2	.	.	PUNCT
dpc-4137	214	1	2020	2020	NUM
dpc-4137	214	2	;	;	PUNCT
dpc-4137	214	3	323	323	NUM
dpc-4137	214	4	:	:	SYM
dpc-4137	214	5	1945	1945	NUM
dpc-4137	214	6	-	-	SYM
dpc-4137	214	7	1960	1960	NUM
dpc-4137	214	8	.	.	PUNCT
dpc-4137	215	1	in	in	ADP
dpc-4137	215	2	the	the	DET
dpc-4137	215	3	pathogenesis	pathogenesis	NOUN
dpc-4137	215	4	of	of	ADP
dpc-4137	215	5	psoriasis	psoriasis	NOUN
dpc-4137	215	6	.	.	PUNCT
dpc-4137	216	1	we	we	PRON
dpc-4137	216	2	must	must	AUX
dpc-4137	216	3	take	take	VERB
dpc-4137	216	4	into	into	ADP
dpc-4137	216	5	consideration	consideration	NOUN
dpc-4137	216	6	,	,	PUNCT
dpc-4137	216	7	though	though	ADV
dpc-4137	216	8	,	,	PUNCT
dpc-4137	216	9	that	that	SCONJ
dpc-4137	216	10	almost	almost	ADV
dpc-4137	216	11	all	all	PRON
dpc-4137	216	12	available	available	ADJ
dpc-4137	216	13	studies	study	NOUN
dpc-4137	216	14	that	that	PRON
dpc-4137	216	15	focused	focus	VERB
dpc-4137	216	16	on	on	ADP
dpc-4137	216	17	the	the	DET
dpc-4137	216	18	role	role	NOUN
dpc-4137	216	19	of	of	ADP
dpc-4137	216	20	gsdma	gsdma	NOUN
dpc-4137	216	21	particularly	particularly	ADV
dpc-4137	216	22	in	in	ADP
dpc-4137	216	23	the	the	DET
dpc-4137	216	24	skin	skin	NOUN
dpc-4137	216	25	were	be	AUX
dpc-4137	216	26	performed	perform	VERB
dpc-4137	216	27	on	on	ADP
dpc-4137	216	28	mice	mouse	NOUN
dpc-4137	216	29	,	,	PUNCT
dpc-4137	216	30	not	not	PART
dpc-4137	216	31	humans	human	NOUN
dpc-4137	216	32	.	.	PUNCT
dpc-4137	217	1	the	the	DET
dpc-4137	217	2	only	only	ADJ
dpc-4137	217	3	experiment	experiment	NOUN
dpc-4137	217	4	on	on	ADP
dpc-4137	217	5	psoriatic	psoriatic	ADJ
dpc-4137	217	6	skin	skin	NOUN
dpc-4137	217	7	tissue	tissue	NOUN
dpc-4137	217	8	,	,	PUNCT
dpc-4137	217	9	albeit	albeit	SCONJ
dpc-4137	217	10	on	on	ADP
dpc-4137	217	11	a	a	DET
dpc-4137	217	12	very	very	ADV
dpc-4137	217	13	small	small	ADJ
dpc-4137	217	14	sample	sample	NOUN
dpc-4137	217	15	size	size	NOUN
dpc-4137	217	16	,	,	PUNCT
dpc-4137	217	17	examined	examine	VERB
dpc-4137	217	18	the	the	DET
dpc-4137	217	19	expression	expression	NOUN
dpc-4137	217	20	of	of	ADP
dpc-4137	217	21	gsdma	gsdma	NOUN
dpc-4137	217	22	gene	gene	NOUN
dpc-4137	217	23	,	,	PUNCT
dpc-4137	217	24	present	present	ADJ
dpc-4137	217	25	in	in	ADP
dpc-4137	217	26	all	all	DET
dpc-4137	217	27	epidermal	epidermal	ADJ
dpc-4137	217	28	layers	layer	NOUN
dpc-4137	217	29	but	but	CCONJ
dpc-4137	217	30	most	most	ADV
dpc-4137	217	31	prominent	prominent	ADJ
dpc-4137	217	32	in	in	ADP
dpc-4137	217	33	the	the	DET
dpc-4137	217	34	stratum	stratum	NOUN
dpc-4137	217	35	corneum	corneum	NOUN
dpc-4137	217	36	[	[	X
dpc-4137	217	37	28	28	NUM
dpc-4137	217	38	]	]	PUNCT
dpc-4137	217	39	.	.	PUNCT
dpc-4137	218	1	we	we	PRON
dpc-4137	218	2	were	be	AUX
dpc-4137	218	3	not	not	PART
dpc-4137	218	4	able	able	ADJ
dpc-4137	218	5	any	any	DET
dpc-4137	218	6	other	other	ADJ
dpc-4137	218	7	study	study	NOUN
dpc-4137	218	8	using	use	VERB
dpc-4137	218	9	immunohistochemistry	immunohistochemistry	NOUN
dpc-4137	218	10	in	in	ADP
dpc-4137	218	11	psoriatic	psoriatic	ADJ
dpc-4137	218	12	tissue	tissue	NOUN
dpc-4137	218	13	to	to	PART
dpc-4137	218	14	assess	assess	VERB
dpc-4137	218	15	the	the	DET
dpc-4137	218	16	role	role	NOUN
dpc-4137	218	17	of	of	ADP
dpc-4137	218	18	gasdermins	gasdermin	NOUN
dpc-4137	218	19	.	.	PUNCT
dpc-4137	219	1	based	base	VERB
dpc-4137	219	2	on	on	ADP
dpc-4137	219	3	the	the	DET
dpc-4137	219	4	significantly	significantly	ADV
dpc-4137	219	5	higher	high	ADJ
dpc-4137	219	6	gsdma	gsdma	NOUN
dpc-4137	219	7	serum	serum	NOUN
dpc-4137	219	8	concentration	concentration	NOUN
dpc-4137	219	9	in	in	ADP
dpc-4137	219	10	psoriatic	psoriatic	ADJ
dpc-4137	219	11	patients	patient	NOUN
dpc-4137	219	12	and	and	CCONJ
dpc-4137	219	13	its	its	PRON
dpc-4137	219	14	more	more	ADV
dpc-4137	219	15	prominent	prominent	ADJ
dpc-4137	219	16	expression	expression	NOUN
dpc-4137	219	17	in	in	ADP
dpc-4137	219	18	plaque	plaque	NOUN
dpc-4137	219	19	psoriasis	psoriasis	NOUN
dpc-4137	219	20	compared	compare	VERB
dpc-4137	219	21	to	to	ADP
dpc-4137	219	22	subjects	subject	NOUN
dpc-4137	219	23	without	without	ADP
dpc-4137	219	24	psoriasis	psoriasis	NOUN
dpc-4137	219	25	,	,	PUNCT
dpc-4137	219	26	we	we	PRON
dpc-4137	219	27	could	could	AUX
dpc-4137	219	28	certainly	certainly	ADV
dpc-4137	219	29	suspect	suspect	VERB
dpc-4137	219	30	that	that	SCONJ
dpc-4137	219	31	it	it	PRON
dpc-4137	219	32	actually	actually	ADV
dpc-4137	219	33	plays	play	VERB
dpc-4137	219	34	a	a	DET
dpc-4137	219	35	role	role	NOUN
dpc-4137	219	36	in	in	ADP
dpc-4137	219	37	psoriasis	psoriasis	NOUN
dpc-4137	219	38	,	,	PUNCT
dpc-4137	219	39	and	and	CCONJ
dpc-4137	219	40	its	its	PRON
dpc-4137	219	41	serum	serum	NOUN
dpc-4137	219	42	concentration	concentration	NOUN
dpc-4137	219	43	could	could	AUX
dpc-4137	219	44	become	become	VERB
dpc-4137	219	45	its	its	PRON
dpc-4137	219	46	biomarker	biomarker	NOUN
dpc-4137	219	47	.	.	PUNCT
dpc-4137	220	1	overexpression	overexpression	NOUN
dpc-4137	220	2	of	of	ADP
dpc-4137	220	3	gsdma	gsdma	NOUN
dpc-4137	220	4	in	in	ADP
dpc-4137	220	5	plaque	plaque	NOUN
dpc-4137	220	6	psoriasis	psoriasis	NOUN
dpc-4137	220	7	compared	compare	VERB
dpc-4137	220	8	to	to	ADP
dpc-4137	220	9	non	non	ADJ
dpc-4137	220	10	-	-	ADJ
dpc-4137	220	11	lesional	lesional	ADJ
dpc-4137	220	12	skin	skin	NOUN
dpc-4137	220	13	and	and	CCONJ
dpc-4137	220	14	healthy	healthy	ADJ
dpc-4137	220	15	skin	skin	NOUN
dpc-4137	220	16	of	of	ADP
dpc-4137	220	17	controls	control	NOUN
dpc-4137	220	18	seems	seem	VERB
dpc-4137	220	19	consistent	consistent	ADJ
dpc-4137	220	20	with	with	ADP
dpc-4137	220	21	findings	finding	NOUN
dpc-4137	220	22	by	by	ADP
dpc-4137	220	23	lin	lin	PROPN
dpc-4137	220	24	et	et	PROPN
dpc-4137	220	25	al	al	PROPN
dpc-4137	220	26	.	.	PUNCT
dpc-4137	221	1	[	[	X
dpc-4137	221	2	20	20	NUM
dpc-4137	221	3	]	]	PUNCT
dpc-4137	221	4	.	.	PUNCT
dpc-4137	222	1	its	its	PRON
dpc-4137	222	2	presence	presence	NOUN
dpc-4137	222	3	may	may	AUX
dpc-4137	222	4	probably	probably	ADV
dpc-4137	222	5	lead	lead	VERB
dpc-4137	222	6	to	to	ADP
dpc-4137	222	7	keratinocytes	keratinocyte	NOUN
dpc-4137	222	8	hyperproliferation	hyperproliferation	NOUN
dpc-4137	222	9	and	and	CCONJ
dpc-4137	222	10	be	be	AUX
dpc-4137	222	11	responsible	responsible	ADJ
dpc-4137	222	12	for	for	ADP
dpc-4137	222	13	triggering	trigger	VERB
dpc-4137	222	14	inflammation	inflammation	NOUN
dpc-4137	222	15	in	in	ADP
dpc-4137	222	16	psoriatic	psoriatic	ADJ
dpc-4137	222	17	skin	skin	NOUN
dpc-4137	222	18	.	.	PUNCT
dpc-4137	223	1	however	however	ADV
dpc-4137	223	2	,	,	PUNCT
dpc-4137	223	3	the	the	DET
dpc-4137	223	4	exact	exact	ADJ
dpc-4137	223	5	mechanism	mechanism	NOUN
dpc-4137	223	6	in	in	ADP
dpc-4137	223	7	psoriasis	psoriasis	NOUN
dpc-4137	223	8	remains	remain	VERB
dpc-4137	223	9	uncertain	uncertain	ADJ
dpc-4137	223	10	.	.	PUNCT
dpc-4137	224	1	on	on	ADP
dpc-4137	224	2	the	the	DET
dpc-4137	224	3	other	other	ADJ
dpc-4137	224	4	hand	hand	NOUN
dpc-4137	224	5	,	,	PUNCT
dpc-4137	224	6	considering	consider	VERB
dpc-4137	224	7	the	the	DET
dpc-4137	224	8	involvement	involvement	NOUN
dpc-4137	224	9	of	of	ADP
dpc-4137	224	10	gsdma	gsdma	NOUN
dpc-4137	224	11	in	in	ADP
dpc-4137	224	12	several	several	ADJ
dpc-4137	224	13	types	type	NOUN
dpc-4137	224	14	of	of	ADP
dpc-4137	224	15	cell	cell	NOUN
dpc-4137	224	16	death	death	NOUN
dpc-4137	224	17	,	,	PUNCT
dpc-4137	224	18	it	it	PRON
dpc-4137	224	19	can	can	AUX
dpc-4137	224	20	not	not	PART
dpc-4137	224	21	be	be	AUX
dpc-4137	224	22	fully	fully	ADV
dpc-4137	224	23	ruled	rule	VERB
dpc-4137	224	24	out	out	ADP
dpc-4137	224	25	that	that	SCONJ
dpc-4137	224	26	gsdma	gsdma	NOUN
dpc-4137	224	27	may	may	AUX
dpc-4137	224	28	be	be	AUX
dpc-4137	224	29	compensatively	compensatively	ADV
dpc-4137	224	30	elevated	elevate	VERB
dpc-4137	224	31	to	to	PART
dpc-4137	224	32	lead	lead	VERB
dpc-4137	224	33	the	the	DET
dpc-4137	224	34	cells	cell	NOUN
dpc-4137	224	35	toward	toward	ADP
dpc-4137	224	36	apoptosis	apoptosis	NOUN
dpc-4137	224	37	–	–	PUNCT
dpc-4137	224	38	which	which	PRON
dpc-4137	224	39	requires	require	VERB
dpc-4137	224	40	further	further	ADJ
dpc-4137	224	41	research	research	NOUN
dpc-4137	224	42	.	.	PUNCT
dpc-4137	225	1	as	as	ADP
dpc-4137	225	2	for	for	ADP
dpc-4137	225	3	the	the	DET
dpc-4137	225	4	urine	urine	NOUN
dpc-4137	225	5	,	,	PUNCT
dpc-4137	225	6	it	it	PRON
dpc-4137	225	7	is	be	AUX
dpc-4137	225	8	an	an	DET
dpc-4137	225	9	ideal	ideal	ADJ
dpc-4137	225	10	fluid	fluid	NOUN
dpc-4137	225	11	to	to	PART
dpc-4137	225	12	collect	collect	VERB
dpc-4137	225	13	for	for	ADP
dpc-4137	225	14	screening	screen	VERB
dpc-4137	225	15	since	since	SCONJ
dpc-4137	225	16	it	it	PRON
dpc-4137	225	17	is	be	AUX
dpc-4137	225	18	easy	easy	ADJ
dpc-4137	225	19	and	and	CCONJ
dpc-4137	225	20	painless	painless	ADJ
dpc-4137	225	21	to	to	PART
dpc-4137	225	22	donate	donate	VERB
dpc-4137	225	23	.	.	PUNCT
dpc-4137	226	1	considering	consider	VERB
dpc-4137	226	2	different	different	ADJ
dpc-4137	226	3	kidney	kidney	NOUN
dpc-4137	226	4	functions	function	NOUN
dpc-4137	226	5	in	in	ADP
dpc-4137	226	6	patients	patient	NOUN
dpc-4137	226	7	,	,	PUNCT
dpc-4137	226	8	we	we	PRON
dpc-4137	226	9	presented	present	VERB
dpc-4137	226	10	our	our	PRON
dpc-4137	226	11	results	result	NOUN
dpc-4137	226	12	as	as	ADP
dpc-4137	226	13	absolute	absolute	ADJ
dpc-4137	226	14	urinary	urinary	ADJ
dpc-4137	226	15	concentrations	concentration	NOUN
dpc-4137	226	16	and	and	CCONJ
dpc-4137	226	17	with	with	ADP
dpc-4137	226	18	creatinine	creatinine	NOUN
dpc-4137	226	19	ratio	ratio	NOUN
dpc-4137	226	20	to	to	PART
dpc-4137	226	21	obtain	obtain	VERB
dpc-4137	226	22	objective	objective	ADJ
dpc-4137	226	23	results	result	NOUN
dpc-4137	226	24	.	.	PUNCT
dpc-4137	227	1	unfortunately	unfortunately	ADV
dpc-4137	227	2	,	,	PUNCT
dpc-4137	227	3	we	we	PRON
dpc-4137	227	4	did	do	AUX
dpc-4137	227	5	not	not	PART
dpc-4137	227	6	observe	observe	VERB
dpc-4137	227	7	significant	significant	ADJ
dpc-4137	227	8	differences	difference	NOUN
dpc-4137	227	9	between	between	ADP
dpc-4137	227	10	patients	patient	NOUN
dpc-4137	227	11	and	and	CCONJ
dpc-4137	227	12	controls	control	NOUN
dpc-4137	227	13	in	in	ADP
dpc-4137	227	14	terms	term	NOUN
dpc-4137	227	15	of	of	ADP
dpc-4137	227	16	urinary	urinary	ADJ
dpc-4137	227	17	gsdma	gsdma	NOUN
dpc-4137	227	18	/	/	SYM
dpc-4137	227	19	creatinine	creatinine	NOUN
dpc-4137	227	20	ratio	ratio	NOUN
dpc-4137	227	21	,	,	PUNCT
dpc-4137	227	22	which	which	PRON
dpc-4137	227	23	would	would	AUX
dpc-4137	227	24	be	be	AUX
dpc-4137	227	25	a	a	DET
dpc-4137	227	26	more	more	ADV
dpc-4137	227	27	objective	objective	ADJ
dpc-4137	227	28	parameter	parameter	NOUN
dpc-4137	227	29	than	than	ADP
dpc-4137	227	30	absolute	absolute	ADJ
dpc-4137	227	31	urinary	urinary	ADJ
dpc-4137	227	32	concentration	concentration	NOUN
dpc-4137	227	33	,	,	PUNCT
dpc-4137	227	34	so	so	ADV
dpc-4137	227	35	urine	urine	NOUN
dpc-4137	227	36	probably	probably	ADV
dpc-4137	227	37	can	can	AUX
dpc-4137	227	38	not	not	PART
dpc-4137	227	39	be	be	AUX
dpc-4137	227	40	used	use	VERB
dpc-4137	227	41	for	for	ADP
dpc-4137	227	42	biomarker	biomarker	NOUN
dpc-4137	227	43	detection	detection	NOUN
dpc-4137	227	44	in	in	ADP
dpc-4137	227	45	this	this	DET
dpc-4137	227	46	group	group	NOUN
dpc-4137	227	47	of	of	ADP
dpc-4137	227	48	patients	patient	NOUN
dpc-4137	227	49	.	.	PUNCT
dpc-4137	228	1	we	we	PRON
dpc-4137	228	2	are	be	AUX
dpc-4137	228	3	not	not	PART
dpc-4137	228	4	familiar	familiar	ADJ
dpc-4137	228	5	with	with	ADP
dpc-4137	228	6	any	any	DET
dpc-4137	228	7	other	other	ADJ
dpc-4137	228	8	study	study	NOUN
dpc-4137	228	9	assessing	assess	VERB
dpc-4137	228	10	urinary	urinary	ADJ
dpc-4137	228	11	gsdma	gsdma	NOUN
dpc-4137	228	12	.	.	PUNCT
dpc-4137	229	1	serum	serum	PROPN
dpc-4137	229	2	gsdma	gsdma	PROPN
dpc-4137	229	3	was	be	AUX
dpc-4137	229	4	not	not	PART
dpc-4137	229	5	directly	directly	ADV
dpc-4137	229	6	correlated	correlate	VERB
dpc-4137	229	7	with	with	ADP
dpc-4137	229	8	psoriasis	psoriasis	NOUN
dpc-4137	229	9	severity	severity	NOUN
dpc-4137	229	10	in	in	ADP
dpc-4137	229	11	pasi	pasi	NOUN
dpc-4137	229	12	,	,	PUNCT
dpc-4137	229	13	nor	nor	CCONJ
dpc-4137	229	14	is	be	AUX
dpc-4137	229	15	there	there	PRON
dpc-4137	229	16	any	any	DET
dpc-4137	229	17	significant	significant	ADJ
dpc-4137	229	18	difference	difference	NOUN
dpc-4137	229	19	between	between	ADP
dpc-4137	229	20	the	the	DET
dpc-4137	229	21	pasi	pasi	NOUN
dpc-4137	229	22	subgroups	subgroup	NOUN
dpc-4137	229	23	regarding	regard	VERB
dpc-4137	229	24	its	its	PRON
dpc-4137	229	25	concentration	concentration	NOUN
dpc-4137	229	26	,	,	PUNCT
dpc-4137	229	27	although	although	SCONJ
dpc-4137	229	28	serum	serum	NOUN
dpc-4137	229	29	gsdma	gsdma	NOUN
dpc-4137	229	30	concentrations	concentration	NOUN
dpc-4137	229	31	were	be	AUX
dpc-4137	229	32	higher	high	ADJ
dpc-4137	229	33	in	in	ADP
dpc-4137	229	34	patients	patient	NOUN
dpc-4137	229	35	with	with	ADP
dpc-4137	229	36	more	more	ADV
dpc-4137	229	37	severe	severe	ADJ
dpc-4137	229	38	psoriasis	psoriasis	NOUN
dpc-4137	229	39	and	and	CCONJ
dpc-4137	229	40	in	in	ADP
dpc-4137	229	41	such	such	ADJ
dpc-4137	229	42	subjects	subject	NOUN
dpc-4137	229	43	,	,	PUNCT
dpc-4137	229	44	there	there	PRON
dpc-4137	229	45	was	be	VERB
dpc-4137	229	46	higher	high	ADJ
dpc-4137	229	47	expression	expression	NOUN
dpc-4137	229	48	of	of	ADP
dpc-4137	229	49	gsdma	gsdma	NOUN
dpc-4137	229	50	in	in	ADP
dpc-4137	229	51	psoriatic	psoriatic	ADJ
dpc-4137	229	52	plaque	plaque	NOUN
dpc-4137	229	53	observed	observe	VERB
dpc-4137	229	54	.	.	PUNCT
dpc-4137	230	1	instead	instead	ADV
dpc-4137	230	2	,	,	PUNCT
dpc-4137	230	3	patients	patient	NOUN
dpc-4137	230	4	with	with	ADP
dpc-4137	230	5	mild	mild	ADJ
dpc-4137	230	6	psoriasis	psoriasis	NOUN
dpc-4137	230	7	had	have	VERB
dpc-4137	230	8	only	only	ADV
dpc-4137	230	9	low	low	ADJ
dpc-4137	230	10	expression	expression	NOUN
dpc-4137	230	11	.	.	PUNCT
dpc-4137	231	1	apparently	apparently	ADV
dpc-4137	231	2	,	,	PUNCT
dpc-4137	231	3	gsdma	gsdma	NOUN
dpc-4137	231	4	concentration	concentration	NOUN
dpc-4137	231	5	or	or	CCONJ
dpc-4137	231	6	expression	expression	NOUN
dpc-4137	231	7	does	do	AUX
dpc-4137	231	8	not	not	PART
dpc-4137	231	9	directly	directly	ADV
dpc-4137	231	10	depend	depend	VERB
dpc-4137	231	11	on	on	ADP
dpc-4137	231	12	psoriasis	psoriasis	NOUN
dpc-4137	231	13	severity	severity	NOUN
dpc-4137	231	14	and	and	CCONJ
dpc-4137	231	15	can	can	AUX
dpc-4137	231	16	not	not	PART
dpc-4137	231	17	be	be	AUX
dpc-4137	231	18	used	use	VERB
dpc-4137	231	19	as	as	ADP
dpc-4137	231	20	its	its	PRON
dpc-4137	231	21	marker	marker	NOUN
dpc-4137	231	22	,	,	PUNCT
dpc-4137	231	23	but	but	CCONJ
dpc-4137	231	24	its	its	PRON
dpc-4137	231	25	involvement	involvement	NOUN
dpc-4137	231	26	in	in	ADP
dpc-4137	231	27	psoriasis	psoriasis	NOUN
dpc-4137	231	28	pathogenesis	pathogenesis	NOUN
dpc-4137	231	29	seems	seem	VERB
dpc-4137	231	30	more	more	ADV
dpc-4137	231	31	prominent	prominent	ADJ
dpc-4137	231	32	in	in	ADP
dpc-4137	231	33	more	more	ADV
dpc-4137	231	34	severe	severe	ADJ
dpc-4137	231	35	cases	case	NOUN
dpc-4137	231	36	.	.	PUNCT
dpc-4137	232	1	as	as	ADP
dpc-4137	232	2	for	for	ADP
dpc-4137	232	3	demographic	demographic	ADJ
dpc-4137	232	4	parameters	parameter	NOUN
dpc-4137	232	5	,	,	PUNCT
dpc-4137	232	6	namely	namely	ADV
dpc-4137	232	7	age	age	NOUN
dpc-4137	232	8	and	and	CCONJ
dpc-4137	232	9	sex	sex	NOUN
dpc-4137	232	10	,	,	PUNCT
dpc-4137	232	11	there	there	PRON
dpc-4137	232	12	were	be	VERB
dpc-4137	232	13	no	no	DET
dpc-4137	232	14	associations	association	NOUN
dpc-4137	232	15	with	with	ADP
dpc-4137	232	16	gsdma	gsdma	NOUN
dpc-4137	232	17	serum	serum	NOUN
dpc-4137	232	18	concentrations	concentration	NOUN
dpc-4137	232	19	,	,	PUNCT
dpc-4137	232	20	so	so	ADV
dpc-4137	232	21	apparently	apparently	ADV
dpc-4137	232	22	it	it	PRON
dpc-4137	232	23	would	would	AUX
dpc-4137	232	24	be	be	AUX
dpc-4137	232	25	equally	equally	ADV
dpc-4137	232	26	useful	useful	ADJ
dpc-4137	232	27	regardless	regardless	ADV
dpc-4137	232	28	of	of	ADP
dpc-4137	232	29	these	these	DET
dpc-4137	232	30	features	feature	NOUN
dpc-4137	232	31	.	.	PUNCT
dpc-4137	233	1	psoriasis	psoriasis	NOUN
dpc-4137	233	2	duration	duration	NOUN
dpc-4137	233	3	does	do	AUX
dpc-4137	233	4	not	not	PART
dpc-4137	233	5	seem	seem	VERB
dpc-4137	233	6	to	to	PART
dpc-4137	233	7	influence	influence	VERB
dpc-4137	233	8	gsdma	gsdma	NOUN
dpc-4137	233	9	concentration	concentration	NOUN
dpc-4137	233	10	either	either	ADV
dpc-4137	233	11	.	.	PUNCT
dpc-4137	234	1	original	original	ADJ
dpc-4137	234	2	article	article	NOUN
dpc-4137	234	3	|	|	ADV
dpc-4137	234	4	dermatol	dermatol	ADJ
dpc-4137	234	5	pract	pract	NOUN
dpc-4137	234	6	concept	concept	NOUN
dpc-4137	234	7	.	.	PUNCT
dpc-4137	235	1	2024;14(3):e2024177	2024;14(3):e2024177	NUM
dpc-4137	235	2	9	9	NUM
dpc-4137	235	3	21	21	NUM
dpc-4137	235	4	.	.	PUNCT
dpc-4137	236	1	tanaka	tanaka	PROPN
dpc-4137	236	2	s	s	PROPN
dpc-4137	236	3	,	,	PUNCT
dpc-4137	236	4	mizushina	mizushina	PROPN
dpc-4137	236	5	y	y	PROPN
dpc-4137	236	6	,	,	PUNCT
dpc-4137	236	7	kato	kato	PROPN
dpc-4137	236	8	y	y	PROPN
dpc-4137	236	9	,	,	PUNCT
dpc-4137	236	10	tamura	tamura	PROPN
dpc-4137	236	11	m	m	PROPN
dpc-4137	236	12	,	,	PUNCT
dpc-4137	236	13	shiroishi	shiroishi	ADJ
dpc-4137	236	14	t.	t.	ADJ
dpc-4137	236	15	functional	functional	ADJ
dpc-4137	236	16	conservation	conservation	NOUN
dpc-4137	236	17	of	of	ADP
dpc-4137	236	18	gsdma	gsdma	NOUN
dpc-4137	236	19	cluster	cluster	NOUN
dpc-4137	236	20	genes	gene	NOUN
dpc-4137	236	21	specifically	specifically	ADV
dpc-4137	236	22	duplicated	duplicate	VERB
dpc-4137	236	23	in	in	ADP
dpc-4137	236	24	the	the	DET
dpc-4137	236	25	mouse	mouse	NOUN
dpc-4137	236	26	genome	genome	NOUN
dpc-4137	236	27	.	.	PUNCT
dpc-4137	237	1	g3	g3	PROPN
dpc-4137	237	2	(	(	PUNCT
dpc-4137	237	3	bethesda	bethesda	PROPN
dpc-4137	237	4	)	)	PUNCT
dpc-4137	237	5	.	.	PUNCT
dpc-4137	238	1	2013;3:1843	2013;3:1843	NUM
dpc-4137	238	2	-	-	SYM
dpc-4137	238	3	50	50	NUM
dpc-4137	238	4	.	.	PUNCT
dpc-4137	239	1	22	22	NUM
dpc-4137	239	2	.	.	PUNCT
dpc-4137	240	1	huang	huang	PROPN
dpc-4137	240	2	ly	ly	PROPN
dpc-4137	240	3	,	,	PUNCT
dpc-4137	240	4	li	li	PROPN
dpc-4137	240	5	st	st	PROPN
dpc-4137	240	6	,	,	PUNCT
dpc-4137	240	7	lin	lin	PROPN
dpc-4137	240	8	sc	sc	PROPN
dpc-4137	240	9	,	,	PUNCT
dpc-4137	240	10	et	et	PROPN
dpc-4137	240	11	al	al	PROPN
dpc-4137	240	12	.	.	PROPN
dpc-4137	240	13	gasdermin	gasdermin	PROPN
dpc-4137	240	14	a	a	PRON
dpc-4137	240	15	is	be	AUX
dpc-4137	240	16	required	require	VERB
dpc-4137	240	17	for	for	ADP
dpc-4137	240	18	epidermal	epidermal	ADJ
dpc-4137	240	19	cornification	cornification	NOUN
dpc-4137	240	20	during	during	ADP
dpc-4137	240	21	skin	skin	NOUN
dpc-4137	240	22	barrier	barrier	NOUN
dpc-4137	240	23	regeneration	regeneration	NOUN
dpc-4137	240	24	and	and	CCONJ
dpc-4137	240	25	in	in	ADP
dpc-4137	240	26	an	an	DET
dpc-4137	240	27	atopic	atopic	NOUN
dpc-4137	240	28	dermatitis	dermatitis	NOUN
dpc-4137	240	29	-	-	PUNCT
dpc-4137	240	30	like	like	ADJ
dpc-4137	240	31	model	model	NOUN
dpc-4137	240	32	.	.	PUNCT
dpc-4137	241	1	j	j	PROPN
dpc-4137	241	2	invest	invest	VERB
dpc-4137	241	3	dermatol	dermatol	NOUN
dpc-4137	241	4	.	.	PUNCT
dpc-4137	242	1	2023;s0022	2023;s0022	NUM
dpc-4137	242	2	-	-	PUNCT
dpc-4137	242	3	202x(23)01938	202x(23)01938	NUM
dpc-4137	242	4	-	-	PUNCT
dpc-4137	242	5	3	3	NUM
dpc-4137	242	6	.	.	NOUN
dpc-4137	242	7	23	23	NUM
dpc-4137	242	8	.	.	PUNCT
dpc-4137	243	1	flisiak	flisiak	PROPN
dpc-4137	243	2	i	i	PROPN
dpc-4137	243	3	,	,	PUNCT
dpc-4137	243	4	porebski	porebski	PROPN
dpc-4137	243	5	p	p	X
dpc-4137	243	6	,	,	PUNCT
dpc-4137	243	7	flisiak	flisiak	PROPN
dpc-4137	243	8	r	r	PROPN
dpc-4137	243	9	,	,	PUNCT
dpc-4137	243	10	chodynicka	chodynicka	PROPN
dpc-4137	243	11	b.	b.	PROPN
dpc-4137	243	12	plasma	plasma	PROPN
dpc-4137	243	13	transforming	transform	VERB
dpc-4137	243	14	growth	growth	NOUN
dpc-4137	243	15	factor	factor	NOUN
dpc-4137	243	16	beta1	beta1	NOUN
dpc-4137	243	17	as	as	ADP
dpc-4137	243	18	a	a	DET
dpc-4137	243	19	biomarker	biomarker	NOUN
dpc-4137	243	20	of	of	ADP
dpc-4137	243	21	psoriasis	psoriasis	NOUN
dpc-4137	243	22	activity	activity	NOUN
dpc-4137	243	23	and	and	CCONJ
dpc-4137	243	24	treatment	treatment	NOUN
dpc-4137	243	25	efficacy	efficacy	NOUN
dpc-4137	243	26	.	.	PUNCT
dpc-4137	244	1	biomarkers	biomarker	NOUN
dpc-4137	244	2	.	.	PUNCT
dpc-4137	245	1	2003;8:437–443	2003;8:437–443	NUM
dpc-4137	245	2	.	.	NOUN
dpc-4137	246	1	24	24	NUM
dpc-4137	246	2	.	.	PUNCT
dpc-4137	247	1	flisiak	flisiak	PROPN
dpc-4137	247	2	i	i	PROPN
dpc-4137	247	3	,	,	PUNCT
dpc-4137	247	4	chodynicka	chodynicka	PROPN
dpc-4137	247	5	b	b	PROPN
dpc-4137	247	6	,	,	PUNCT
dpc-4137	247	7	porebski	porebski	ADJ
dpc-4137	247	8	p	p	X
dpc-4137	247	9	,	,	PUNCT
dpc-4137	247	10	flisiak	flisiak	PROPN
dpc-4137	247	11	r.	r.	PROPN
dpc-4137	247	12	association	association	PROPN
dpc-4137	247	13	between	between	ADP
dpc-4137	247	14	psoriasis	psoriasis	NOUN
dpc-4137	247	15	severity	severity	NOUN
dpc-4137	247	16	and	and	CCONJ
dpc-4137	247	17	transforming	transform	VERB
dpc-4137	247	18	growth	growth	NOUN
dpc-4137	247	19	factor	factor	NOUN
dpc-4137	247	20	beta(1	beta(1	NOUN
dpc-4137	247	21	)	)	PUNCT
dpc-4137	247	22	and	and	CCONJ
dpc-4137	247	23	beta	beta	NOUN
dpc-4137	247	24	(	(	PUNCT
dpc-4137	247	25	2	2	NUM
dpc-4137	247	26	)	)	PUNCT
dpc-4137	247	27	in	in	ADP
dpc-4137	247	28	plasma	plasma	NOUN
dpc-4137	247	29	and	and	CCONJ
dpc-4137	247	30	scales	scale	NOUN
dpc-4137	247	31	from	from	ADP
dpc-4137	247	32	psoriatic	psoriatic	ADJ
dpc-4137	247	33	lesions	lesion	NOUN
dpc-4137	247	34	.	.	PUNCT
dpc-4137	248	1	cytokine	cytokine	NOUN
dpc-4137	248	2	.	.	PUNCT
dpc-4137	249	1	2002;19:121–125	2002;19:121–125	X
dpc-4137	249	2	.	.	PUNCT
dpc-4137	250	1	25	25	NUM
dpc-4137	250	2	.	.	PUNCT
dpc-4137	251	1	dobrică	dobrică	PROPN
dpc-4137	251	2	ec	ec	PROPN
dpc-4137	251	3	,	,	PUNCT
dpc-4137	251	4	cozma	cozma	PROPN
dpc-4137	251	5	ma	ma	PROPN
dpc-4137	251	6	,	,	PUNCT
dpc-4137	251	7	găman	găman	PROPN
dpc-4137	251	8	ma	ma	PROPN
dpc-4137	251	9	,	,	PUNCT
dpc-4137	251	10	voiculescu	voiculescu	PROPN
dpc-4137	251	11	vm	vm	PROPN
dpc-4137	251	12	,	,	PUNCT
dpc-4137	251	13	găman	găman	NOUN
dpc-4137	251	14	am	be	AUX
dpc-4137	251	15	.	.	PUNCT
dpc-4137	252	1	the	the	DET
dpc-4137	252	2	involvement	involvement	NOUN
dpc-4137	252	3	of	of	ADP
dpc-4137	252	4	oxidative	oxidative	ADJ
dpc-4137	252	5	stress	stress	NOUN
dpc-4137	252	6	in	in	ADP
dpc-4137	252	7	psoriasis	psoriasis	NOUN
dpc-4137	252	8	:	:	PUNCT
dpc-4137	252	9	a	a	DET
dpc-4137	252	10	systematic	systematic	ADJ
dpc-4137	252	11	review	review	NOUN
dpc-4137	252	12	.	.	PUNCT
dpc-4137	253	1	antioxidants	antioxidant	NOUN
dpc-4137	253	2	(	(	PUNCT
dpc-4137	253	3	basel	basel	PROPN
dpc-4137	253	4	)	)	PUNCT
dpc-4137	253	5	.	.	PUNCT
dpc-4137	254	1	2022	2022	NUM
dpc-4137	254	2	;	;	PUNCT
dpc-4137	254	3	11:282	11:282	NUM
dpc-4137	254	4	.	.	PUNCT
dpc-4137	255	1	26	26	NUM
dpc-4137	255	2	.	.	PUNCT
dpc-4137	256	1	wang	wang	PROPN
dpc-4137	256	2	z	z	PROPN
dpc-4137	256	3	,	,	PUNCT
dpc-4137	256	4	zhou	zhou	PROPN
dpc-4137	256	5	h	h	PROPN
dpc-4137	256	6	,	,	PUNCT
dpc-4137	256	7	zheng	zheng	PROPN
dpc-4137	256	8	h	h	PROPN
dpc-4137	256	9	,	,	PUNCT
dpc-4137	256	10	et	et	PROPN
dpc-4137	256	11	al	al	PROPN
dpc-4137	256	12	.	.	PUNCT
dpc-4137	256	13	autophagy	autophagy	NOUN
dpc-4137	256	14	-	-	PUNCT
dpc-4137	256	15	based	base	VERB
dpc-4137	256	16	unconventional	unconventional	ADJ
dpc-4137	256	17	secretion	secretion	NOUN
dpc-4137	256	18	of	of	ADP
dpc-4137	256	19	hmgb1	hmgb1	NOUN
dpc-4137	256	20	by	by	ADP
dpc-4137	256	21	keratinocytes	keratinocyte	NOUN
dpc-4137	256	22	plays	play	VERB
dpc-4137	256	23	a	a	DET
dpc-4137	256	24	pivotal	pivotal	ADJ
dpc-4137	256	25	role	role	NOUN
dpc-4137	256	26	in	in	ADP
dpc-4137	256	27	psoriatic	psoriatic	ADJ
dpc-4137	256	28	skin	skin	NOUN
dpc-4137	256	29	inflammation	inflammation	NOUN
dpc-4137	256	30	.	.	PUNCT
dpc-4137	257	1	autophagy	autophagy	NOUN
dpc-4137	257	2	.	.	PUNCT
dpc-4137	258	1	2021;17:529	2021;17:529	ADV
dpc-4137	258	2	-	-	SYM
dpc-4137	258	3	552	552	NUM
dpc-4137	258	4	.	.	PUNCT
dpc-4137	259	1	27	27	NUM
dpc-4137	259	2	.	.	PUNCT
dpc-4137	260	1	wu	wu	PROPN
dpc-4137	260	2	dj	dj	PROPN
dpc-4137	260	3	,	,	PUNCT
dpc-4137	260	4	adamopoulos	adamopoulos	ADV
dpc-4137	260	5	ie	ie	ADJ
dpc-4137	260	6	.	.	PUNCT
dpc-4137	261	1	autophagy	autophagy	NOUN
dpc-4137	261	2	and	and	CCONJ
dpc-4137	261	3	autoimmunity	autoimmunity	NOUN
dpc-4137	261	4	.	.	PUNCT
dpc-4137	262	1	clin	clin	PROPN
dpc-4137	262	2	immunol	immunol	NOUN
dpc-4137	262	3	.	.	PUNCT
dpc-4137	263	1	2017;176:55	2017;176:55	NUM
dpc-4137	263	2	-	-	PUNCT
dpc-4137	263	3	62	62	NUM
dpc-4137	263	4	.	.	PUNCT
dpc-4137	264	1	28	28	NUM
dpc-4137	264	2	.	.	X
dpc-4137	265	1	zhang	zhang	PROPN
dpc-4137	265	2	,	,	PUNCT
dpc-4137	265	3	d.	d.	PROPN
dpc-4137	265	4	,	,	PUNCT
dpc-4137	265	5	li	li	PROPN
dpc-4137	265	6	,	,	PUNCT
dpc-4137	265	7	y.	y.	PROPN
dpc-4137	265	8	,	,	PUNCT
dpc-4137	265	9	du	du	PROPN
dpc-4137	265	10	,	,	PUNCT
dpc-4137	265	11	c	c	X
dpc-4137	265	12	,	,	PUNCT
dpc-4137	265	13	et	et	PROPN
dpc-4137	265	14	al	al	PROPN
dpc-4137	265	15	.	.	PROPN
dpc-4137	265	16	evidence	evidence	NOUN
dpc-4137	265	17	of	of	ADP
dpc-4137	265	18	pyroptosis	pyroptosis	NOUN
dpc-4137	265	19	and	and	CCONJ
dpc-4137	265	20	ferroptosis	ferroptosis	NOUN
dpc-4137	265	21	extensively	extensively	ADV
dpc-4137	265	22	involved	involve	VERB
dpc-4137	265	23	in	in	ADP
dpc-4137	265	24	autoimmune	autoimmune	ADJ
dpc-4137	265	25	diseases	disease	NOUN
dpc-4137	265	26	at	at	ADP
dpc-4137	265	27	the	the	DET
dpc-4137	265	28	single	single	ADJ
dpc-4137	265	29	-	-	PUNCT
dpc-4137	265	30	cell	cell	NOUN
dpc-4137	265	31	transcriptome	transcriptome	ADJ
dpc-4137	265	32	level	level	NOUN
dpc-4137	265	33	.	.	PUNCT
dpc-4137	266	1	j	j	PROPN
dpc-4137	266	2	transl	transl	PROPN
dpc-4137	266	3	med	me	VERB
dpc-4137	266	4	2022	2022	NUM
dpc-4137	266	5	;	;	PUNCT
dpc-4137	266	6	20:363	20:363	NUM
dpc-4137	266	7	.	.	PUNCT
dpc-4137	267	1	29	29	NUM
dpc-4137	267	2	.	.	PUNCT
dpc-4137	268	1	knorr	knorr	PROPN
dpc-4137	268	2	j	j	PROPN
dpc-4137	268	3	,	,	PUNCT
dpc-4137	268	4	wree	wree	X
dpc-4137	268	5	a	a	PRON
dpc-4137	268	6	,	,	PUNCT
dpc-4137	268	7	feldstein	feldstein	PROPN
dpc-4137	268	8	ae	ae	PROPN
dpc-4137	268	9	.	.	PUNCT
dpc-4137	269	1	pyroptosis	pyroptosis	PROPN
dpc-4137	269	2	in	in	ADP
dpc-4137	269	3	steatohepatitis	steatohepatitis	NOUN
dpc-4137	269	4	and	and	CCONJ
dpc-4137	269	5	liver	liver	NOUN
dpc-4137	269	6	diseases	disease	NOUN
dpc-4137	269	7	.	.	PUNCT
dpc-4137	270	1	j	j	PROPN
dpc-4137	270	2	mol	mol	ADP
dpc-4137	270	3	biol	biol	PROPN
dpc-4137	270	4	.	.	PUNCT
dpc-4137	271	1	2022;434:167271	2022;434:167271	NUM
dpc-4137	271	2	.	.	PUNCT
dpc-4137	272	1	30	30	NUM
dpc-4137	272	2	.	.	PUNCT
dpc-4137	273	1	wang	wang	PROPN
dpc-4137	273	2	j	j	PROPN
dpc-4137	273	3	,	,	PUNCT
dpc-4137	273	4	huang	huang	PROPN
dpc-4137	273	5	z	z	PROPN
dpc-4137	273	6	,	,	PUNCT
dpc-4137	273	7	lu	lu	PROPN
dpc-4137	273	8	h	h	NOUN
dpc-4137	273	9	,	,	PUNCT
dpc-4137	273	10	zhang	zhang	PROPN
dpc-4137	273	11	r	r	PROPN
dpc-4137	273	12	,	,	PUNCT
dpc-4137	273	13	feng	feng	PROPN
dpc-4137	273	14	q	q	AUX
dpc-4137	273	15	,	,	PUNCT
dpc-4137	273	16	he	he	PRON
dpc-4137	273	17	a.	a.	VERB
dpc-4137	273	18	a	a	DET
dpc-4137	273	19	pyroptosis	pyroptosis	NOUN
dpc-4137	273	20	related	relate	VERB
dpc-4137	273	21	gene	gene	NOUN
dpc-4137	273	22	signature	signature	NOUN
dpc-4137	273	23	to	to	PART
dpc-4137	273	24	predict	predict	VERB
dpc-4137	273	25	patients	patient	NOUN
dpc-4137	273	26	’	'	PUNCT
dpc-4137	273	27	prognosis	prognosis	NOUN
dpc-4137	273	28	and	and	CCONJ
dpc-4137	273	29	immune	immune	ADJ
dpc-4137	273	30	landscape	landscape	NOUN
dpc-4137	273	31	in	in	ADP
dpc-4137	273	32	liver	liver	NOUN
dpc-4137	273	33	hepatocellular	hepatocellular	ADJ
dpc-4137	273	34	carcinoma	carcinoma	NOUN
dpc-4137	273	35	.	.	PUNCT
dpc-4137	274	1	comput	comput	PROPN
dpc-4137	274	2	math	math	NOUN
dpc-4137	274	3	methods	method	NOUN
dpc-4137	274	4	med	me	VERB
dpc-4137	274	5	.	.	PUNCT
dpc-4137	275	1	2022	2022	NUM
dpc-4137	275	2	feb	feb	PROPN
dpc-4137	275	3	16;2022:1258480	16;2022:1258480	PROPN
dpc-4137	275	4	.	.	PROPN
dpc-4137	275	5	9	9	NUM
dpc-4137	275	6	.	.	PUNCT
dpc-4137	276	1	rogers	rogers	PROPN
dpc-4137	276	2	c	c	PROPN
dpc-4137	276	3	,	,	PUNCT
dpc-4137	276	4	alnemri	alnemri	NOUN
dpc-4137	276	5	es	es	NOUN
dpc-4137	276	6	.	.	PROPN
dpc-4137	276	7	gasdermins	gasdermin	VERB
dpc-4137	276	8	in	in	ADP
dpc-4137	276	9	apoptosis	apoptosis	NOUN
dpc-4137	276	10	:	:	PUNCT
dpc-4137	276	11	new	new	ADJ
dpc-4137	276	12	players	player	NOUN
dpc-4137	276	13	in	in	ADP
dpc-4137	276	14	an	an	DET
dpc-4137	276	15	old	old	ADJ
dpc-4137	276	16	game	game	NOUN
dpc-4137	276	17	.	.	PUNCT
dpc-4137	277	1	yale	yale	PROPN
dpc-4137	277	2	j	j	PROPN
dpc-4137	277	3	biol	biol	PROPN
dpc-4137	277	4	med	me	VERB
dpc-4137	277	5	.	.	PUNCT
dpc-4137	278	1	2019;92:603	2019;92:603	PROPN
dpc-4137	278	2	-	-	SYM
dpc-4137	278	3	617	617	NUM
dpc-4137	278	4	.	.	NOUN
dpc-4137	278	5	10	10	NUM
dpc-4137	278	6	.	.	PUNCT
dpc-4137	279	1	kovacs	kovacs	PROPN
dpc-4137	279	2	sb	sb	PROPN
dpc-4137	279	3	,	,	PUNCT
dpc-4137	279	4	miao	miao	PROPN
dpc-4137	279	5	ea	ea	PROPN
dpc-4137	279	6	.	.	PUNCT
dpc-4137	280	1	gasdermins	gasdermin	VERB
dpc-4137	280	2	:	:	PUNCT
dpc-4137	280	3	effectors	effector	NOUN
dpc-4137	280	4	of	of	ADP
dpc-4137	280	5	pyroptosis	pyroptosis	NOUN
dpc-4137	280	6	.	.	PUNCT
dpc-4137	281	1	trends	trend	NOUN
dpc-4137	281	2	cell	cell	NOUN
dpc-4137	281	3	biol	biol	NOUN
dpc-4137	281	4	.	.	PUNCT
dpc-4137	282	1	2017;27:673	2017;27:673	NUM
dpc-4137	282	2	-	-	SYM
dpc-4137	282	3	684	684	NUM
dpc-4137	282	4	.	.	PUNCT
dpc-4137	283	1	11	11	NUM
dpc-4137	283	2	.	.	PUNCT
dpc-4137	284	1	zou	zou	PROPN
dpc-4137	284	2	j	j	PROPN
dpc-4137	284	3	,	,	PUNCT
dpc-4137	284	4	zheng	zheng	PROPN
dpc-4137	284	5	y	y	PROPN
dpc-4137	284	6	,	,	PUNCT
dpc-4137	284	7	huang	huang	PROPN
dpc-4137	284	8	y	y	PROPN
dpc-4137	284	9	,	,	PUNCT
dpc-4137	284	10	tang	tang	X
dpc-4137	285	1	d	d	NOUN
dpc-4137	285	2	,	,	PUNCT
dpc-4137	285	3	kang	kang	PROPN
dpc-4137	285	4	r	r	PROPN
dpc-4137	285	5	,	,	PUNCT
dpc-4137	285	6	chen	chen	PROPN
dpc-4137	285	7	r.	r.	PROPN
dpc-4137	285	8	the	the	DET
dpc-4137	285	9	versatile	versatile	ADJ
dpc-4137	285	10	gasdermin	gasdermin	ADJ
dpc-4137	285	11	family	family	NOUN
dpc-4137	285	12	:	:	PUNCT
dpc-4137	285	13	their	their	PRON
dpc-4137	285	14	function	function	NOUN
dpc-4137	285	15	and	and	CCONJ
dpc-4137	285	16	roles	role	NOUN
dpc-4137	285	17	in	in	ADP
dpc-4137	285	18	diseases	disease	NOUN
dpc-4137	285	19	.	.	PUNCT
dpc-4137	286	1	front	front	ADJ
dpc-4137	286	2	immunol	immunol	NOUN
dpc-4137	286	3	.	.	PUNCT
dpc-4137	287	1	2021;12:751533	2021;12:751533	NUM
dpc-4137	287	2	.	.	PROPN
dpc-4137	287	3	12	12	NUM
dpc-4137	287	4	.	.	PUNCT
dpc-4137	288	1	kuc	kuc	NOUN
dpc-4137	288	2	-	-	PUNCT
dpc-4137	288	3	ciepluch	ciepluch	ADJ
dpc-4137	288	4	d	d	NOUN
dpc-4137	288	5	,	,	PUNCT
dpc-4137	288	6	ciepluch	ciepluch	ADJ
dpc-4137	288	7	k	k	NOUN
dpc-4137	288	8	,	,	PUNCT
dpc-4137	288	9	arabski	arabski	ADJ
dpc-4137	288	10	m.	m.	NOUN
dpc-4137	288	11	gasdermin	gasdermin	NOUN
dpc-4137	288	12	family	family	NOUN
dpc-4137	288	13	proteins	protein	NOUN
dpc-4137	288	14	as	as	ADP
dpc-4137	288	15	a	a	DET
dpc-4137	288	16	permeabilization	permeabilization	NOUN
dpc-4137	288	17	factor	factor	NOUN
dpc-4137	288	18	of	of	ADP
dpc-4137	288	19	cell	cell	NOUN
dpc-4137	288	20	membrane	membrane	NOUN
dpc-4137	288	21	in	in	ADP
dpc-4137	288	22	pyroptosis	pyroptosis	NOUN
dpc-4137	288	23	process	process	NOUN
dpc-4137	288	24	.	.	PUNCT
dpc-4137	289	1	postepy	postepy	PROPN
dpc-4137	289	2	hig	hig	PROPN
dpc-4137	289	3	med	med	PROPN
dpc-4137	289	4	dosw	dosw	PROPN
dpc-4137	289	5	2021;75:337	2021;75:337	PROPN
dpc-4137	289	6	-	-	PUNCT
dpc-4137	289	7	344	344	NUM
dpc-4137	289	8	.	.	NOUN
dpc-4137	289	9	13	13	NUM
dpc-4137	289	10	.	.	PUNCT
dpc-4137	290	1	lunny	lunny	PROPN
dpc-4137	290	2	dp	dp	PROPN
dpc-4137	290	3	,	,	PUNCT
dpc-4137	290	4	weed	weed	VERB
dpc-4137	290	5	e	e	NOUN
dpc-4137	290	6	,	,	PUNCT
dpc-4137	290	7	nolan	nolan	PROPN
dpc-4137	290	8	pm	pm	PROPN
dpc-4137	290	9	,	,	PUNCT
dpc-4137	290	10	marquardt	marquardt	PROPN
dpc-4137	290	11	a	a	PROPN
dpc-4137	290	12	,	,	PUNCT
dpc-4137	290	13	augustin	augustin	PROPN
dpc-4137	290	14	m	m	PROPN
dpc-4137	290	15	,	,	PUNCT
dpc-4137	290	16	porter	porter	PROPN
dpc-4137	290	17	rm	rm	PROPN
dpc-4137	290	18	.	.	PUNCT
dpc-4137	291	1	mutations	mutation	NOUN
dpc-4137	291	2	in	in	ADP
dpc-4137	291	3	gasdermin	gasdermin	NOUN
dpc-4137	291	4	3	3	NUM
dpc-4137	291	5	cause	cause	VERB
dpc-4137	291	6	aberrant	aberrant	ADJ
dpc-4137	291	7	differentiation	differentiation	NOUN
dpc-4137	291	8	of	of	ADP
dpc-4137	291	9	the	the	DET
dpc-4137	291	10	hair	hair	NOUN
dpc-4137	291	11	follicle	follicle	NOUN
dpc-4137	291	12	and	and	CCONJ
dpc-4137	291	13	sebaceous	sebaceous	ADJ
dpc-4137	291	14	gland	gland	NOUN
dpc-4137	291	15	.	.	PUNCT
dpc-4137	292	1	j	j	PROPN
dpc-4137	292	2	invest	invest	VERB
dpc-4137	292	3	dermatol	dermatol	NOUN
dpc-4137	292	4	.	.	PUNCT
dpc-4137	293	1	2005;124:615	2005;124:615	NUM
dpc-4137	293	2	-	-	SYM
dpc-4137	293	3	21	21	NUM
dpc-4137	293	4	.	.	PUNCT
dpc-4137	294	1	14	14	NUM
dpc-4137	294	2	.	.	PUNCT
dpc-4137	295	1	liu	liu	PROPN
dpc-4137	295	2	x	x	PROPN
dpc-4137	295	3	,	,	PUNCT
dpc-4137	295	4	xia	xia	PROPN
dpc-4137	295	5	s	s	PROPN
dpc-4137	295	6	,	,	PUNCT
dpc-4137	295	7	zhang	zhang	PROPN
dpc-4137	295	8	z	z	PROPN
dpc-4137	295	9	,	,	PUNCT
dpc-4137	295	10	wu	wu	PROPN
dpc-4137	295	11	h	h	PROPN
dpc-4137	295	12	,	,	PUNCT
dpc-4137	295	13	lieberman	lieberman	PROPN
dpc-4137	295	14	j.	j.	PROPN
dpc-4137	295	15	channelling	channel	VERB
dpc-4137	295	16	inflammation	inflammation	NOUN
dpc-4137	295	17	:	:	PUNCT
dpc-4137	295	18	gasdermins	gasdermin	VERB
dpc-4137	295	19	in	in	ADP
dpc-4137	295	20	physiology	physiology	NOUN
dpc-4137	295	21	and	and	CCONJ
dpc-4137	295	22	disease	disease	NOUN
dpc-4137	295	23	.	.	PUNCT
dpc-4137	296	1	nat	nat	PROPN
dpc-4137	296	2	rev	rev	VERB
dpc-4137	296	3	drug	drug	NOUN
dpc-4137	296	4	discov	discov	NOUN
dpc-4137	296	5	.	.	PUNCT
dpc-4137	297	1	2021;20:384	2021;20:384	NUM
dpc-4137	297	2	-	-	SYM
dpc-4137	297	3	405	405	NUM
dpc-4137	297	4	.	.	PUNCT
dpc-4137	298	1	15	15	NUM
dpc-4137	298	2	.	.	PUNCT
dpc-4137	299	1	li	li	PROPN
dpc-4137	299	2	l	l	PROPN
dpc-4137	299	3	,	,	PUNCT
dpc-4137	299	4	kovacs	kovacs	PROPN
dpc-4137	299	5	sb	sb	PROPN
dpc-4137	299	6	,	,	PUNCT
dpc-4137	299	7	jørgensen	jørgensen	PROPN
dpc-4137	299	8	i	i	PROPN
dpc-4137	299	9	,	,	PUNCT
dpc-4137	299	10	larson	larson	PROPN
dpc-4137	299	11	hn	hn	PROPN
dpc-4137	299	12	,	,	PUNCT
dpc-4137	299	13	lazear	lazear	VERB
dpc-4137	299	14	hm	hm	INTJ
dpc-4137	299	15	,	,	PUNCT
dpc-4137	299	16	miao	miao	PROPN
dpc-4137	299	17	ea	ea	PROPN
dpc-4137	299	18	.	.	PUNCT
dpc-4137	300	1	role	role	NOUN
dpc-4137	300	2	of	of	ADP
dpc-4137	300	3	caspases	caspase	NOUN
dpc-4137	300	4	and	and	CCONJ
dpc-4137	300	5	gasdermin	gasdermin	VERB
dpc-4137	300	6	a	a	PRON
dpc-4137	300	7	during	during	ADP
dpc-4137	300	8	hsv-1	hsv-1	X
dpc-4137	300	9	infection	infection	NOUN
dpc-4137	300	10	in	in	ADP
dpc-4137	300	11	mice	mouse	NOUN
dpc-4137	300	12	.	.	PUNCT
dpc-4137	301	1	viruses	virus	NOUN
dpc-4137	301	2	.	.	PUNCT
dpc-4137	302	1	2022;14:2034	2022;14:2034	NUM
dpc-4137	302	2	.	.	NOUN
dpc-4137	302	3	16	16	NUM
dpc-4137	302	4	.	.	PUNCT
dpc-4137	303	1	deng	deng	PROPN
dpc-4137	303	2	w	w	PROPN
dpc-4137	303	3	,	,	PUNCT
dpc-4137	303	4	bai	bai	PROPN
dpc-4137	303	5	y	y	PROPN
dpc-4137	303	6	,	,	PUNCT
dpc-4137	303	7	deng	deng	PROPN
dpc-4137	303	8	f	f	PROPN
dpc-4137	303	9	,	,	PUNCT
dpc-4137	303	10	et	et	PROPN
dpc-4137	303	11	al	al	PROPN
dpc-4137	303	12	.	.	PROPN
dpc-4137	303	13	streptococcal	streptococcal	PROPN
dpc-4137	303	14	pyrogenic	pyrogenic	PROPN
dpc-4137	303	15	exotoxin	exotoxin	PROPN
dpc-4137	303	16	b	b	PROPN
dpc-4137	303	17	cleaves	cleave	VERB
dpc-4137	303	18	gsdma	gsdma	NOUN
dpc-4137	303	19	and	and	CCONJ
dpc-4137	303	20	triggers	trigger	NOUN
dpc-4137	303	21	pyroptosis	pyroptosis	NOUN
dpc-4137	303	22	.	.	PUNCT
dpc-4137	304	1	nature	nature	NOUN
dpc-4137	304	2	.	.	PUNCT
dpc-4137	305	1	2022;602	2022;602	NUM
dpc-4137	305	2	:	:	PUNCT
dpc-4137	305	3	496	496	NUM
dpc-4137	305	4	-	-	SYM
dpc-4137	305	5	502	502	NUM
dpc-4137	305	6	.	.	PUNCT
dpc-4137	306	1	17	17	NUM
dpc-4137	306	2	.	.	PUNCT
dpc-4137	307	1	söderman	söderman	PROPN
dpc-4137	307	2	j	j	PROPN
dpc-4137	307	3	,	,	PUNCT
dpc-4137	307	4	berglind	berglind	ADP
dpc-4137	307	5	l	l	PROPN
dpc-4137	307	6	,	,	PUNCT
dpc-4137	307	7	almer	almer	PROPN
dpc-4137	307	8	s.	s.	PROPN
dpc-4137	307	9	gene	gene	PROPN
dpc-4137	307	10	expression	expression	NOUN
dpc-4137	307	11	-	-	PUNCT
dpc-4137	307	12	genotype	genotype	NOUN
dpc-4137	307	13	analysis	analysis	NOUN
dpc-4137	307	14	implicates	implicate	VERB
dpc-4137	307	15	gsdma	gsdma	NOUN
dpc-4137	307	16	,	,	PUNCT
dpc-4137	307	17	gsdmb	gsdmb	NOUN
dpc-4137	307	18	,	,	PUNCT
dpc-4137	307	19	and	and	CCONJ
dpc-4137	307	20	lrrc3c	lrrc3c	PROPN
dpc-4137	307	21	as	as	ADP
dpc-4137	307	22	contributors	contributor	NOUN
dpc-4137	307	23	to	to	ADP
dpc-4137	307	24	inflammatory	inflammatory	ADJ
dpc-4137	307	25	bowel	bowel	NOUN
dpc-4137	307	26	disease	disease	NOUN
dpc-4137	307	27	susceptibility	susceptibility	NOUN
dpc-4137	307	28	.	.	PUNCT
dpc-4137	308	1	biomed	biome	VERB
dpc-4137	308	2	res	re	NOUN
dpc-4137	308	3	int	int	NOUN
dpc-4137	308	4	.	.	PUNCT
dpc-4137	309	1	2015;2015:834805	2015;2015:834805	NUM
dpc-4137	309	2	.	.	NOUN
dpc-4137	310	1	18	18	NUM
dpc-4137	310	2	.	.	PUNCT
dpc-4137	310	3	terao	terao	NOUN
dpc-4137	310	4	c	c	PROPN
dpc-4137	310	5	,	,	PUNCT
dpc-4137	310	6	kawaguchi	kawaguchi	PROPN
dpc-4137	310	7	t	t	PROPN
dpc-4137	310	8	,	,	PUNCT
dpc-4137	310	9	dieude	dieude	VERB
dpc-4137	310	10	p	p	NOUN
dpc-4137	310	11	,	,	PUNCT
dpc-4137	310	12	et	et	PROPN
dpc-4137	310	13	al	al	PROPN
dpc-4137	310	14	.	.	PUNCT
dpc-4137	311	1	transethnic	transethnic	ADJ
dpc-4137	311	2	metaanalysis	metaanalysis	NOUN
dpc-4137	311	3	identifies	identify	VERB
dpc-4137	311	4	gsdma	gsdma	NOUN
dpc-4137	311	5	and	and	CCONJ
dpc-4137	311	6	prdm1	prdm1	NOUN
dpc-4137	311	7	as	as	ADP
dpc-4137	311	8	susceptibility	susceptibility	NOUN
dpc-4137	311	9	genes	gene	NOUN
dpc-4137	311	10	to	to	ADP
dpc-4137	311	11	systemic	systemic	ADJ
dpc-4137	311	12	sclerosis	sclerosis	NOUN
dpc-4137	311	13	.	.	PUNCT
dpc-4137	312	1	ann	ann	PROPN
dpc-4137	312	2	rheum	rheum	PROPN
dpc-4137	312	3	dis	dis	PROPN
dpc-4137	312	4	.	.	PUNCT
dpc-4137	313	1	2017;76:1150	2017;76:1150	NUM
dpc-4137	313	2	-	-	SYM
dpc-4137	313	3	1158	1158	NUM
dpc-4137	313	4	.	.	PUNCT
dpc-4137	314	1	19	19	NUM
dpc-4137	314	2	.	.	NUM
dpc-4137	314	3	yu	yu	PROPN
dpc-4137	314	4	j	j	PROPN
dpc-4137	314	5	,	,	PUNCT
dpc-4137	314	6	kang	kang	PROPN
dpc-4137	314	7	mj	mj	PROPN
dpc-4137	314	8	,	,	PUNCT
dpc-4137	314	9	kim	kim	PROPN
dpc-4137	314	10	bj	bj	PROPN
dpc-4137	314	11	,	,	PUNCT
dpc-4137	314	12	et	et	PROPN
dpc-4137	314	13	al	al	PROPN
dpc-4137	314	14	.	.	PUNCT
dpc-4137	314	15	polymorphisms	polymorphism	NOUN
dpc-4137	314	16	in	in	ADP
dpc-4137	314	17	gsdma	gsdma	NOUN
dpc-4137	314	18	and	and	CCONJ
dpc-4137	314	19	gsdmb	gsdmb	NOUN
dpc-4137	314	20	are	be	AUX
dpc-4137	314	21	associated	associate	VERB
dpc-4137	314	22	with	with	ADP
dpc-4137	314	23	asthma	asthma	NOUN
dpc-4137	314	24	susceptibility	susceptibility	NOUN
dpc-4137	314	25	,	,	PUNCT
dpc-4137	314	26	atopy	atopy	NOUN
dpc-4137	314	27	and	and	CCONJ
dpc-4137	314	28	bhr	bhr	PROPN
dpc-4137	314	29	.	.	PUNCT
dpc-4137	314	30	pediatr	pediatr	PROPN
dpc-4137	314	31	pulmonol	pulmonol	NOUN
dpc-4137	314	32	.	.	PUNCT
dpc-4137	315	1	2011;46:701	2011;46:701	NOUN
dpc-4137	315	2	-	-	SYM
dpc-4137	315	3	8	8	NUM
dpc-4137	315	4	.	.	NOUN
dpc-4137	315	5	20	20	NUM
dpc-4137	315	6	.	.	PUNCT
dpc-4137	316	1	lin	lin	PROPN
dpc-4137	316	2	hy	hy	PROPN
dpc-4137	316	3	,	,	PUNCT
dpc-4137	316	4	lin	lin	PROPN
dpc-4137	316	5	ph	ph	PROPN
dpc-4137	316	6	,	,	PUNCT
dpc-4137	316	7	wu	wu	PROPN
dpc-4137	316	8	sh	sh	PROPN
dpc-4137	316	9	,	,	PUNCT
dpc-4137	316	10	yang	yang	PROPN
dpc-4137	316	11	lt	lt	PROPN
dpc-4137	316	12	.	.	PROPN
dpc-4137	316	13	inducible	inducible	ADJ
dpc-4137	316	14	expression	expression	NOUN
dpc-4137	316	15	of	of	ADP
dpc-4137	316	16	gasdermin	gasdermin	ADJ
dpc-4137	316	17	a3	a3	NOUN
dpc-4137	316	18	in	in	ADP
dpc-4137	316	19	the	the	DET
dpc-4137	316	20	epidermis	epidermis	NOUN
dpc-4137	316	21	causes	cause	VERB
dpc-4137	316	22	epidermal	epidermal	ADJ
dpc-4137	316	23	hyperplasia	hyperplasia	NOUN
dpc-4137	316	24	and	and	CCONJ
dpc-4137	316	25	skin	skin	NOUN
dpc-4137	316	26	inflammation	inflammation	NOUN
dpc-4137	316	27	.	.	PUNCT
dpc-4137	317	1	exp	exp	NOUN
dpc-4137	317	2	dermatol	dermatol	NOUN
dpc-4137	317	3	.	.	PUNCT
dpc-4137	318	1	2015;24:897	2015;24:897	X
dpc-4137	318	2	-	-	PUNCT
dpc-4137	318	3	9	9	NUM
dpc-4137	318	4	.	.	PUNCT